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 ABBREVIATIONS 
 
3H-uridine incorporation   an indicator of proliferation 
ALS     acid-labile subunit 
ASARM motif   acidic-serine-aspartate-rich-MEPE 
ATA2     amino acid transporter system A 
BF     bone formation 
BMD     bone mineral density 
BMPs     bone morphogenetic proteins 
Bone Gla protein   osteocalcin 
cAMP     cyclic adenosine monophosphate 
cGMP     cyclic guanosine monophosphate 
CKM     creatine kinase (muscle form) 
COX-2 cyclooxygenase-2, an inducible isoform of 
prostaglandin G/H synthase 
CSF     cerebrospinal fluid 
E12     immunoglobulin enhancer-binding factor 
ECM     extracellular matrix 
ecNOS    endothelial constitutive NO synthase 
Endocortical osteocytes osteocytes situated in the cortex near the endosteal 
side of the shaft 
Endosteal side of shaft  inner side of shaft 
G6PD     glucose 6-phosphate dehydrogenase 
GAPDH    glyceraldehyde-3-phosphate dehydrogenase 
GARNL1    GTPase activating RANGAP domain-like 1 
GH     growth hormone 
GH-IGF-system   growth hormone-insulin-like growth factor system 
GLAST    glutamate/aspartate transporter 
GRIPE     GAP-related interacting protein to E12  
IGF-I     insulin-like growth factor-I 
IGF-II     insulin-like growth factor-II 
IGFBPs    insulin-like growth factor binding proteins 1-6 
LOAD loaded tibia: a combination of bending and squeezing 
of the tibia 
MAR     mineral apposition rate 
MEPE     matrix extracellular phosphoglycoprotein 
MS/BS mineralizing surface expressed as a percentage of                   
the bone surface 
NO     nitric oxide 
Ob     osteoblast 
Ocyt     osteocyte 
OF45     osteoblast/osteocyte factor 45 
Periosteal side of shaft outer side of shaft which is covered with the 
periosteum 
PF     periosteal fibroblast 
PGE2     prostaglandin E2 
PGF2α     prostaglandin F2α 
PGI2     prostacyclin 
PHEX phosphate regulating gene with homologies to 
endopeptidases on the X chromosome (XLH) 
PBGD     housekeeping gene porphobilinogen deaminase 
RGD motif    arginine-glycine-asparagine motif 
SERMs    selective estrogen receptor modulators 
SHAM     sham-loaded tibia: leading to squeezing of the tibia 
TGF-β    transforming growth factor-β 
TULIP1    tuberin-like protein 1 
V2R2B tissue-type vomeronasal neurons putative 
pheromone receptor 
XLH     X-linked hypophosphatemia 
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GENERAL INTRODUCTION 
 
Mechanical loading plays a major role in the maintenance of the skeleton. Disuse or 
unloading is an important cause of osteoporosis. The consequences of osteoporosis, 
fractures of the hip, wrist, vertebra, humerus and other bones have a severe impact 
on the individual and society. Physical activity is one of the components to treat 
osteoporosis. Mechanosensitive genes play an important role in the translation of 
mechanical stimuli into bone formation. Knowledge of mechanosensitive genes will 
lead to a better understanding of the osteogenic response or, in other words, the 
process of bone formation after mechanical stimulation. Hopefully, this leads to an 
improvement of the current or alternative better treatment modalities of 
osteoporosis. 
This thesis focuses on the effect of a single mechanical loading session on 
gene expression in bone, and on the effect of IGF-II overexpression in brain. In this 
chapter the process of bone remodeling, bone cell biology, and osteoporosis are 
introduced. Because the growth hormone-insulin-like growth factor (GH-IGF)-system 
probably plays an important role during bone formation a short overview of the 
IGF-system is subsequently given. At the end of the introduction the effects of 
mechanical loading on bone and animal models to study the effects of mechanical 
loading are discussed. The final part comprises the outline of this thesis. 
 
BONE REMODELING AND BONE CELL BIOLOGY 
 
Throughout life bone remodeling occurs in order to maintain and repair the skeletal 
system, which has important biomechanical and metabolic functions. Maintenance of 
body shape, protection of vital organs, attachment of muscles, and enablement of 
locomotion are the main functions of the skeleton. In addition bone provides a 
reservoir for calcium and phosphate and serves as storage for bone marrow cells. The 
skeletal system is able to withstand functional loads without either breaking or 
suffering extensive damage, because bones have evolved the capacity to adapt to their 
habitual loading environment (Goodship et al. 1979; Rubin 1984; Lanyon 1984). When 
a mechanical load is applied to the skeleton, it will influence the bone structure 
according to Wolff’s law (Wolff 1986). Disruption of the bone remodeling will lead to 
a poorly functioning skeleton. 
The skeletal system consists of cortical (compact) and trabecular (spongious 
or cancellous) bone, which are arranged in the axial and the appendicular skeleton, 
according to functional demands. At the microscopic level cortical bone is composed 
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of concentric lamellae which form the osteons (Haversian system). The trabecular 
bone is a framework of bone plates and rods with inner space for the bone marrow. 
Tubular bones (e.g. tibia, humerus, and femur) contain cortical bone, which is mainly 
located in the diaphysis, and trabecular bone, which is present in the metaphysis and 
epiphysis (Figure 1.1A). 
Bone remodeling is a complex process of bone resorption by osteoclasts 
followed by formation of new bone by osteoblasts (Parfitt 1982). Osteoclasts dissolve 
the mineral and organic components of the bone matrix. An active osteoclast is 
characterized by its giant size, a ruffled border and multiple nuclei. The precursors of 
osteoclasts are derived from cells in the mononuclear/phagocytic lineage of the 
hematopoietic marrow. After bone resorption, a new bone matrix is formed and 
subsequently mineralized. The osteoblasts are responsible for bone formation and 
have a cylindrical shape and a large nucleus, while they are active (Figure 1.1B).  
Collagen and non-collagenous matrix proteins constitute the non-mineralized 
bone matrix or osteoid synthesized by osteoblasts. Osteoblast precursors are derived 
from mesenchymal progenitors/mesenchymal stem cells. An osteoblast will ultimately 
become a bone lining cell on the bone surface, or an osteocyte when it is surrounded 
by the bone matrix, or will die (apoptosis). Osteocytes are located in lacunae of the 
bone matrix and are characterized by a large nucleus (Figure 1.1B) and have the ability 
to be mechanosensitive. They are able to communicate via a network of gap junctions 
and canaliculi between themselves and osteoblasts.  
Bone remodeling is regulated by both systemic hormones and local factors. 
The components of the GH-IGF-system are important systemic and local regulators 
of the bone remodeling (Kasukawa et al. 2004). 
 General introduction 
 15 
 
 
 
Figure 1.1 (A) Schematic diagram of a tibia showing the epiphysis, metaphysis and diaphysis. The 
localization of cortical and trabecular (cancellous) bone are also depicted (From Weiss, L., Ed., Cell 
and Tissue Biology, A Textbook of Histology, Urban and Schwarzenberg, Baltimore, 1988). 
(B) Longitudinal section of the tibia of a rat. This detail of the endosteal side of tibia shaft shows 
osteoblasts (Ob)(indicated by arrows) and osteocytes (Ocyt)(indicated by arrow heads). Photograph 
of in situ hybridization experiment Reijnders. 
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OSTEOPOROSIS 
 
Osteoporosis is a disease which is characterized by a decreased bone mass and a 
deteriorated micro-architecture, leading to enhanced bone fragility and increased 
fracture risk (Burckhardt et al. 1991). Skeletal and extra-skeletal factors are involved 
in the pathogenesis of osteoporotic fractures. The main determinant is a low bone 
mass caused by an imbalance between bone resorption and bone formation and/or a 
low peak bone mass. Other contributing causes are non-environmental factors, such 
as genetic predisposition, programming after birth, hormones, and environmental 
factors like exercise, nutrition, disuse and medication. Bone loss occurs in the post-
menopausal years and/or is caused by age-related factors.  
Regulation of the activity of the osteoclasts and osteoblasts, or, in other 
words, prevention of bone loss and stimulation of bone formation, resulting in an 
increase of the bone mass, are the main therapeutic targets in osteoporosis. Inhibition 
of bone resorption in osteoporotic patients is the main target of the currently 
available drugs such as bisphosphonates or selective estrogen receptor modulators 
(SERMs)(Ettinger et al. 1999). Another approach in the treatment of osteoporosis is 
the use of anabolic agents, which stimulate bone formation, such as the N-terminal 
parathyroid hormone fragment (1-34)(teriparatide)(Neer et al. 2001) and the insulin-
like growth factor-I (IGF-I)(Bagi et al. 1995). Although administration of free rhIGF-I 
has beneficial effects on the markers of bone formation and resorption (Johansson et 
al. 1992), there are severe adverse effects, such as hypoglycemia (Geusens & Boonen 
2002). Several of the current treatments for osteoporosis affect the IGF-system 
indirectly or directly (Rosen et al. 1994). 
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THE INSULIN-LIKE GROWTH FACTOR SYSTEM  
 
The insulin-like growth factor (IGF) system consist of two ligands, IGF-I and IGF-II, 
two IGF receptors, six IGF binding proteins (IGFBP-1 to IGFBP-6) and IGFBP 
proteases. IGF-I is an anabolic polypeptide (7.6 kilodalton) which has structural and 
functional homology with (pro)insulin and insulin-like growth factor-II (IGF-II) 
(Daughaday & Rotwein 1989; Lowe 1991). IGFs are potent mitogenic, anti-apoptotic 
and differentiating promoting growth factors. In most mammals growth hormone 
(GH) induces IGF-I synthesis in the liver and controls IGF-I plasma levels by formation 
of the ALS (acid-labile subunit)/IGFBP-3/IGF-I complex, which stabilizes IGF-I in the 
serum (Salmon, Jr. & Daughaday 1957; Zapf et al. 1984; Le Roith et al. 2001)(Figure 
1.2). Besides, IGF-I is produced by brain (Reijnders et al. 2004), bone, cartilage, 
muscle, and other tissues. The IGF binding proteins (IGFBP-1 to IGFBP-6) are able to 
modulate the bioactivity of IGFs in an endocrine as well as in an autocrine/paracrine 
manner.  
 
Figure 1.2 The somatomedin hypothesis 2001 (Le Roith et al. 2001). 
Bone growth is regulated in a GH-dependent and GH-independent IGF-mediated manner, besides GH 
directly stimulates bone growth (II). 
GH-dependent IGF-I actions (a) are regulated via stimulation of IGF-I production by GH in an 
endocrine fashion via the liver (I) or an autocrine/paracrine fashion via bone (III); GH-independent 
IGF-I-mediated growth acts in an autocrine/paracrine fashion (b). In addition to stimulating IGF-I 
synthesis in the liver, GH also stimulates the formation of IGFBP-3 and the acid-labile subunit, which 
stabilizes IGF-I in the serum. 
 
I 
a/b 
GH 
a 
III 
II 
Bone 
Pituitary 
Liver 
IGF-I IGF-I 
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Brain and IGF-system 
 
The IGFs and IGF binding proteins are widely expressed in the central nervous system 
and play an important role during brain development (D'Ercole et al. 1996; Walter et 
al. 1997; Naeve et al. 2000). In rodents IGF-I is predominantly expressed in neuronal 
cells in the adult, whereas the regional distribution of IGF-II has been shown to be 
mainly restricted to non-neuronal cells like the meninges and the choroid plexus 
(Stylianopoulou et al. 1988; Bondy & Lee 1993; Lee et al. 1993; Logan et al. 1994). 
During brain development, IGF binding proteins are often coexpressed with IGFs, 
thus enabling IGF binding proteins to modulate the actions of IGFs (Leventhal et al. 
1999). So far, it has been shown that IGFBP-2 is mainly colocalized with IGF-II in the 
meninges and the choroid plexus (Logan et al. 1994) and with IGF-I in neuronal 
structures (Lee et al. 1993; Logan et al. 1994), whereas IGFBP-5 has been shown to 
colocalize with IGF-I or in the vicinity of IGF-I producing neurons, suggesting that 
both IGFBP-2 and IGFBP-5 can modulate the action of IGFs (Bondy & Lee 1993). 
 
Bone and IGF-system 
 
According to the somatomedin hypothesis 2001 (Le Roith et al. 2001) bone growth is 
regulated in a GH-dependent and GH-independent IGF-mediated manner. Besides 
bone growth is stimulated directly by GH. IGF-I actions, which are GH-dependent, 
are regulated via stimulation of IGF-I production by GH in an endocrine fashion via 
the liver or in an autocrine/paracrine fashion via bone. GH-independent 
IGF-I-mediated growth acts in an autocrine/paracrine fashion in bone (Figure 1.2). 
In bone, IGFs can be synthesized de novo by bone cells (predominantly 
osteoblasts) and released from stored peptide in the bone matrix. IGFs can act in an 
autocrine/paracrine manner to regulate bone cell specific function. In human bone the 
major produced IGF is IGF-II, whereas in rodents IGF-I is primarily synthesized by the 
bone cells. IGF binding proteins are also produced by bone cells (predominantly by 
osteoblasts)(Conover 1996). IGFBP-2 is the major IGF binding protein, which is 
synthesized by rat osteoblastic cells (Conover 1996). The IGF binding proteins can 
modify the local IGF activity by inhibiting or stimulating the IGF action. IGFBP-4, which 
is locally produced by osteoblasts, has an inhibitory effect on bone metabolism, 
whereas locally synthesized IGFBP-5 by osteoblasts has a stimulatory effect (Mohan et 
al. 1995; Conover 1996; Canalis 1997). However, the effects of IGFBP-4 on 
osteoblasts are IGF-I-dependent, whereas IGFBP-5 probably acts as a store for IGFs in 
bone tissue (Mohan et al. 1995; Conover 1996; Canalis 1997). The IGFBP proteases 
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can regulate the bioavailability of the IGF binding proteins by proteolysis of the 
secreted IGF binding protein (Conover 1996). 
The IGF system plays an important role in bone remodeling. In rats bone 
formation is mainly regulated by IGF-I (Bikle & Halloran 1999). During puberty in 
humans the serum level of IGF-I peaks parallel to the acquisition of peak bone mass, 
whereas serum IGF-I levels decline with aging (Hammerman 1987; Slootweg 1993; 
Rosen & Conover 1997). With aging, a decrease of the IGF-I level is also found in 
cortical bone, but not in trabecular bone (Nicolas et al. 1994). The IGF-I serum levels 
are positively associated with the bone mineral density in older women (Langlois et al. 
1998). Decreased IGF-I serum levels are associated with an increased the risk of 
osteoporotic fractures in women (Garnero et al. 2000).  
Osteoporosis is associated with a decreased GH secretion (Dequeker et al. 
1982) and growth hormone deficiency is associated with an increased risk of fractures 
(Rosen et al. 1997; Wuster et al. 2001). Perturbations in the IGF-system may be 
responsible for the pathogenesis of selected forms of osteoporosis (Canalis & 
Agnusdei 1996). On the other hand, by acromegaly GH is overproduced, which 
causes thickening of the bone. In conclusion, the IGF-system is an interesting starting 
point to study bone formation. 
 
EFFECTS OF MECHANICAL LOADING IN HUMANS 
 
Immobilization or unloading 
 
Immobilization, a consequence of long-term bed-rest or long-duration spaceflights, 
leads to a reduced loading of the skeleton resulting in significant bone loss in both 
men and women (Jaworski & Uhthoff 1986; Leblanc et al. 1990; Schneider et al. 1995). 
Eight weeks of relative immobility, due to a tibia fracture, led to a decrease of bone 
mineral density (BMD) of the femoral neck and trochanteric region at the injured side 
after the immobilization period. This decrease continued up to 12 months after the 
fracture (van der Wiel et al. 1994). Bone loss starts already after 4 days of bed-rest 
shown by an enhancement of bone resorption markers during a 10 days bed-rest 
period (van der Wiel et al. 1991). 
A long-lasting space-flight also has a negative influence on the bone mass of 
the skeleton. In humans a decrease in BMD of the lower extremity bones was 
observed in a spaceflight with a duration varying from 4.5 until 14.5 months (Grigoriev 
et al. 1998). A time-dependent decrease in BMD was shown in a spaceflight with 
duration of 28-84 days (Tilton et al. 1980). 
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Mechanical loading 
 
Exercise increases bone mass in men as well as in women. High-peak loading like 
weight-bearing exercise increases BMD (Rutherford et al. 1990). The magnitude of 
peak loading is a more important determinant for bone mass than the number of 
repetitions of the loading cycles (Lanyon 1987; Whalen et al. 1988). 
 In men, intensive weightlifting exercise results in a significantly higher bone 
mass of the upper limbs than non-intensive weightlifting exercise, like running (Hamdy 
et al. 1994). Another way of high impact training like rowing also results in a significant 
increase of bone mass in male subjects (Smith & Rutherford 1993; Cohen et al. 1995). 
In women, training including high strain rates in versatile movements and high peak 
forces, seems to be more beneficial for bone formation than training with a large 
number of low-strain repetitions (Heinonen et al. 1995). At several locations in the 
skeleton, lumbar spine, femoral neck, proximal tibia and the calcaneus, female squash 
players had a higher BMD than the sedentary control group. Aerobics and speed 
skating in women was also associated with significantly higher BMD (Heinonen et al. 
1995). 
 In summary, to maintain a well-functioning skeleton it is necessary to exercise 
and high peak loading is more effective than the duration of exercise. The formation 
of bone induced by mechanical loading is site-specific. 
 
IN VIVO MECHANICAL LOADING MODELS  
 
Many animal models have been developed to study the effects of mechanical loading in 
vivo. At first the mechanical load was applied in an invasive manner, soon these models 
were followed by non-invasive models, in which load was applied non-invasively. 
Among these models are physiological models with normal strain distributions and 
non-physiological models with abnormal strain distributions. 
 
Invasive methods 
 
The first animal models, which were developed, consisted of removal of the ulna in 
pigs (Goodship et al. 1979), sheep (Lanyon et al. 1982), or dogs (Burr et al. 1989). 
Another invasive method to induce loading is the use of inserted implants into the 
radius, ulna (O'Connor et al. 1982) and the metacarpal bones of sheep (Churches & 
Howlett 1982) or the seventh and ninth caudal vertebrae of rats (Chambers et al. 
1993). In the latter model, the eight caudal vertebrae can be compressed 
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(Figure 1.3A). An important model is the turkey ulna model of Rubin and Lanyon 
(Rubin & Lanyon 1984; Rubin & Lanyon 1985) in which the ulna can be compressed 
(Figure 1.3B). All these models induced abnormal strain distributions, which produced 
an osteogenic response, and were able to increase the bone mass. 
 
 
Figure 1.3 Invasive models (Robling et al. 2001) 
(A) Eight caudal vertebrae (CV8) compression model in rat developed by Chambers. Ventral view of 
seventh and ninth caudal vertebrae (CV7-9) and intervertebral discs (grey). Pins are inserted through 
the bodies of CV7 and CV9 leaving CV8 undisturbed. When the pins are brought together by an 
actuator, axial compressive loads are transmitted to CV8 through the adjacent discs and vertebrae. 
Between loading sessions, the pins are clamped together to prevent significant deformation of CV8 
and CV6 (not shown). CV6 receives no load and is used as control.  
(B) Turkey ulna model of Rubin and Lanyon. The ends of the isolated diaphysis are fitted with caps, 
which are then pierced with Steinmann pins to receive loading generated in the actuator, leading to 
deformation of the ulna shaft.  
Figures are used with written permission of the Chambers and Lanyon. 
A B 
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Non-invasive methods 
 
A model, which is based on a physiological strain, is treadmill running. Treadmill 
running or repetitive loading of the tibia and femur of rats results in an increased 
appositional growth at the endosteal surface of the mid-diaphysis of the femur, but a 
reduced appositional growth of the periosteal and endosteal surface at the mid-
diaphysis of the tibia (Forwood & Parker 1991). A variation of the treadmill running 
model is the rat-with-backpack model (van der Wiel et al. 1995), in which an 
additional load in the backpack is added during the exercise, resulting in an 
enhancement of the peak load. Van der Wiel and colleagues showed that additional 
weight-bearing during exercise had more influence on the anabolic response of bone 
than the duration of exercise (van der Wiel et al. 1995). Fifteen minutes of running 
with backpack was more effective for BMD than 30 minutes running without backpack 
(van der Wiel et al. 1995). Five weeks of extensive swim training in rats did not lead 
to a significant increase of bone volume (Bourrin et al. 1992). 
More standardized models are the ulna model and the four-point bending 
system, which are ideal to study short term effects of mechanical loading. During axial 
ulna loading the ulna of a rat will be compressed resulting in an osteogenic response 
after a short daily period of loading. This osteogenic response is related to peak strain 
magnitude (Lee et al. 2002). The advantages of ulna loading are the absence of trauma 
and no periosteal bone formation (Torrance et al. 1994). The four-point bending 
system (Figure 1.4) has been developed and optimized by Turner and Forwood 
(Turner et al. 1991; Turner et al. 1994b; Forwood et al. 1998). The benefits of the 
four-point bending system are that it requires no surgical intervention and allows 
normal activity of the rats between loading sessions. Furthermore the loading points 
are positioned in such a way that damage to the muscle tissue is minimized during 
loading. The four-point bending system has the advantage that force, frequency and 
total number of cycles can be set by the operator. The four-point bending model has 
been developed to induce a mechanical load on the right tibia of the rat, which is 
placed between the four-points. Bending is applied in the mediolateral direction 
causing compression on the lateral surface of the tibia and tension on the 
anteromedial surface. Loading also induces fluid flow through the canaliculi as well as 
deformations in the extracellular matrix (Weinbaum et al. 1994; Turner et al. 1994a). 
Depending on the mechanical loading regime, i.e. magnitude of applied load, frequency 
and number of cycles, the four-point bending model produces new lamellar bone 
formation at the endosteal surface and lamellar or woven bone formation at 
periosteal surfaces (Turner et al. 1991; Raab-Cullen et al. 1994a; Turner et al. 1994b). 
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No significant increase of lamellar bone formation was observed during sham-loading, 
in which no bending moment was introduced (Forwood & Turner 1995)(Figure 1.4B). 
During sham-loading the tibia is squeezed, while loading causes bending and squeezing 
of the tibia. The sham-loading is used to correct for squeezing of the tibia during 
loading. 
The number of loading sessions has an influence on the bone formation. One 
single loading session increases the periosteal woven bone formation with 0-40%, 
whereas 5 subsequent loading sessions show an 80% increase (Forwood & Turner 
1994). A single short period of dynamic loading leads to an increased lamellar bone 
formation rate at the endosteal side of the rat tibia with a maximum 5-8 days after 
loading (Forwood et al. 1996). A force of 65N was more osteogenic than loads varying 
from 31-53 N (Forwood et al. 1996). 
 
Figure 1.4 The non-invasive four-point bending device of Forwood and Turner (Robling et al. 2001). 
 (A) – LOAD position - A mediolateral bending moment is produced in the shaft of the tibia when a 
force is applied to the upper device. The distance between the two upper padded load points is 11 
mm and between the lower points 23 mm.  
(B) – SHAM position - The lower points are removed inward, so that they directly oppose the upper 
points (11 mm). When a force is applied to the upper device, it will squeeze the shaft of the tibia and 
surrounding soft tissues, like muscles, but no bending of the shaft occurs.  
Figures are used with written permission of Turner. 
 
A 
B 
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MOLECULAR EVENTS MECHANICAL LOADING IN VITRO AND IN VIVO 
 
Several in vitro and in vivo studies tried to determine which mediators are involved 
during the osteogenic response (Table 1.1). This response has been measured in many 
different mechanical loading models and various species. The response to mechanical 
loading of the mediators is time-dependent and cell-specific. An increase in 3H-uridine 
incorporation, an indicator of proliferation, was observed in bone cells 6 hours (el Haj 
et al. 1990) and 8-24 hours after in vitro loading (Dallas et al. 1993) and 24 hours after 
in vivo mechanical stimulation (Pead et al. 1988; Lanyon 1992). 
 
Early response mediators 
 
Within only 5 minutes after in vitro (el Haj et al. 1990; Dallas et al. 1993; Zaman et al. 
1997) and in vivo (Skerry et al. 1989; Lanyon 1992) loading, increased levels of 
glucose-6-phosphate dehydrogenase (G6PD) activity in osteocytes were reported. 
The levels of cAMP significantly rose early in stretched cell-models (Mikuni-
Takagaki et al. 1996; Mikuni-Takagaki 1999), as well as in a mechanical perturbation 
model (Harell et al. 1977). The in vivo study of Davidovitch showed an increase in 
cAMP and cGMP level 15-60 minutes after loading (Davidovitch et al. 1984). 
Loading increases the production of prostaglandins, i.e. prostaglandin E2 
(PGE2), prostacyclin (PGI2) or prostaglandin F2α (PGF2α) in bone in vitro (Harell et al. 
1977; Rawlinson et al. 1991; Klein-Nulend et al. 1995b; Ajubi et al. 1996; Zaman et al. 
1997; Klein-Nulend et al. 1997). The response to pulsating fluid flow in osteocytes is 
higher than in osteoblasts (Klein-Nulend et al. 1995b; Ajubi et al. 1996). In vivo loading 
results in an enhancement of PGE 15-60 minutes after loading (Davidovitch et al. 
1984). 
Nitric oxide (NO) has also been shown to be mechanosensitive and to induce 
bone formation. Many different in vitro models, i.e. pulsating fluid flow (Klein-Nulend et 
al. 1995a), fluid shear stress (Johnson et al. 1996; McAllister & Frangos 1999), four-
point bending (Pitsillides et al. 1995; Zaman et al. 1999) and the bone core model 
(Pitsillides et al. 1995) and the in vivo ulna model (Zaman et al. 1999) have shown an 
increased NO production after loading. This mechanically induced formation of nitric 
oxide appears to result from activation of endothelial nitric oxide synthase (ecNOS) 
in bone cells (Klein-Nulend et al. 1998; Zaman et al. 1999). 
Induction of cyclooxygenase-2 (COX-2, prostaglandin G/H synthase) 
production and mRNA expression has been shown in bone cells after pulsating fluid 
flow, fluid shear stress and stretching (Kawata & Mikuni-Takagaki 1998; Ogasawara et 
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al. 2001; Wadhwa et al. 2002b; Bakker et al. 2003). In vivo studies have also shown an 
increase in COX-2 after loading (Forwood 1996). 
Stretching of calvarial cells in vitro increased c-fos mRNA expression (Kawata 
& Mikuni-Takagaki 1998). In vivo four-point bending upregulated c-fos mRNA 
expression in the periosteum of rat tibiae (Raab-Cullen et al. 1994b) and in osteocytes 
of compressed caudal vertebrae (Lean et al. 1995; Lean et al. 1996). 
 
Late response mediators 
 
The early events are followed by an enhancement of IGF-I mRNA expression in 
trabecular and cortical osteocytes of rat caudal vertebrae within 6 hours following a 
single loading session (Lean et al. 1995). Other investigators showed that the IGF-I 
enhancement was followed by increased expression of type I collagen and osteocalcin 
on the bone surface (Lean et al. 1995). Raab-Cullen and colleagues reported an 
increase of IGF-I and transforming-growth factor-β (TGF-β) mRNA 4 hours after 
loading (Raab-Cullen et al. 1994b). After running exercise with additional weight the 
concentrations of IGF-I protein within the humerus increased, whereas the 
concentrations of TGF-β in the humerus decreased (Bravenboer et al. 2001). IGF-I 
levels also increased in stretched bone cells (Mikuni-Takagaki et al. 1996; Kawata & 
Mikuni-Takagaki 1998). With the axial ulna loading model Mason and colleagues 
showed a decrease in glutamate-aspartate transporter (GLAST) mRNA 6 hours after 
loading (Mason et al. 1997). 
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References 
(el Haj et al. 1990) 
(Dallas et al. 1993) 
(Pead et al. 1988) 
(Lanyon 1992) 
(el Haj et al. 1990) 
(Dallas et al. 1993) 
(Zaman et al. 1997) 
(Skerry et al. 1989) 
(Lanyon 1992) 
(Kawata & Mikuni-Takagaki 
1998) 
(Raab-Cullen et al. 1994b) 
(Lean et al. 1996) 
(Harell et al. 1977) 
(Mikuni-Takagaki et al. 1996; 
Mikuni-Takagaki 1999) 
(Davidovitch et al. 1984) 
Time 
6 h  
8 - 24 h 
- 
24 h 
immediate 
immediate 
immediate 
6 min 
5 min 
15 min - 2 h* 
2 h 
30 min - 1 h 
5 - 15 min 
immediate 
15 min; 60 min 
(cathode) 
Method 
bone core biopsy model 
single 20 min period of intermittent 
loading at 0.4 Hz 
deprivation of functional load followed 
by single period of cyclic load 24 h 
later 
ulna loading 
bone core biopsy model 
single 20 min period of intermittent 
loading at 0.4 Hz 
cell-loading apparatus 
ulna loading (single period of loading) 
ulna loading 
stretching (3 h) 
4-point bending 
compression vertebra 
mechanical perturbations 
stretching 
canine teeth loading 
 Cell type 
osteocytes 
- 
cortical osteocytes 
osteocytes 
lining cells 
osteoblasts; osteocytes 
osteoblast-like cells 
periosteal cells; osteocytes 
lining cells; osteocytes 
osteoblasts; osteocytes 
periosteum 
cortical and trabecular 
osteocytes 
periosteum cell cultures 
osteoblasts; osteocytes 
periosteal osteoblasts 
Bone type 
distal femur 
tibiotarsus 
ulna 
ulna 
distal femur 
tibiotarsus 
femur 
ulna 
ulna 
calvaria 
tibia 
vertebra 
- 
calvaria  
teeth 
Mediators of the effects of mechanical stimuli  
Species 
dog  
chicken 
rooster 
avian 
dog 
chicken 
rat 
turkey 
avian 
rat  
rat  
rat  
- 
rat 
cat 
In vitro 
in vivo 
in vitro 
in vitro 
in vivo 
in vivo 
in vitro 
in vitro 
in vitro 
in vivo 
in vivo 
in vitro 
in vivo 
in vivo 
in vitro 
in vitro 
in vivo 
Table 1.1 
Mediator 
3H-uridine 
 
 
 
G6PD 
 
 
 
 
c-fos 
 
 
cAMP 
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References 
(Davidovitch et al. 1984) 
(Harell et al. 1977) 
(Rawlinson et al. 1991) 
(Klein-Nulend et al. 1995b) 
(Klein-Nulend et al. 1995b) 
(Klein-Nulend et al. 1995b) 
(Ajubi et al. 1996) 
(Klein-Nulend et al. 1995a) 
(Davidovitch et al. 1984) 
(Ajubi et al. 1996) 
(Klein-Nulend et al. 1997) 
(Zaman et al. 1997) 
(Klein-Nulend et al. 1995b) 
(Klein-Nulend et al. 1997) 
Time 
15 min; 60 min  
(cathode) 
5 - 60 min; 
peak 30 min 
0 - 10 min*  
immediate 
immediate 
<1 h 
5 min* (Ocyt);  
10 min* (Ob, PF) 
10 - 60 min* 
15 min; 60 min 
(cathode) 
5 min* (Ocyt);  
10 min* (Ob, PF) 
30 min; 60 min* 
immediate 
immediate 
5 - 10 min* 
Method 
canine teeth loading 
mechanical perturbations 
bone core biopsy model (15 min) 
hydrostatic compression (6 h) 
hydrostatic compression (24 h) 
pulsating fluid flow (1 h) 
pulsating fluid flow (1 h) 
pulsating fluid flow (1 h) 
canine teeth loading 
pulsating fluid flow (1 h) 
pulsating fluid flow (1 h) 
cell-loading apparatus 
intermittent hydrostatic compression 
(24 h) 
pulsating fluid flow (1 h) 
 Cell type 
periosteal osteoblasts 
periosteum cell cultures 
lining cells 
osteoblasts; osteocytes 
osteocytes 
osteocytes 
osteoblasts; osteocytes; 
periosteal fibroblasts 
primary bone cell cultures 
periosteal osteoblasts 
osteoblasts; osteocytes; 
periosteal fibroblasts 
primary bone cell cultures 
osteoblast-like cells 
osteocytes 
primary bone cell cultures 
Bone type 
teeth 
- 
femur 
calvaria 
calvaria 
calvaria 
calvaria 
calvaria 
teeth 
calvaria 
calvaria 
femur 
calvaria 
calvaria 
Species 
cat 
- 
dog 
chicken 
chicken 
chicken 
chicken 
mouse 
cat 
chicken 
mouse 
rat 
chicken 
mouse 
In vitro 
in vivo 
in vivo 
in vitro 
in vitro 
in vitro 
in vitro 
in vitro 
in vitro 
in vitro 
in vivo 
in vitro 
in vitro 
in vitro 
in vitro 
in vitro 
Mediator 
cGMP 
PGE2 
 
 
 
 
 
 
 
PGI2 
 
 
 
PGF2α 
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References 
(Klein-Nulend et al. 1995a) 
(Klein-Nulend et al. 1995a) 
(Pitsillides et al. 1995) 
(Pitsillides et al. 1995) 
(Pitsillides et al. 1995) 
(Pitsillides et al. 1995) 
(Pitsillides et al. 1995) 
(Johnson et al. 1996) 
(McAllister & Frangos 1999) 
(Zaman et al. 1999) 
(Zaman et al. 1999) 
(Zaman et al. 1999) 
(Klein-Nulend et al. 1998) 
(Kawata & Mikuni-Takagaki 
1998) 
(Ogasawara et al. 2001) 
(Wadhwa et al. 2002a) 
Time 
5 - 10 min* 
5 - 15 min* 
10 - 15 min* 
2 min 
5 min 
10 min 
2 - 5 min* 
immediate - 12 h* 
immediate - 6 h* 
5 min 
5 min 
- 
1 h 
15 min - 2 h*; 5 h 
1 h* - 3 h* (max) 
- 9 h* 
peak 4 h* 
(mRNA); 
 8 h* (protein) 
Method 
pulsating fluid flow (45 min) 
pulsating fluid flow (45 min) 
bone core biopsy model (15 min) 
axial compression 
axial compression 
4-point bending (10 min) 
4-point bending (10 min) 
fluid shear stress (12 h) 
fluid shear stress (6 h) 
axial compression 
4-point bending 
4-point bending 
pulsating fluid flow (1 h) 
stretching (3 h) 
fluid shear stress (9 h) 
fluid shear stress (8 h) 
 Cell type 
osteocytes 
bone cells 
- 
osteoblasts 
- 
osteoblasts 
osteocytes 
osteoblasts 
osteoblasts 
- 
osteoblasts 
osteoblasts; osteocytes 
primary bone cells; 
osteoblasts 
 osteoblasts; osteocytes 
MC3T3-E1 osteoblasts 
MC3T3-E1 osteoblasts 
Bone type 
calvaria 
calvaria 
femur 
ulna  
vertebra 
femur 
tibiotarsus 
calvaria 
calvaria 
ulna 
femur; 
calvaria 
tibiotarsus 
 
calvaria 
calvaria 
calvaria 
Species 
chicken 
mouse 
dog 
rat  
rat  
rat 
chicken 
rat  
rat  
rat  
rat 
chicken 
human  
rat  
mouse 
mouse 
In vitro 
in vivo 
in vitro 
in vitro 
in vitro 
in vitro 
in vitro 
in vitro 
in vitro 
in vitro 
in vitro 
in vitro 
in vitro 
in vitro 
in vitro 
in vitro 
in vitro 
in vitro 
Mediator 
NO 
 
 
 
 
 
 
 
 
 
 
 
ecNOS 
COX-2 
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References 
(Bakker et al. 2003) 
(Bakker et al. 2003) 
(Forwood 1996) 
(Lean et al. 1995;  
Lean et al. 1996) 
(Mikuni-Takagaki et al. 1996) 
(Raab-Cullen et al. 1994b) 
(Bravenboer et al. 2001) 
(Zaman et al. 1997) 
(Raab-Cullen et al. 1994b) 
(Bravenboer et al. 2001) 
(Mason et al. 1997) 
(Mikuni-Takagaki et al. 1996) 
Time 
1 h; 24 h 
1 h; 24 h 
- 
30 min - 1 h - 
6 h (peak) 
late 
4 h 
modulated 
increased 
4 h 
decreased 
6 h (decrease) 
- 
Method 
pulsating fluid flow (1 h) 
pulsating fluid flow (1 h) 
4-point bending 
compression vertebra 
stretching 
4-point bending 
rat-with-backpack 
cell-loading apparatus 
4-point bending 
rat-with-backpack 
ulna 
stretching 
 Cell type 
bone cells 
trabecular bone cells 
- 
trabecular and cortical 
osteocytes 
osteoblasts; osteocytes 
periosteum 
- 
osteoblast-like cells 
periosteum 
- 
osteocytes 
osteoblasts; osteocytes 
Bone type 
long bone 
femur 
tibia 
 
calvaria  
tibia 
humerus 
femur 
tibia 
humerus 
ulna 
calvaria 
Species 
mouse 
human  
rat  
rat  
rat  
rat  
rat  
rat  
rat  
rat  
rat  
rat  
In vitro 
in vivo 
in vitro 
in vitro 
in vivo 
in vivo 
in vitro 
in vivo 
in vivo 
in vitro 
in vivo 
in vivo 
in vivo 
in vitro 
Mediator 
COX-2 
 
 
IGF-I 
 
 
 
IGF-II 
TGF-β;  
 
GLAST 
Gla protein 
3H-uridine incorporation: an indicator of proliferation; G6PD: glucose 6-phosphate dehydrogenase; cAMP-cGMP: cyclic nucleotides; PGE2: prostaglandin E2; 
PGI2: prostacyclin; PGF2α: prostaglandin F2α; NO: nitric oxide; ecNOS; endothelial NO synthase; COX-2: cyclooxygenase-2, an inducible isoform of prostaglandin 
G/H synthase; IGF-I: insulin-like growth factor-I; IGF-II: insulin-like growth factor-II; TGF-β: transforming growth factor-β; GLAST: glutamate/aspartate 
transporter; Bone Gla protein: osteocalcin; 
Ocyt: osteocyte; Ob: osteoblast; PF: periosteal fibroblast; BF: bone formation; 
Time represents the response post-loading in min (minutes) or h (hours); Time with * represents the response during the loading-period. 
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OUTLINE OF THIS THESIS 
 
This thesis reports studies on the effects of a single mechanical loading session on 
gene expression levels. It is necessary to elucidate the role of known 
mechanosensitive genes, like those of the IGF-system, and to identify novel candidate 
genes which are involved in the osteogenic response or the process of bone 
formation after mechanical stimulation. For this study the four-point bending model of 
Forwood was used to induce a single period of dynamic loading in vivo, which results 
in an increased bone formation rate with a maximal increase during day 5-8 (Forwood 
et al. 1996). As animal model the female Wistar rat was used. In addition, the effect of 
IGF-II overexpression on the IGF components in the brain was investigated in this 
thesis. 
To test the hypothesis that mechanical loading affects local gene expression of 
the IGF-system, in situ hybridization studies were performed. First the role of 
insulin-like growth factor-I (IGF-I) during bone formation after a single session of 
mechanical loading was reported in Chapter 3. The IGF-I mRNA expression of 
loaded rat tibia using non-radioactive in situ hybridization was determined and 
compared to the endogenous gene expression pattern in rat tibia. Since it is known 
that IGF binding proteins might influence the biological activity of IGFs, the role of 
IGFBP-2 during the osteogenic response was investigated in Chapter 4. The 
localization of endogenous IGFBP-2 mRNA was studied, and the influence of a single 
mechanical loading session on IGFBP-2 mRNA expression. In addition, the 
physiological role of IGF-II overexpression in the brain was studied in Chapter 2. 
Brain tissue was used as positive control tissue for the components of the IGF-system 
in bone during the in situ hybridizations. 
With regard to the spectrum of mechanosensitive genes, an explorative 
microarray analysis was performed to investigate which other genes are involved 
during the osteogenic response. The endogenous gene expression profile of rat tibia is 
described in Chapter 5. Finally we examined differential gene expression in rat tibia 
after a single mechanical loading session in Chapter 6.  
 
In summary, the studies described in this thesis were performed to answer 
the following questions: 
1) What is the endogenous localization of IGF-I and IGFBP-2 mRNA expression 
in rat tibiae? 
2) Does a single mechanical loading session affect the IGF-I and IGFBP-2 mRNA 
expression locally in rat tibia 6 hours after stimulation? 
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3) What is the endogenous gene expression profile in rat tibia? 
4) Which genes are differentially expressed 6 hours after mechanical 
stimulation? 
5) What is the effect of IGF-II overexpression on the components of the 
IGF-system in brain? 
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ABSTRACT 
 
The insulin-like growth factors, IGF-I and IGF-II, and their binding proteins play an 
important role in the growth and development of the central nervous system. In the 
brain, co-localization of IGFs and IGFBPs often occurs, suggesting that IGFBPs can 
modulate IGF action. In one strain of our human (h)IGF-II transgenic mice, which 
carry an hIGF-II transgene driven by the H-2Kb promoter, we found overexpression 
of hIGF-II in the brain, as measured by Northern blot analysis. To clarify the 
localization and the influence of the hIGF-II transgene on different components of the 
GH-IGF axis in the brain, we studied the expression pattern of the hIGF-II transgene, 
endogenous IGF-I and IGF-II and IGFBP-2, -3, and -5, in the brain of prepubertal 
4-week-old mice, using non-radioactive in situ hybrization. 
We found that the hIGF-II transgene is exclusively expressed in neurons of 
the piriform cortex, the cerebral cortex, the medulla oblongata and the granular layer 
of the cerebellum. In general, this pattern is comparable to the expression pattern of 
endogenous IGF-I, with a few exceptions: there is no expression of IGF-I in the 
granular layer of the cerebellum, whereas the Purkinje cells of the cerebellum and 
thalamus both express IGF-I but no hIGF-II transgene. This hIGF-II transgene 
expression pattern contrasts markedly with endogenous IGF-II expression, which is 
mainly located in non-neuronal cells such as the meninges and choroid plexus, and in 
some nuclei of the medulla oblongata. The hIGF-II transgene affects neither 
endogenous IGF-I and IGF-II expression, nor the expression of IGFBP-3, which is 
located in the choroid plexus. Although the hIGF-II transgene is expressed in neuronal 
structures similar to IGF-I and IGFBP-5, it is not able to regulate IGFBP-5 expression, 
as has previously been reported for IGF-I. In the medulla oblongata, the IGFBP-2 
expression level showed 10-fold upregulation by the transgene, suggesting a 
modulating role for IGFBP-2 at the hIGF-II transgene action in this region. 
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INTRODUCTION 
 
The insulin-like growth factors, IGF-I and IGF-II, and their binding proteins (IGFBPs) 
are widely expressed and temporally and spatially distributed in the central nervous 
system, suggesting that they play an important role during brain development 
(D'Ercole et al. 1996; Walter et al. 1997; Naeve et al. 2000). It has been generally 
accepted that IGF-I is predominantly expressed in neuronal cells in the adult, whereas 
the regional distribution of IGF-II has been shown to be mainly restricted to the 
neuro-epithelial cells of the meninges and choroid plexus (Stylianopoulou et al. 1988; 
Bondy et al. 1992; Lee et al. 1993; Logan et al. 1994). In one strain of our human 
(h)IGF-II transgenic mice, which carry a transgene driven by the H-2Kb promoter, we 
found overexpression of hIGF-II mRNA in the brain, as measured by Northern blot 
analysis (Buul-Offers van et al. 1995). This was surprising, since this promoter is 
usually not expressed in the brain (Drezen et al. 1992). Ectopic expression of 
transgenes has been reported previously. Swanson and colleagues showed that 
growth hormone (GH) under the control of the metallothionein (MT) promoter is 
expressed in specific brain areas, where GH and MT are usually not expressed 
(Swanson et al. 1985). In contrast, IGF-I transgenic mice, where the transgene is 
driven by the MT or IGF-II promoter, show specific expression of the IGF-I transgene 
in a similar pattern as the endogenous IGF-I gene (Ye et al. 1996). In the light of these 
discrepancies, we first investigated whether the regional expression of the IGF-II 
transgene coincides with that of endogenous IGF-I or IGF-II. 
During brain development, IGFBPs are often co-expressed with IGFs, thus 
enabling IGFBPs to modulate the actions of the IGFs (Leventhal et al. 1999). So far, it 
has been shown that IGFBP-2 is mainly co-localized with IGF-II in the meninges and 
choroid plexus (Logan et al. 1994) and with IGF-I in neuronal structures (Lee et al. 
1993), whereas IGFBP-5 has been shown to co-localize with IGF-I or in the vicinity of 
IGF-I producing neurons, suggesting that both IGFBP-2 and -5 can modulate the action 
of the IGFs (Bondy & Lee 1993). In addition, it has been shown that IGFBP-5 mRNA 
expression is upregulated by IGF-I in the brain of pubertal 6-week-old IGF-I transgenic 
mice (Ye et al. 1996). By contrast, hypoxia or brain injuries cause an increased 
expression of both IGF-II and IGFBP-2 (Beilharz et al. 1995; Guan et al. 1996; Walter 
et al. 1997).  
In a previous study, we found upregulation of IGF-I expression in the growth 
plate of hIGF-II transgenic mice in comparison with normal mice (Smink et al. 2002). In 
addition, IGFBP-2 and -5 were increased in the spleen and thymus of these mice, 
whereas IGFBP-3 was increased exclusively in the spleen (Smink et al. 1999). Since 
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nothing is known about the regulation of these binding proteins by IGF-II in the brain, 
we also studied the modulating action of the IGF-II transgene on the expression 
pattern of IGFBP-2, -3 and -5 as well as of IGF-I, by using non-radioactive in situ 
hybrization. 
 
MATERIALS AND METHODS 
 
Materials 
 
All restriction enzymes and modifying enzymes were purchased from Roche 
Molecular Biochemicals (Mannheim, Germany), as well as digoxigenin-UTP, anti-
digoxigenin Fab fragments, nitro-blue tetrazolium chloride, 5-bromo-4-chloro-
3-indolyl phosphatase and blocking reagent. Nylon membranes were purchased from 
Schleicher & Schuell (Dassel, Germany).  
Mouse IGFBP-2, -3 and -5 cDNAs were kindly provided by prof.dr. S.L.S. 
Drop and dr. J.W. van Neck (Department of Pediatrics, Subdivision of Pediatric 
Endocrinology, Sophia Children’s Hospital, Erasmus University, Rotterdam, The 
Netherlands).  
Polyvinylalcohol was obtained from Aldrich (Milwaukee, WI, USA). Euparal 
mounting medium was purchased from Chroma Gesellschaft (Schmid GmbH, Köngen, 
Norway). 
 
Animals 
 
hIGF-II transgenic mice were generated by introduction of a human IGF-II gene into 
FVB/N control mice as described in detail by van Buul-Offers and colleagues (Buul-
Offers van et al. 1995). The human IGF-II gene is controlled by the H-2Kb promoter 
and contains the small t-intron of SV40 as polyadenylation signal. Throughout the 
study, the line designated 5'-2 (Tg-II) was used for our experiments. As controls 
normal FVB/N mice were used. The animals were kept under standard laboratory 
conditions.  
All animal experiments were in accordance with governmental guidelines for 
care and use of laboratory animals and were approved by the Committee for Animal 
Research of the Medical Faculty, University of Utrecht. 
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Synthesis of digoxigenin-labeled complementary RNA (cRNA) probes 
 
Standard RNA synthesis reactions using T7- or T3-RNA polymerase were carried out 
using digoxigenin-UTP as a substrate (Melton et al. 1984). cDNAs encoding human 
IGF-I (258 bp, containing exon 2 and 3)(Jansen et al. 1983) and human IGF-II (304 bp, 
SacII-XhoI fragment containing exon 7 [3'part], 8 and 9 [5'part])(Jansen et al. 1985) 
and mouse IGFBP-2, -3, and -5 cDNAs, corresponding to amino acid position 98-258, 
137-204, 88-182, respectively (Schuller et al. 1993), as well as a cDNA encompassing 
the 1 kb BamHI-BamHI SV40 fragment (Buul-Offers van et al. 1995), were used as 
templates for the synthesis of antisense and sense digoxigenin-labeled RNA probes. 
All probes used were specific for the mRNAs analyzed. The human IGF-II probe 
detects both endogenous mouse IGF-II and the transgene (Smink et al. 1999). The 
SV40 fragment detects only the mRNAs of the transgene as verified by Northern blot 
analysis (Buul-Offers van et al. 1995). The use of both probes makes it possible to 
discriminate between endogenous and transgene IGF-II mRNAs (Smink et al. 1999; 
Smink et al. 2002). Probes were checked for cross-hybrization using in situ hybrization 
on different types of mouse tissues (spleen, thymus and whole embryos) for the 
IGFBP probes (Smink et al. 1999; Kleffens van et al. 2001; Smink et al. 2002) and on 
spleen and growth plate cartilage for the IGF probes (Smink et al. 2002). The various 
probes displayed distinct expression patterns in these tissues. Northern blot analysis 
of different tissues using the same probes yielded bands of the expected sizes, 
verifying the correct identity of the probes (data not shown). 
 
Tissue preparation 
 
Mice were killed by decapitation after ether anesthesia at the age of 4 weeks and the 
spleen and brain were dissected. For in situ hybridization the spleen and brain were 
fixed in 4% (w/v) formaldehyde (buffered in phosphate buffered saline (PBS) 
pH 6.8-7.2) at 19°C for 20 h, washed in PBS and dehydrated through a series of 
ethanol. The fixed brain was cut rostral to the cerebellum (interaural co-ordinate 
0 mm) and the hippocampus (interaural co-ordinate 4 mm) in three coronal blocks, 
and embedded in paraffin. Of each brain part, 5 µm sections were cut, and every 50th 
section was stained with methylene blue in order to verify the position of the sections 
within the brain of the different animals using the mouse brain atlas (Franklin & 
Paxinos 1997). All sections were mounted onto RNase-free TESPA-coated 
(3-aminopropyltriethoxysilan) glass slides, dried overnight at 37°C and stored at 4°C 
until further use. Comparable sections of normal and transgenic brains were mounted 
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on one slide and analyzed with an RNA probe. A second check of the position of each 
section was determined by staining with hematoxylin-eosin and cresyl violet 
(Kawamura & Niimi 1972). 
 
Non-radioactive in situ hybridization 
 
Paraffin tissue sections of the spleen and brain (5 µm) were dewaxed, hydrated, rinsed 
in PBS and treated with proteinase K (0.1 U/ml) for 30 min at 37°C, and subjected to 
acetylation (Wilkinson 1992). Sections were rinsed in 2x SSC and kept in this solution 
until hybridization.  
Hybridization was performed in a solution containing 50% formamide, 
2x SSC, 1x Denhardt’s solution, 1 µg/µl yeast RNA and 10% dextran-sulfate and 
digoxigenin-labeled cRNA probe at a concentration of 500-1250 pg/µl depending on 
the probe. Sections were hybridized overnight at 50°C (hIGF-I), 53°C (SV40 and 
IGFBP-2, -3 and -5) and 63°C (hIGF-II). After hybridization, sections were washed 
with 50% formamide in 2x SSC at the same temperature as the hybridization 
temperature for 30 min and treated with RNase A (1 U/ml) for 30 min at 37°C.  
Subsequently, sections were rinsed in 2x SSC, treated with 10% lamb serum 
for 30 min and incubated with sheep anti-digoxigenin Fab fragments conjugated with 
alkaline phosphatase (1:500) for 2 h at 19ºC. 
Chromogenesis was performed with 0.38 mg/ml nitro blue tetrazolium 
chloride and 0.19 mg/ml 5-bromo-4-chloro-3-indolyl phosphatase in the presence of 
6% (w/v) polyvinylalcohol (De Block & Debrouwer 1993), resulting in a blue 
precipitate. Sections were counterstained with nuclear fast red, dehydrated through a 
series of ethanol and mounted with Euparal. 
Sense probes were used to investigate the level of non-specific binding. The 
brains of three to five different animals of each strain were analyzed per mRNA of 
interest using in situ hybridizations. The gene expression must be located in the 
cytoplasm, because mRNA is located in the cytoplasm. Positive signal is shown as a 
blue precipitate in the cytoplasm, whereas the nucleus is stained red. 
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Quantification and statistics 
 
We first performed a semi-quantitative screening of the glass-slides. Two independent 
investigators scored blind all slides in a semi-quantitative manner (-, no expression; 
+, expression). 
Only for IGFBP-2 expression were differences between normal and hIGF-II 
transgenic mice found within the nuclei of the medulla oblongata. Therefore, 
quantitative analysis of IGFBP-2 expression was performed with the Image Pro Plus 
program (version 4.5)(media Cybernetics Inc, Silver Spring, MD, USA). We defined an 
area of interest of 900 x 900 pixels (900 pixels=500 µm) within the trigeminal nucleus. 
This nucleus is a very recognizable structure of the medulla oblongata. In this area, we 
measured the total IGFBP-2 positive pixels by color segmentation (histogram based) 
in the hIGF-II transgene mice (n=5) and the FVB mice (n=4). The Student’s t-test was 
used for statistical analysis. A P<0.05 was considered statistically significant. 
 
Photography 
 
Brightfield photographs were made, using a gray filter and full light (10.5 V), with a 
microscope (Leica type DM-RD), a digital camera (automatic exposure)(Leica DC200) 
and Axio Vision 3.1 (Zeiss). 
 
RESULTS  
 
Specificity of the hIGF-II transgene probe 
 
Hybridization of the transgenic mice spleen, using either the hIGF-II transgene-specific 
antisense SV40 probe (Figure 2.1A) or the IGF-II antisense probe (Figure 2.1B), 
showed hIGF-II transgene expression in the white pulpa of the hIGF-II transgenic mice 
spleen. Since no transgenic or endogenous IGF-II expression was observed in the 
normal mice spleen using the same antisense probes (Figure 2.1C and 2.1D), we 
considered that both probes could detect the hIGF-II transgene.  
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IGF-II transgene expression in neuronal structures of the brain 
 
Analysis of endogenous IGF-II expression in normal mouse brain by non-radioactive in 
situ hybridization showed expression in the meninges (Figure 2.2A) and in the simple 
cuboidal epithelium of the choroid plexus (Figure 2.2D). In addition, IGF-II expression 
was observed in the vestibular (cerebellar) nucleus, the trigeminal nucleus, the 
interposed nucleus and the cochlear nucleus of the medulla oblongata (Figure 2.2D). 
In contrast to the endogenous IGF-II expression, the hIGF-II transgene was not 
expressed in the meninges and the choroid plexus (Figure 2.2B and 2.2E). Transcripts 
of the transgene were detected in the neurons of the piriform cortex (Figure 2.2B), in 
the pyramidal and non-pyramidal neurons of the cerebral cortex layers II, III and V, 
and in a few cells of the granular layer of the cerebellum (Table 2.1). Within the 
medulla oblongata, the nuclei that were positive for endogenous IGF-II expression 
(Figure 2.2D) also expressed the transgene (Figure 2.2E), as detected with the SV40 
probe. Moreover, the transgene is expressed in the reticular nucleus of the medulla 
oblongata (Figure 2.2E). 
Endogenous IGF-I was present in normal mice and was co-localized with the 
transgene in the neurons of the piriform cortex, the cerebral cortex layers II, III and 
V, and the above mentioned nuclei of the medulla oblongata, including the reticular 
nucleus (Figure 2.2G and 2.2H). In addition, IGF-I was expressed in the thalamus and 
the Purkinje cells of the cerebellum, but not in the granular layer of the cerebellum 
(Table 2.1). 
Figure 2.1 Expression of 
hIGF-II transgene and 
IGF-II in the spleen of 
prepubertal 4-week-old 
normal (FVB)(C and D) 
and hIGF-II transgenic 
mice (Tg)(A and B). 
Sections were hybridized 
with antisense dig-
oxigenin-labeled cRNA 
probes, specific for hIGF-II 
transgene (A and C) and 
IGF-II (B and D), and 
visualized under 
brightfield illumination. 
The RNA signal is shown 
as a blue precipitate. The 
sections were counter-
stained with nuclear fast 
red. The scale bar 
represents 100 µm (A-D). 
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Endogenous IGF-I and IGF-II expression levels were not affected by the IGF-II 
transgene expression, because no differences were detected between the expression 
in the normal and the transgenic brain (Table 2.1). Control hybridizations of brain 
sections with the corresponding sense RNA probes showed no signals (Figure 2.2C, 
2.2F and 2.2J). 
Figure 2.2 Expression of IGF-II, hIGF-II transgene and IGF-I in the brain of prepubertal 4-week-old 
normal (FVB)(A, C, D and G-J) and hIGF-II transgenic mice (Tg)(B, E and F). Sections were hybridized 
with antisense digoxigenin-labeled cRNA probes, specific for IGF-II (A and D), hIGF-II transgene (B 
and E) and IGF-I (G and H), and were visualized under brightfield illumination. The RNA signal is 
shown as a blue precipitate. The sections were counterstained with nuclear fast red. Control sections 
hybridized with the sense probes showed no signal (C, F and J). The scale bars represent 200 µm 
(A-C), 50 µm (H) or 500 µm (D-G and J), respectively. Men, meninges; Cp, choroid plexus; Pir, 
piriform cortex; TNu, trigeminal nucleus; VNu, vestibulo cerebellar nucleus; RNu, reticular nucleus. 
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Effects of neuronal hIGF-II overexpression on IGFBP-2, -3 and -5 expression 
 
As the bioactivity of IGF-II can be regulated by IGFBPs, we studied the influence of 
hIGF-II overexpression on the localization and regulation of IGFBP-2, -3 and -5 mRNA 
expression. IGFBP-2 was expressed and co-localized with endogenous IGF-II in the 
meninges and the simple cuboidal epithelium of the choroid plexus, and lower 
expression was observed in the nuclei of the medulla oblongata (Figure 2.3A). In 
contrast to IGF-II expression, IGFBP-2 was also expressed in the reticular nucleus of  
the medulla oblongata. Endogenous IGFBP-2 expression was detected at the 
expression sites of the IGF-I gene (that is, the piriform cortex; the cerebral cortex 
layers II, III and V, and the nuclei of the medulla oblongata). However, IGFBP-2 was 
not detected in the Purkinje cells of the cerebellum and in the thalamus (Table 2.1). 
Table 2.1 Localization of IGFs and IGFBPs mRNA expression in the brain of 
normal mice and changes in expression in hIGF-II transgenic mice visualized 
by in situ hybridization 
 Normal mice Transgenic mice 
 IGF-I IGF-II IGFBP-2 IGFBP-3 IGFBP-5 
hIGF-II 
transgene 
IGFBP-2 
Non-neuronal        
Choroid plexus -    + a)    + a)    + b)    + b) - = 
Meninges - + + - - - = 
Lateral ventricle - - - - + - = 
Neuronal        
Piriform cortex + - + - + + = 
Cerebral cortex + - + - + + = 
Thalamus + - - - + - = 
Purkinje cells + - - - - - = 
Granular layer - - - - + + = 
Nuclei of medulla oblongata        
Cochlear + + + - + + ↑ 
Interposed + + + - + + ↑ 
Reticular + - + - + + ↑ 
Trigeminal + + + - + + ↑ 
Vestibular cerebellar + + + - + + ↑ 
+, expression; -, no expression; ↑, upregulated; =, no change. 
a) Cuboidal epithelial cells; b) Flat epithelial cells of blood vessels. 
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Figure 2.3 Influence of hIGF-II transgene on IGFBP-2 expression in medulla oblongata. IGFBP-2 
expression in prepubertal normal mice (FVB)(A and F) and hIGF-II transgenic mice (Tg)(B and D). The 
RNA signal is shown as a blue precipitate. The sections were counterstained with nuclear fast red. 
Control sections hybridized with the sense probe showed no signal (C). The scale bars represent 
500 µm (A-C) or 50 µm (D and F), respectively. 
(E) Ten-fold IGFBP-2 upregulation in the trigeminal nucleus of transgene mice depicted as total 
positive pixels within the measured area (means ± SEM are given; 1434 ± 284 [FVB] vs 
13984 ± 2084 [Tg] IGFBP-2 positive pixels; FVB n=4; Tg n=5; * P<0.0011). 
Cp, choroid plexus; TNu, trigeminal nucleus; VNu, vestibular cerebellar nucleus; RNu, reticular 
nucleus. 
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Figure 2.4 IGFBP-2, -3 and -5 expression in the choroid plexus of prepubertal 4-week-old hIGF-II 
transgenic mice (Tg). Sections were hybridized with antisense digoxigenin-labeled cRNA probes, 
specific for IGF-II (A), IGFBP-2 (B), IGFBP-3 (C), and IGFBP-5 (D), and were visualized under 
brightfield illumination. The RNA signal is shown as a blue precipitate. The sections were 
counterstained with nuclear fast red. Control sections hybridized with the sense probes showed no 
signal (E and F). The scale bar represents 50 µm (F). The magnification of each panel is equal. 
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            In the nuclei of the medulla oblongata, IGFBP-2 expression was upregulated 
by the hIGF-II transgene (Figure 2.3). Quantification of IGFBP-2 expression in a 
defined area of interest within the trigeminal nucleus showed 10-fold upregulation of 
IGFBP-2 expression (Figure 2.3E, means ± SEM are given; 1434 ± 284 [FVB] vs 
13984 ± 2084 [Tg] IGFBP-2 positive pixels; FVB n=4; Tg n=5; P<0.0011). IGFBP-2 
expression levels within the other regions of the brain expressing the transgene were 
not affected by IGF-II overexpression (Table 2.1). 
In contrast to the IGF-II and IGFBP-2 expression in epithelial cuboidal cells of 
the choroid plexus (Figure 2.4A and 2.4B), IGFBP-3 and -5 expression was found in 
the flat epithelial cells of blood vessels present in the choroid plexus (Figure 2.4C and 
2.4D), which lack expression of both IGFs and the transgene. IGFBP-5 was co-
expressed with the transgene and endogenous IGF-I in the piriform cortex, the 
cerebral cortex layers II, III and V, and the nuclei medulla oblongata (Table 2.1). In 
addition, IGFBP-5 was co-expressed with IGF-I within the thalamus and with the 
hIGF-II transgene in the granular layer of the cerebellum. IGFBP-5 was also expressed 
in the endothelial cells of the lateral ventricle (Table 2.1). No differences in expression 
level or expression pattern were detected between the normal and the hIGF-II 
transgenic mice for IGFBP-3 and -5 (Table 2.1). Control hybridization of brain sections 
with the corresponding sense RNA probes showed no signals (Figure 2.3C, 2.4E and 
2.4F). 
 
DISCUSSION 
 
Expression patterns of IGF-axis components in the brain of prepubertal mice as analyzed by 
non-radioactive in situ hybridization 
 
In this study, we used the non-radioactive in situ hybridization technique to detect the 
expression patterns of IGF-I, IGF-II and IGFBP-2, -3 and -5 in the brain of prepubertal 
mice. The hIGF-II transgene probe has been shown to be specific for the transgene, 
because no hIGF-II transgene expression was observed in the spleen of normal mice 
when hybridized with the hIGF-II transgene antisense probe.  
Endogenous IGF-II is mainly present in non-neuronal structures such as the 
meninges and the choroid plexus, confirming the data reported by others during rat 
brain development, who used radioactive in situ hybridization (Stylianopoulou et al. 
1988; Bondy et al. 1990; Bondy et al. 1992; Lee et al. 1993; Logan et al. 1994). 
Although IGF-II is predominantly expressed in non-neuronal cells, we also noticed 
that neuronal cells, specifically the nuclei of the medulla oblongata, express the 
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endogenous IGF-II gene. This observation extends the findings of Rotwein and 
colleagues, who found IGF-II expression in the medulla oblongata of the adult rat 
brain with a solution-hybridization nuclease–protection assay (Rotwein et al. 1988). 
The expression pattern of IGF-I in neuronal structures such as the piriform 
cortex, Purkinje cells and medulla oblongata corresponds with that observed by 
others in rats and mice, using radioactive in situ hybridization (Bondy et al. 1992; 
D'Ercole et al. 1996). 
With respect to the IGFBPs, detailed analysis of the expression patterns 
showed that the simple cuboidal epithelium expresses both endogenous IGF-II and 
IGFBP-2, whereas IGFBP-3 and -5 are expressed within the cells of the blood vessels 
belonging to the choroid plexus. Although IGFBP-3 expression in the choroid plexus 
of the intact rat brain has been reported before (Walter et al. 1997), the exact 
localization of the expression within the choroid plexus was not known. Our 
observation that both IGFBP-3 and -5 are expressed in blood vessel cells suggests that 
these IGFBPs could play an important role in the transport of IGFs across the blood- 
brain barrier (Armstrong et al. 2000; Pan & Kastin 2000), as in the local increase in 
IGFBP-3 within the cerebral wound, especially around blood vessels in lesioned rat 
brains (Walter et al. 1999). In addition, the expression of IGF-II together with IGFBP-2 
suggests a role for IGFBP-2 in targeting IGF-II action in the cerebrospinal fluid 
(CSF)(Wood et al. 1990; Bondy et al. 1992). 
 
Topology of transgenic IGF-II expression 
 
Whereas endogenous IGF-II is predominantly expressed in non-neuronal cells, it is 
remarkable that the hIGF-II transgene is exclusively expressed in neuronal brain 
structures such as neuronal cells in the piriform cortex, the cerebral cortex (layers II, 
III and V), the medulla oblongata and the granular layer of the cerebellum. Although 
the expression pattern of the IGF-II transgene co-localizes for a large part with that of 
IGF-I in the neurons of the piriform cortex, the cerebral cortex and the medulla 
oblongata, IGF-I expression was also detected in the thalamus and the Purkinje cells of 
the cerebellum, as reported by others before using different techniques (Rotwein et 
al. 1988; Bondy & Lee 1993). It has been shown in vitro that IGF-II can stimulate the 
proliferation of neuronal cells and supporting glial cells (Enberg et al. 1985; Lim et al. 
1985) as well as the neurite outgrowth (Recio-Pinto et al. 1986). Thus, the hIGF-II 
produced within the neuronal cells might be able to mimic the actions of IGF-I. 
It has been reported by several authors that the use of different promoters 
can display ectopic expression of different transgenes in vivo (Swanson et al. 1985; 
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Kondoh et al. 1987; Russo et al. 1988). In this study, we show ectopic expression of 
the IGF-II transgene to be under the control of the H-2Kb promoter in neuronal cells 
of specific brain areas, places where normally IGF-II and H-2Kb do not occur (Ruther 
et al. 1988; Drezen et al. 1992). This is probably due to the site of integration of the 
transgene in the genome, since only one of the three founders expressed IGF-II in 
areas in the brain, where normally IGF-II and H-2Kb are not expressed (Buul-Offers 
van et al. 1995). This ectopic IGF-II expression contrasts with the IGF-I expression as 
observed in IGF-I transgenic mice. When IGF-I is under the control of either the 
IGF-II promoter or the MT promoter, the expression pattern of the transgene is 
identical with that obtained for endogenous IGF-I (Ye et al. 1996). 
 
Changes in IGF-axis components upon hIGF-II overexpression 
 
Although the hIGF-II gene is expressed in considerable amounts in neuronal cells of 
the cortex and the piriform cortex, this did not affect the endogenous IGF-I and/or 
IGF-II expression levels in these areas. Nor did IGF-II overexpression in the brain 
affect the growth of the brain during postnatal growth (Buul-Offers van et al. 1995). 
This contrasts with the increased growth of the brain in IGF-I transgenic mice (Ye et 
al. 1996), suggesting that IGF-II is much less important for brain growth than IGF-I 
(Carson et al. 1993; Ye et al. 1995).  
The biological activity of IGFs is largely dependent on the presence of IGFBPs 
(Firth & Baxter 2002). It has been suggested by Smink and co-authors that the absence 
of increased growth induced by IGF-II overexpression in the spleen of our transgenic 
mice was caused by an increase in IGFBP-2, -3 and -5 expression. In contrast, the 
thymus showed overgrowth, but no upregulation of these IGFBPs (Smink et al. 1999). 
In the brain of these mice, however, only an upregulation of IGFBP-2 expression 
became apparent in the nuclei of the medulla oblongata, with a 10-fold IGFBP-2 
upregulation in the trigeminal nucleus, without any consequences for brain growth. 
This again shows the tissue dependency of the actions of the IGFs and their binding 
proteins.  
In normal mice, a strictly positive relationship exists between the spatial 
distribution of IGF-II and IGFBP-2 expression within the choroid plexus and the 
meninges (Lee et al. 1993). Also after brain injury in the rat, an increased IGF-II and 
IGFBP-2 expression has been observed within the choroid plexus together with an 
increased secretion within the CSF (Walter et al. 1999). In the neuronal structures 
expressing the IGF-II transgene, upregulation of IGFBP-2 could be detected only in the 
nuclei of the medulla oblongata, with a 10-fold IGFBP-2 upregulation in the trigeminal 
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nucleus, but no upregulation occured in the piriform and cerebral cortex. Such a 
difference in upregulation between IGF-II and IGFBP-2 in the different brain areas 
consisting of neuronal cells has not been observed before, and it suggests at least that 
different regulatory mechanisms play a role in gene regulation of IGF-II and IGFBP-2. 
IGFBP-5 is present within neuronal cells at high concentrations, managing 
IGF-I activity (Leventhal et al. 1999). The positive relationship between IGFBP-5 and 
IGF-I manifests itself in the decreased IGFBP-5 expression concurrent with the 
decrease in IGF-I expression in neuronal cells after brain injury induced by hypoxic-
ischemia (Clawson et al. 1999) and the increased IGFBP-5 expression in brain tissue 
overexpressing the IGF-I gene (Ye & D'Ercole 1998). Although the hIGF-II transgene 
is expressed at high levels in neuronal cells and can bind IGFBP-5 with an even higher 
affinity than IGF-I (Jones & Clemmons 1995), it does not influence its expression. This 
suggests that IGF-II may not be an important regulator of IGFBP-5 expression in vivo, 
in contrast to IGF-I, which upregulates IGFBP-5 in the brain of adult mice (Ye et al. 
1996; Ye & D'Ercole 1998). 
In summary, we can conclude that, in contrast to endogenous IGF-II, which is 
predominantly expressed in non-neuronal structures, the IGF-II transgene is 
exclusively expressed in neuronal cells. Furthermore, the transgene affects neither the 
expression of endogenous IGF-I and IGF-II, nor that of IGFBP-3 and -5. However, the 
IGFBP-2 expression in the nuclei of the medulla oblongata is upregulated by the IGF-II 
transgene, with a 10-fold IGFBP-2 upregulation in the trigeminal nucleus, suggesting 
that IGFBP-2 can modulate IGF-II action in neuronal cells. 
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ABSTRACT 
 
Mechanical loading plays an essential role in maintaining skeletal integrity. Mechanical 
stimulation leads to increased bone formation. However, the cellular and molecular 
mechanisms, which are involved in the translation of mechanical stimuli into bone 
formation, are not completely understood. Growth factors and osteocytes, which act 
as mechanosensors, play a key role during the bone formation after mechanical 
stimulation. The aim of this study was to characterize the role of insulin-like growth 
factor-I (IGF-I) in the translation of mechanical stimuli into bone formation locally in 
rat tibiae. 
 Fifteen female Wistar rats were randomly assigned to three groups (n=5): 
load, sham-loaded and control. The four-point bending model of Forwood and Turner 
was used to induce a single period of mechanical loading on the tibia shaft. The effects 
on IGF-I mRNA expression 6 hours after the mechanical loading session were 
determined with non-radioactive in situ hybridization on decalcified tibiae sections. 
Endogenous IGF-I mRNA was expressed in trabecular and cortical 
osteoblasts, some trabecular and sub-endocortical osteocytes, intracortical 
endothelial cells of blood vessels and periosteum. Megakaryocytes, macrophages and 
myeloid cells also expressed IGF-I mRNA. In the growth plate, IGF-I mRNA was 
located in proliferative and hypertrophic chondrocytes. Mechanical loading did not 
affect the IGF-I mRNA expression in osteoblasts, bone marrow cells and 
chondrocytes, but the osteocytes at the endosteal side of the shaft showed a 2-fold 
increase of IGF-I mRNA expression. The proportion of IGF-I mRNA positive 
osteocytes in loaded tibiae was 29.3 ± 12.9% (mean ± SD; n=5), whereas sham-loaded 
and contra-lateral control tibiae exhibited a percentage of 16.7 ± 4.4% (n=5) and 
14.7 ± 4.2% (n=10), respectively (P<0.05). Lamellar bone formation after a single 
mechanical loading session was observed at the endosteal side of the shaft. 
 In conclusion, a single loading session results in a 2-fold upregulation of IGF-I 
mRNA synthesis in osteocytes which are present in multiple layers extending into the 
cortical bone of mechanically stimulated tibia shaft 6 hours after loading. This supports 
the hypothesis that IGF-I, which is located in osteocytes, is involved in the translation 
of mechanical stimuli into bone formation. 
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INTRODUCTION 
 
Mechanical loading plays an essential role in maintaining skeletal integrity in both 
humans and animals (Forwood & Parker 1991; Turner et al. 1991; Yeh et al. 1993; 
Smith & Rutherford 1993; Turner et al. 1994; Hamdy et al. 1994; Torrance et al. 1994; 
van der Wiel et al. 1995; Forwood et al. 1998). Bone modifies its structure throughout 
life in order to serve as a structural support for the body. According to the 
mechanostat theory decreased physical activity results in decreased bone formation 
and increased bone resorption, whereas increased physical activity has the opposite 
effect (Yeh et al. 1993). It has been suggested that osteocytes function as 
mechanosensors via canalicular processes and communicating gap junctions in the 
early stage of bone remodeling (Cowin et al. 1991; Nomura & Takano-Yamamoto 
2000). 
 Several in vivo studies have shown that many biochemical signal molecules are 
involved in the translation of mechanical stimuli into bone formation including glucose-
6-phosphate dehydrogenase (G6PD)(Skerry et al. 1989; Lanyon 1992), c-fos (Raab-
Cullen et al. 1994; Lean et al. 1996), cAMP (Davidovitch et al. 1984), cyclooxygenase-2 
(COX-2)(Forwood 1996), nitric oxide (NO) and prostanoid (Pitsillides et al. 1995), 
insulin-like growth factors (IGFs)(Raab-Cullen et al. 1994; Lean et al. 1995; Bravenboer 
et al. 2001), transforming growth factor-β (TGF-β)(Raab-Cullen et al. 1994; 
Bravenboer et al. 2001), protein kinase B (PKB or Akt)(Skerry & Suva 2003), and 
glutamate transporter (GLAST)(Mason et al. 1997; Skerry 1999; Skerry & Genever 
2001; Skerry & Suva 2003). These responses to in vivo mechanical loading are time-
dependent and site-specific. Early strain related changes within 5 minutes after loading 
are shown in osteocytes in which the G6PD activity is increased (Skerry et al. 1989; 
Lanyon 1992), whereas an increase of IGF-I mRNA expression is located on 
trabecular surfaces and in osteocytes of the diaphysial cortex (cortical and trabecular 
osteocytes) of rat caudal vertebrae within 6 hours after a single loading session (Lean 
et al. 1995). 
 The aim of this study was to characterize the role of IGF-I mRNA in the 
cortical tibia shaft during the translation of mechanical stimuli into bone formation. To 
this end we developed an in situ hybridization method especially for bone tissue to 
detect the local osteogenic response on cellular level 6 hours after a single period of 
dynamic loading. To induce a single period of mechanical loading the four-point 
bending model of Forwood and Turner has been used (Turner et al. 1991; Turner et 
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al. 1994; Forwood et al. 1998) resulting in bone formation in the rat tibia 5-8 days 
after stimulation (Forwood et al. 1996). 
 
MATERIALS AND METHODS 
 
Study design 
 
This study comprised two parts: 1. Validation study of the four-point bending system 
to verify bone formation after a single mechanical loading session, and 2. Detection of 
changes in mRNA expression of IGF-I after a single mechanical loading session with 
non-radioactive in situ hybridization. 
The animal experiments were in accordance with the governmental guidelines 
for care and use of laboratory animals and approved by the Institutional Animal Care 
and Use Committee (IACUC) of the VU University Medical Center Amsterdam, The 
Netherlands. 
 
Validation study four-point bending system 
 
Female Wistar rats of 12 weeks old (Harlan, Zeist, The Netherlands) were randomly 
assigned to two groups (n=3 per group): LOAD and SHAM. The right tibiae 
underwent “medio-lateral” loading (LOAD)(distance between the centers of the 
loading pads: upper pads: 11 mm and lower pads: 23 mm) or sham-loading 
(SHAM)(opposed pads were placed at the inner position: 11 mm) using the four-point 
bending system of Forwood and Turner (Figure 3.1)(Turner et al. 1991; Forwood et al. 
1998). Since loading will result in bending and squeezing of the tibia and sham-loading 
only in squeezing of the tibia, the SHAM group was used as control for the LOAD 
group. The left non-loaded tibiae served as contra-lateral controls (CONTROL). The 
four-point bending model (Forwood et al. 1996) was used to generate a single period 
of dynamic loading of the right tibia in rats in vivo. The rats were subjected to a single 
episode of loading comprising 300 cycles (2 Hz) using a peak magnitude of 60 N, 
which generates a mean strain of 2664 µstrain in the loaded tibia compared to a mean 
strain of 350 µstrain in the sham-loaded tibia (Forwood et al. 1998). Five and twelve 
days after the single loading session tetracycline (25 mg/kg body weight) was 
administered intraperitoneally to the rats. The rats were sacrificed 15 days after 
loading. 
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The tibiae were removed, fixed in 4% phosphate buffered formaldehyde and 
embedded in methyl metacrylate. Three cross-sectional sections of 30 µm were sawn 
with a sawing microtome (FMTA, Amsterdam, The Netherlands) through the region 
of applied loading or through the corresponding region of the contra-lateral tibia. The 
endosteal surfaces of all sections were used for histomorphometry measurements. 
Mineralizing surface (MS/BS [%]) expressed as a percentage of the bone surface (BS) 
and mineral apposition rate (MAR [µm/day]) were measured semi-automatically, using 
Osteomeasure (OsteoMetrics Inc Decatur, GA, USA). MAR was defined as the mean 
distance between the fluorescent labels, divided by the labeling period. Nomenclature 
and calculations were according to the ASBMR nomenclature committee. Data are 
expressed as mean values of the analyzed sections. Since the sample size was limited, 
statistical analyses were not made. 
 
In vivo mechanical loading in situ hybridization 
 
Fifteen female 12-week-old Wistar rats (235 ± 12 g)(Harlan, Zeist, The Netherlands) 
were randomly assigned to three weight-matched groups (n=5/group): LOAD, SHAM 
and CONTROL. The right tibiae underwent “medio-lateral” loading (LOAD), sham-
loading (SHAM) or no loading (CONTROL) using the four-point bending system of 
Forwood and Turner (Figure 3.1)(Turner et al. 1991; Forwood et al. 1998). The left 
tibiae served as contra-lateral controls. The four-point bending model (Forwood et al. 
1996) was used to generate a single period of dynamic loading of the right tibia in rats 
in vivo in order to detect acute changes of IGF-I mRNA locally in bone tissue after 
stimulation by mechanical stress. The rats were subjected to a single episode of 
loading comprising 300 cycles (2 Hz) using a peak magnitude of 60 N. The loading 
experiment was performed under general anesthesia (2% isoflurane in 1 l/min O2 and 
2 l/min N2O). The rats were sacrificed exactly 6 hours after loading. This time-point 
was based on literature (Lean et al. 1995) which was confirmed by a time-course pilot 
experiment at our laboratory using real-time rt-PCR analysis (H.W. van Essen, 
personal communication). The tibiae were dissected and immediately fixed in 4% (w/v) 
paraformaldehyde (buffered in phosphate-buffered saline [PBS] pH 7.4) at 4°C for 
24 h. 
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Tissue 
 
After the fixation, the tibiae were decalcified in 10% EDTA with 0.5% 
paraformaldehyde in PBS at 4°C for 4½ weeks. Finally, the tibiae were washed in PBS 
and dehydrated through a series of ethanol and xylene at room temperature and 
embedded in paraffin. Control brains were dissected rostrally to the cerebellum 
(interaural coordinate 0 mm) and the hippocampus (interaural coordinate 4 mm) in 
three coronal blocks and immediately fixed in 4% (w/v) paraformaldehyde (buffered in 
phosphate-buffered saline [PBS] pH 7.4) at 4°C for 24 h, followed by washing in PBS, 
dehydration through a series of ethanol and xylene at room temperature and 
embedding in paraffin. 
 
Reagents 
 
All restriction enzymes and modifying enzymes were purchased from Roche 
Molecular Biochemicals (Mannheim, Germany), as well as digoxigenin-UTP, anti-
digoxigenin Fab fragments, nitro-blue-tetrazolium chloride, 5-bromo-
4-chloro-3-indolyl phosphate and blocking reagent. Nylon membranes were 
purchased from Qiagen (Hilden, Germany). Polyvinylalcohol was obtained from 
Aldrich (Milwaukee, WI USA). Euparal mounting medium was purchased from 
Chroma Gesellschaft (Schmid GmbH Köngen/N). Silane-coated glass slides were 
obtained from Sigma-Aldrich (St. Louis, MO, USA). Ribosomal RNA and human IGF-I 
cDNA was kindly provided by dr. S.C. van Buul-Offers (Department of Metabolic and 
Endocrine Diseases, University Medical Center Utrecht, Utrecht, The Netherlands). 
Figure 3.1 Four-point bending model 
including a schematic diagram of sectioning. 
LOAD: A mediolateral bending moment is 
produced in the shaft of the tibia when a 
force is applied to the upper device. The 
distance between the two upper padded load 
points is 11 mm and between the lower 
points 23 mm; SHAM: The lower points are 
removed inwards, so that they directly 
oppose the upper points (11 mm). When a 
force is applied to the upper device, it will 
squeeze the shaft of the tibia and 
surrounding soft tissues, like muscles, but no 
bending of the shaft occurs. The sectioning 
was performed in the posterior-anterior 
direction. The semi-quantitative analysis 
comprised 5 sections per tibia with a 
distance of 50 sections in between, 
respectively shown as section I, II, III, IV and 
V, covering the whole tibia. Figure used with 
written permission of Turner. 
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Synthesis of digoxigenin-labeled complementary RNA (cRNA) probes 
 
Standard in vitro transcription reactions were carried out using T7- and SP6-RNA 
polymerase with digoxigenin-UTP as a substrate (Melton et al. 1984). cDNA encoding 
ribosomal 28S RNA and human (h)IGF-I (259 bp, containing exon 2 and 3, 120-379 nt, 
gene ID X00173)(Jansen et al. 1983) was used as a template for the synthesis of 
antisense and sense digoxigenin-labeled RNA probe. The probe was specific for the 
mRNAs analyzed. The IGF-I probe was checked for cross-hybridization using in situ 
hybridization on spleen and growth plate cartilage (Smink et al. 2002). 
 
Non-radioactive in situ hybridization  
 
Serial, longitudinal, tibia sections (5 µm), which were cut in posterior-anterior 
direction, and cross-sectional control brain sections (5 µm) were mounted onto 
RNase-free silane-coated glass slides and dried at 56°C for at least 3 days. In situ 
hybridization was performed on every 50th section with a total of five slides per tibia 
(i.e., sections I, II, II, IV and V)(Figure 3.1). Sections I, II, II, IV and V included the 
loading zone of the loaded and sham-loaded tibia and were taken to obtain regular 
sampling throughout the whole tibia. Corresponding sections of the right and left tibia 
sections of one rat were mounted on the same glass slide. All sections were dewaxed, 
rehydrated and rinsed in water. The sections were pretreated with 0.2 N HCl for 
15 min at room temperature, permeabilized in proteinase K (15 µg/ml) for 30 min at 
37°C and subjected to an acetylation treatment (Wilkinson 1992). The sections were 
rinsed in 2x SSC (0.3 M Sodium Chloride and 0.03 M Sodium Citrate) and kept in this 
solution until the start of the hybridization. 
Hybridization was performed in a solution containing 50% formamide, 2x SSC, 
1x Denhardt’s solution, 250 µg/ml transfer RNA, 480 µg/ml herring sperm RNA, 
10% dextran-sulphate and the ribosomal RNA digoxigenin-labeled cRNA probe at a 
concentration of 250 pg/µl and the hIGF-I digoxigenin-labeled cRNA probe at a 
concentration of 1500 pg/µl. Sections were hybridized overnight at 53°C. After 
hybridization, sections were washed with 50% formamide in 2x SSC at the 
hybridization temperature for 30 min and treated with RNase A (1 unit/ml) for 30 min 
at 37°C. Subsequently, sections were rinsed in 2x SSC, treated with 1% blocking 
reagent for 30 min and incubated with sheep anti-digoxigenin Fab fragments 
conjugated with alkaline phosphatase (1:1500) overnight at 4ºC. 
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Chromogenesis was performed in the dark with 0.38 mg/ml NBT (nitro-blue- 
tetrazoliumchloride) and 0.19 mg/ml BCIP (5-bromo-4-chloro-3-indolyl phosphate) in 
the presence of 6% (w/v) polyvinylalcohol (De Block & Debrouwer 1993) resulting in 
a blue precipitate. The sections were counterstained with nuclear fast red. Thus, 
positive cells will have a blue cytoplasmatic staining, whereas negative cells will be 
pink. Finally, the sections were dehydrated through a series of ethanol and mounted 
with Euparal. Sense probes were used to investigate the level of non-specific binding. 
 
Quantification and statistics 
  
First, a semi-quantitative screening of five different animals per group was performed 
to collect the in situ hybridization data. All tibiae were scored in a semi-quantitative 
manner which was defined as following: no expression (0), low expression (1), average 
expression (2) and high expression (3) as shown in Figure 3.2. 
Effects of mechanical loading were expected in the shaft of the tibiae. 
Therefore, quantitative scoring of the endocortical osteocytes expressing IGF-I 
mRNA was performed with Lucia G Version 4.82 (Uvikon, Bunnik, The Netherlands) 
using coded slides of sections II and III. The defined area of interest, which comprised 
the loading zone, started below the primary spongiosa at the endosteal side of the 
shaft following the total length of the shaft to the distal side (total length maximal 
3852 µm). At the endosteal side of the shaft all osteocytes, which were positioned 
within 100 µm of the endosteal surface, were included in the area of interest. Within 
the area of interest total osteocyte number and total IGF-I mRNA positive osteocyte 
number were measured using coded slides, resulting in a percentage of IGF-I mRNA 
positive osteocytes. We analyzed the sections of all rats per group within two 
different in situ hybridizations. The intra-individual mean SD of the quantitative 
measurement of the percentage positive osteocytes was 2.00% and the inter-individual 
mean SD was 0.94% 
Analysis of variance (one-way ANOVA) was used for statistical analysis using 
SPSS version 9.0 for Windows. A P-value of <0.05 was considered to reflect statistical 
significance. 
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Photography 
 
Brightfield photographs were made using a Leica microscope (DM4000B) with a digital 
camera (Leica DC500) and the Leica software IM50 (Leica Microsystems, Rijswijk, The 
Netherlands).  
 
IGF-I protein assay 
 
IGF-I protein was measured in serum by a radioimmunoassay for the quantitative 
measurement of human somatomedin-C (BioSource Europe, Belgium). The intra-assay 
coefficient of variation was <5.2% (n=15) for levels between 925 ng/ml and 2000 ng/ml 
and the inter-assay coefficient of variation was <10% (n=20) for levels between 
120 ng/ml and 500 ng/ml. The minimal detectable concentration was 35 ng/ml. 
 
 
 
Figure 3.2 Representation 
of the semiquantative 
scoring system assessing 
the levels of expression in 
osteoblasts (A, C, E and G) 
and osteocytes (B, D, F and 
H) in the tibiae of a 12-
week-old female Wistar rat. 
Level 0: no expression (A-
B), level 1: low expression 
(C-D), level 2: average 
expression (E-F) and level 
3: high expression (G-H). 
The scale bars represent  
20 µm (A-H). 
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RESULTS 
 
Validation study four-point bending system 
 
The loaded right tibiae of the rats showed lamellar bone formation at the endosteal 
surface (Figure 3.3A-C) and woven bone formation at the periosteal surface 
(Figure 3.3A). The mineralizing surface (MS/BS) expressed as a percentage of the bone 
surface of the loaded tibiae was 58%, whereas the contralateral control tibiae showed 
a mineralizing surface (MS/BS) of 40%. The mineralizing surface (MS/BS) was 38% for 
both sham-loaded tibiae and their contralateral control tibiae (Table 3.1). 
 
Table 3.1 MS/BS and MAR at the endosteal bone surface of rat tibia 
n 
right 
tibiae 
MS/BS 
(%) 
MAR 
(µm/day) 
left 
tibiae 
MS/BS 
(%) 
MAR 
(µm/day) 
3 load 58 1.41 control 40 1.71 
3 sham 38 1.52 control 38 1.58 
MS/BS: mineralizing surface is expressed as a percentage of the bone surface; MAR: mineral 
apposition rate. MAR is defined as the mean distance between the fluorescent labels, divided by 
the labeling period. Data are mean values for each group of rats. 
 
IGF-I protein concentrations in serum 
 
The IGF-I protein concentrations in serum, expressed as mean ± SEM, were 
1506 ± 126 ng/ml in the control group, 1409 ± 155 ng/ml in the load group and 
1408 ± 93 ng/ml in the sham group respectively. Differences between groups were 
not observed (P=0.808). 
 
Ribosomal 28S RNA expression in tibiae 
 
Analysis of ribosomal 28S RNA in control tibiae using non-radioactive in situ 
hybridization exhibited cytoplasmatic expression within every cell type, including all 
osteocytes (Figure 3.4A), osteoblasts (Figure 3.4A), chondrocytes and bone marrow 
cells (data not shown). Control hybridizations of control tibiae with the sense 
ribosomal RNA probe showed no signals (Figure 3.4B). 
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Figure 3.3  
Photographs of fluorescence 
label in a cross-sectional 
sawing section of a loaded 
tibia. At the endosteal bone 
surface lamellar bone 
formation is shown (double 
label)(A-C), whereas at the 
periosteal bone surface 
woven bone formation is 
present (A). B and C are 
details of A. The scale bars 
represent 100 µm (A-C). 
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Endogenous IGF-I mRNA expression in tissue  
 
The control brain showed IGF-I mRNA expression in Purkinje cells of the cerebellum 
and in neurons of the medulla oblongata (data not shown). In the internal control of 
the tibia, i.e. the growth plate, IGF-I mRNA was located in chondrocytes of the 
proliferative and hypertrophic zone (Figure 3.4C). In control tibiae, IGF-I mRNA was 
expressed in osteoblasts, which were situated against the surface of trabecular bone 
(Figure 3.4C) and endocortical bone (Figure 3.4E). IGF-I mRNA expression was also 
observed in osteocytes, which were lying within the first lamella at the endosteal side 
of the shaft (Figure 3.4E) and some trabecular osteocytes (Figure 3.4C). The 
endocortical osteocytes, which were located within the deeper lamellae (Figure 3.4E), 
and the periosteal osteocytes (data not shown) did not express IGF-I mRNA. IGF-I 
mRNA was expressed in the intracortical endothelial cells of blood vessels (Figure 
3.4F) and in the periosteum of control tibiae (data not shown). Some cells of the bone 
marrow i.e. megakaryocytes, macrophages and myeloid cells also expressed IGF-I 
mRNA (data not shown). Control hybridization of tibiae sections with the 
corresponding sense RNA probe did not show signals (Figure 3.4D). 
 
Effect of mechanical loading on IGF-I mRNA expression in osteocytes of the tibia shaft 
 
Mechanical loading induced IGF-I mRNA expression in osteocytes within multiple 
layers at the endosteal side of the shaft of the tibia in contrast to the contra-lateral 
control tibia where IGF-I mRNA expression was only seen within the superficial layer 
at the endosteal side of the shaft (Figure 3.4E and 3.4F). Quantitative analysis of the 
osteocytes within the endosteal side of the shaft showed a 2-fold increase of IGF-I 
mRNA expression 6 hours after mechanical loading (Figure 3.4F and 3.5). The 
proportion of IGF-I mRNA positive osteocytes was 29.3 ± 12.9% (mean ± SD) for 
loaded tibiae (n=5), 16.7 ± 4.4% (mean ± SD) for sham-loaded tibiae (n=5) and 
14.7 ± 4.2% (mean ± SD) for contra-lateral control tibiae (n=10)(Figure 3.5). 
Mechanical loading significantly increased the number of osteocytes, which express 
IGF-I mRNA (P<0.01, load versus contra-lateral control and P<0.05, load versus 
sham)(Figure 3.5). 
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Figure 3.4 Expression of ribosomal RNA in longitudinal control (A) tibiae sections and IGF-I mRNA in 
longitudinal control (C, E) tibiae sections and longitudinal loaded (F) tibiae sections of 12-week-old female 
Wistar rats. The RNA signal is shown as a blue precipitate. The sections were counterstained with nuclear 
fast red and were visualized under brightfield illumination. The scale bars represent 50 µm (A-B, D-F), and 100 
µm (C), respectively. (A) 28S ribosomal RNA expression within all endocortical osteocytes and osteoblasts; 
(B) hybridization with representative 28S ribosomal sense probe showed no signal in the endocortical 
osteocytes and osteoblasts; (C) IGF-I mRNA expression in the growth plate and primary spongiosa, 
trabecular osteocytes and trabecular osteoblasts; (D) hybridization with a representative IGF-I sense probe 
showed no signal in the endocortical osteocytes and osteoblasts; (E) IGF-I mRNA expression within the 
superficial endocortical osteocytes (indicated by arrow heads) and osteoblasts of a contra-lateral control tibia; 
(F) IGF-I mRNA expression in the endocortical osteocytes within multiple layers (indicated by arrow heads 
and by arrows) and osteoblasts of a loaded tibia. 
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Effects of mechanical loading on IGF-I mRNA expression in osteoblasts, chondrocytes and 
bone marrow cells 
No differences in IGF-I mRNA expression between loaded, sham-loaded and contra-
lateral control tibiae were observed in the osteoblasts, chondrocytes, and bone 
marrow cells by semi-quantitative screening. No differences in morphology of the 
cells were observed between groups. 
 
 
Figure 3.5 Influence of mechanical loading on IGF-I mRNA expression in osteocytes at the endosteal 
side of the shaft of rat tibiae. Values are expressed as mean percentage positive osteocytes ± SD 
(∗∗P<0.01, load versus contra-lateral control; ∗ P<0.05, load versus sham). 
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DISCUSSION  
 
This in vivo study showed that a single mechanical loading session was sufficient to 
increase lamellar bone formation at the endosteal side of loaded tibiae shaft and to 
increase the IGF-I mRNA synthesis in the endocortical osteocytes of loaded tibiae 6 
hours after a single period of mechanical stimulation with the four-point bending 
system. The 2-fold increase of IGF-I mRNA expression was restricted to osteocytes 
at the endosteal side of the shaft and inner lamellae. Loaded tibiae exhibited a higher 
number of IGF-I mRNA positive osteocytes within multiple endosteal lamellae than 
non-loaded tibiae, whereas sham-loaded tibiae showed a similar pattern of IGF-I 
mRNA expression in sub-endocortical osteocytes as non-loaded contra-lateral 
control tibiae. We conclude that the increase of IGF-I mRNA expression in the 
osteocytes is a consequence of bending, because squeezing of the tibiae during sham-
loading did not influence the IGF-I mRNA expression pattern. We suggest that the 
IGF-I mRNA in the endocortical osteocytes plays a role in lamellar bone formation.  
 
These results confirm previous findings. Lean and colleagues (Lean et al. 1995) 
showed an increase of IGF-I mRNA in cortical and trabecular osteocytes of the 8th 
caudal vertebra 6 hours after mechanical stimulation with the invasive vertebra 
compression model demonstrated by in situ hybridization and Raab-Cullen and 
colleagues (Raab-Cullen et al. 1994) showed an increase of IGF-I mRNA in the 
periosteum 4 hours after loading with the four-point bending model demonstrated by 
Northern blot (Raab-Cullen et al. 1994). Moreover, IGF-I protein concentration in 
bone is also increased after stimulation by mechanical stress using additional weight 
bearing (rat-with-backpack) as was previously reported (Bravenboer et al. 2001). The 
current study is the first study which showed a 2-fold increase of IGF-I mRNA in 
osteocytes in a non-invasive mechanical loading model (four-point bending model) at 
cellular level in vivo (non-radioactive in situ hybridization). 
In addition, the 2-fold increase of IGF-I mRNA was specifically detected in the 
osteocytes at the endosteal side of the shaft within the deeper lamellae. It has 
generally been accepted that osteocytes are responsible for the predominant sensing 
of mechanical strains in bone (Klein-Nulend et al. 1995). It can be concluded that the 
osteocytes at the endosteal side of the shaft and inner lamellae are mechanosensitive, 
because these osteocytes synthesize IGF-I mRNA 6 hours after mechanical loading. 
This is also shown by Gross and colleagues, who reported that mice overexpressing 
 Mechanical loading and IGF-I mRNA expression 
 81 
IGF-I in osteoblasts had an increased periosteal bone formation, suggesting that IGF-I 
increased sensitivity of the osteocytes and osteoblasts (Gross et al. 2002). 
Furthermore, we suggest that the mechanosensitive osteocytes, which 
synthesize IGF-I mRNA 6 hours after mechanical loading, are important for the 
increased lamellar bone formation after mechanical loading. Forwood and colleagues 
reported that a single short period of loading, using the four-point bending model, 
resulted in an increased lamellar bone formation rate at the endosteal surface of rat 
tibia (Forwood et al. 1996). Mechanical loading with an external bending load of 60 N 
in vivo will result in an increased woven bone formation rate at the periosteal surface 
and increased lamellar bone formation rate at the endosteal surface (Forwood et al. 
1998). This has been confirmed in the validation study at our laboratory which 
showed that a single mechanical loading session was sufficient to induce lamellar bone 
formation at the endosteal side of the tibiae and woven bone at the periosteal bone 
side. The lamellar bone formation is located at the endosteal side of the shaft, which is 
similar to the location of newly synthesized IGF-I mRNA after mechanical loading. 
This study also showed that IGF-I mRNA expression was not observed in the 
osteocytes at the periosteal side of the shaft, but was restricted to the sub-
endocortical osteocytes and osteocytes in multiple lamellae. The IGF-I mRNA may be 
less involved in the formation of woven bone, which is the result of irritation of the 
periosteum (Forwood et al. 1998). This suggests that IGF-I mRNA in the 
mechanosensitive osteocytes is specifically important for lamellar bone formation. 
No differences in serum IGF-I concentrations were observed between the 
loaded, sham-loaded and contra-lateral control groups. This implies that the acute 
effect of mechanical loading is restricted to the bone region, which is deformed, 
because the systemic serum IGF-I concentrations are unaffected. This supports the 
hypothesis that the osteogenic response to mechanical loading occurs locally 
(Bravenboer et al. 2001). However, the level of IGF-I mRNA, that has to be produced 
at a single skeletal site to observe the effect on IGF-I protein in the serum, is 
unknown. A 2-fold upregulation of IGF-I mRNA in one tibia might be too low. 
The other bone cells and bone marrow cells in the tibiae showed no difference 
in IGF-I mRNA expression before and 6 hours after mechanical loading. Our results 
showed that osteoblasts and osteocytes, within the first lamella at the endosteal side 
of the shaft and trabecular bone, synthesize IGF-I mRNA. These bone cells play a role 
during bone remodeling. Although the osteoblasts are responsible for new bone 
formation after loading, their IGF-I mRNA expression was not increased after 
mechanical stimulation; this is probably due to the fact that the endogenous IGF-I 
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mRNA expression level in osteoblasts was already very high. Several investigators 
have also demonstrated endogenous IGF-I mRNA expression within osteocytes of 
rodents (Inaoka et al. 1995; Mason et al. 1996; Zhao et al. 2000). In contrast, a number 
of other studies did not observe endogenous IGF-I mRNA expression within 
osteocytes of rodents and humans (Yeh et al. 1993; Middleton et al. 1995; Lean et al. 
1995). These contradictory results could be explained by the fact that different bones, 
including tibiae, distal femurs, ulnae and vertebrae, were examined. The daily loading 
of these bones varies considerably, which results in differences in gene expression. A 
second explanation could be the use of various molecular techniques and the 
preparation of the bone tissue, either undecalcified bone or decalcified bone. Finally, 
there is a difference in age between the studied species. 
 
 For this study we used the four-point bending model of Forwood, because this 
four-point bending apparatus produces a controlled mechanical strain in the tibia of 
living rats. An advantage of this approach is that it does not require surgical 
intervention and allows normal physical activity after the loading session (Turner et al. 
1991; Forwood et al. 1998). The osteogenic response will occur locally in bone. 
Therefore we have used the in situ hybridization technique in order to detect the local 
osteogenic response on cellular level. The non-radioactive in situ hybridization is a 
powerful and sensitive technique method to localize gene expression within 
decalcified rat tibiae. In this study a ribosomal 28S RNA probe was used to verify the 
RNA integrity of the decalcified tibiae. All bone cells, including osteocytes and 
osteoblasts, and chondrocytes and bone marrow cells showed ribosomal 28S RNA 
expression within the cytoplasm. Therefore we conclude that the RNA integrity was 
maintained during the entire decalcification and embedding procedure. It is 
demonstrated that the IGF-I cRNA probe is specific, because the brain showed IGF-I 
mRNA expression in the Purkinje cells of the cerebellum and in neurons of the 
medulla oblongata as described earlier (Bondy et al. 1992; D'Ercole et al. 1996; 
Reijnders et al. 2004) and IGF-I mRNA was expressed in the chondrocytes of the 
proliferative and hypertrophic zone of the growth plate as shown earlier by Reinecke 
and Nilsson (Nilsson et al. 1990; Reinecke et al. 2000). 
Nevertheless, this study has some limitations. The applied load of 60 N is 
supra-physiological and the insulin-like growth factor binding proteins (IGFBPs) have 
not been studied. IGF-I is one component of the IGF-system. IGFBPs can influence the 
biological activity of IGF-I (Firth & Baxter 2002) by regulating the bioavailability of 
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IGFs (Collett-Solberg & Cohen 1996). Therefore it is necessary to study the effects of 
mechanical loading on local IGFBP expression level as well. 
In conclusion, this study shows that IGF-I mRNA is 2-fold upregulated within 
the endocortical osteocytes of the shaft and multiple layers extending into the cortical 
bone 6 hours after mechanical loading in vivo. We conclude that these osteocytes are 
mechanosensitive as shown by newly synthesized IGF-I mRNA after a single short 
period of loading. This supports the hypothesis that these osteocytes translate 
mechanical stimuli into bone formation through IGF-I. The process occurs rather 
early in a series of cellular events, which take place after mechanical loading. 
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ABSTRACT 
 
Mechanical stimulation is essential for maintaining skeletal integrity. Mechanosensitive 
osteocytes are important during the osteogenic response. The growth hormone-
insulin-like growth factor (GH-IGF)-axis plays a key role during regulation of bone 
formation and remodeling. Insulin-like growth factor binding proteins (IGFBPs) are 
able to modulate the IGF activity. The aim of this study was to characterize the role 
of insulin-like growth factor binding protein-2 (IGFBP-2) in the translation of 
mechanical stimuli into bone formation locally in rat tibiae. 
Female Wistar rats were assigned to three groups (n=5): LOAD, SHAM and 
CONTROL. The four-point bending model was used to induce a single period of 
mechanical loading on the tibia shaft. The effect on IGFBP-2 mRNA expression 
6 hours after stimulation was determined with non-radioactive in situ hybridization on 
decalcified tibiae sections. 
Endogenous IGFBP-2 mRNA was expressed in trabecular and cortical 
osteoblasts, some trabecular and subendocortical osteocytes, intracortical endothelial 
cells of blood vessels and periosteum. Megakaryocytes, macrophages and myeloid cells 
also expressed IGFBP-2 mRNA. Loading and sham-loading did not affect the IGFBP-2 
mRNA expression in osteoblasts, bone marrow cells and chondrocytes. An increase 
of IGFBP-2 mRNA positive osteocytes was shown in loaded (1.68-fold) and sham-
loaded (1.35-fold) endocortical tibia shaft. 
In conclusion, 6 hours after a single loading session the number of IGFBP-2 
mRNA expressing osteocytes at the endosteal side of the shaft and inner lamellae is 
increased in squeezed and bended tibiae. Mechanical stimulation modulates IGFBP-2 
mRNA expression in endocortical osteocytes. We suggest that IGFBP-2 plays a role in 
the lamellar bone formation process. 
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INTRODUCTION 
 
Mechanical stimulation is important for the maintenance of the skeleton of humans 
and animals (Forwood & Parker 1991; Turner et al. 1991; Yeh et al. 1993; Smith & 
Rutherford 1993; Turner et al. 1994; Hamdy et al. 1994; Torrance et al. 1994; van der 
Wiel et al. 1995; Forwood et al. 1998). Bone serves as a structural support for the 
body and has the ability to modify its architecture throughout life. According to 
Frost’s mechanostat hypothesis mechanical stimulation regulates bone mass and 
architecture. Physical activity results in increased bone formation and decreased bone 
resorption, whereas inactivity has the opposite effect (Martin & Burr 1989; Frost 
2003). 
 The growth hormone-insulin-like growth factor (GH-IGF)-axis plays an 
important role in the regulation of bone remodeling. Of the IGFs, IGF-I is 
predominantly expressed in rat bone, whereas IGF-II is predominantly expressed in 
human bone (Shinar et al. 1993; Wang et al. 1995; Middleton et al. 1995). IGFs are 
involved in bone formation after mechanical stimulation. Mechanical loading 
upregulates the IGF-I mRNA expression in osteocytes as shown in rat vertebra by 
Lean and colleagues using the caudal vertebra compression model (Lean et al. 1995). 
Northern blot analysis also showed an enhanced periosteal IGF-I mRNA expression 
after mechanical stimulation (Raab-Cullen et al. 1994). Besides an increase of the IGF-I 
mRNA synthesis, Bravenboer and colleagues reported an upregulation of IGF-I 
protein concentration in bone after mechanical stimulation using additional weight 
bearing in running rats (rat-with-backpack)(Bravenboer et al. 2001). 
 As in other tissues, the autocrine and paracrine actions of IGFs in bone are 
modulated by a family of six structurally related binding proteins, the insulin-like 
growth factor binding proteins (IGFBPs). IGFBPs can be synthesized by osteoblasts 
(Hassager et al. 1992; Conover 1996) and are capable to modulate the effects of IGFs 
by potentiating or inhibiting their action, and some IGFBPs also have IGF-independent 
actions that can either inhibit or stimulate cellular function. 
 Since rat osteoblasts do not express IGFBP-1 (Conover 1996; Chen et al. 
1998; Palermo et al. 2004), it is most likely that IGFBP-1 does not play a significant 
role during bone formation after mechanical stimulation in rats. Although IGFBP-2 is 
the major IGFBP synthesized by rat osteoblastic cells (Conover 1996), a role for 
IGFBP-2 during mechanical loading has not yet been established. IGFBP-3 has both 
inhibitory and stimulatory effects on bone cells. IGFBP-4, which is locally produced by 
osteoblasts, has an inhibitory effect on bone metabolism, whereas locally synthesized 
 Mechanical loading and IGFBP-2 mRNA expression 
 93 
IGFBP-5 by osteoblasts has a stimulatory effect (Mohan et al. 1995; Conover 1996; 
Canalis 1997). However, the effects of IGFBP-4 on osteoblasts are IGF-I-dependent, 
whereas IGFBP-5 probably acts as a store for IGFs in bone tissue (Mohan et al. 1995; 
Conover 1996; Canalis 1997). IGFBP-6 is expressed in rat osteoblasts (Gabbitas & 
Canalis 1997). In conclusion, IGFBP-2 is the most abundant IGFBP in rat osteoblasts; 
however the role of IGFBP-2 during bone formation after mechanical stimulation in 
vivo has not yet been determined. We hypothesized that the IGFBP-2 mRNA 
expression level might be changed in bone cells during bone formation after 
mechanical stimulation. 
 The aim of this study, therefore, was to determine the localization of IGFBP-2 
mRNA in the cortical tibia shaft after mechanical stimulation. To this end we induced 
a single period of mechanical loading using the four-point bending model of Forwood 
and Turner (Turner et al. 1991; Turner et al. 1994; Forwood et al. 1998). This resulted 
in bone formation in the rat tibia 5-8 days after stimulation (Forwood et al. 1996). We 
developed an in situ hybridization method especially for bone tissue to detect the local 
osteogenic response at the cellular level 6 hours after a single period of dynamic 
loading. 
 
MATERIALS AND METHODS 
 
Animals 
 
Fifteen female 12-week-old Wistar rats (235 ± 12 g)(Harlan, Zeist, The Netherlands) 
were randomly assigned to three weight-matched groups (n=5 per group): LOAD, 
SHAM and CONTROL. The animal experiment was in accordance with the 
governmental guidelines for care and use of laboratory animals and approved by the 
Institutional Animal Care and Use Committee (IACUC) of the VU University Medical 
Center Amsterdam, The Netherlands. 
 
In vivo mechanical loading 
 
The right tibiae underwent “medio-lateral” loading (LOAD), sham-loading (SHAM)(in 
which the opposed pads were placed at the inner position, 11 mm apart) or no 
loading (CONTROL) using the four-point bending system of Forwood and Turner 
(Turner et al. 1991; Forwood et al. 1998)(Figure 3.1). Since loading will result in 
bending and squeezing of the tibia and sham-loading only in squeezing of the tibia, the 
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SHAM group was used as control for the LOAD group. The left tibiae served as 
contra-lateral controls. The four-point bending model (Forwood et al. 1996) was used 
to generate a single period of dynamic loading of the right tibia in rats in vivo in order 
to detect acute changes of IGFBP-2 mRNA locally in bone tissue after stimulation by 
mechanical stress. The rats were subjected to a single episode of loading comprising 
300 cycles (2 Hz) using a peak magnitude of 60 N. Forwood and Turner showed that 
a single loading session resulted in bone formation in the rat tibia 5-8 days after 
stimulation (Forwood et al. 1996). Characterization of the in vivo strain using the four-
point bending system was reported by Akhter and colleagues (Akhter et al. 1992). 
Using the four-point bending system at our laboratory we demonstrated bone 
formation at the endosteal surface of the rat tibia 15 days after a single loading session 
with a frequency of 2 Hz during 300 cycles and an applied peak magnitude of 60 N 
(Chapter 3). The loading experiment was performed under general anesthesia (2% 
isoflurane in 1 l/min O2 and 2 l/min N2O). The rats were sacrificed exactly 6 hours 
after loading. This time-point was based on literature (Lean et al. 1995) which was 
confirmed by a time-course pilot experiment at our laboratory using real-time rt-PCR 
analysis (H.W. van Essen, personal communication) showing the highest IGF-I mRNA 
expression 6 hours after loading. Since the actions of IGFs are influenced by their 
IGFBPs, we examined IGFBP-2 mRNA expression at 6 hours after loading. The tibiae 
were dissected and immediately fixed in 4% (w/v) paraformaldehyde (buffered in 
phosphate-buffered saline [PBS] pH 7.4) at 4°C for 24 h. 
 
Tissue 
 
After the fixation, the tibiae were decalcified in 10% EDTA with 
0.5% paraformaldehyde in PBS at 4°C for 4½ weeks. Finally, the tibiae were washed in 
PBS and dehydrated through a series of ethanol and xylene at room temperature and 
embedded in paraffin.  
As a positive control, brain tissue was used (Reijnders et al. 2004). Brains 
were dissected rostrally to the cerebellum (interaural coordinate 0 mm) and the 
hippocampus (interaural coordinate 4 mm) in three coronal blocks and immediately 
fixed in 4% (w/v) paraformaldehyde (buffered in PBS pH 7.4) at 4°C for 24 h, followed 
by washing in PBS, dehydration through a series of ethanol and xylene at room 
temperature and embedding in paraffin. 
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Reagents 
 
All restriction enzymes and modifying enzymes were purchased from Roche 
Molecular Biochemicals (Mannheim, Germany), as well as digoxigenin-UTP, anti-
digoxigenin Fab fragments, nitro-blue-tetrazolium chloride, 5-bromo-
4-chloro-3-indolyl phosphate and blocking reagent. Nylon membranes were 
purchased from Qiagen (Hilden, Germany). Polyvinylalcohol was obtained from 
Aldrich (Milwaukee, WI, USA). Euparal mounting medium was purchased from 
Chroma Gesellschaft (Waldeck GmBH & Co, Division Chroma, Münster, Germany). 
Silane-coated glass slides were obtained from Sigma-Aldrich (St. Louis, MO, USA). 
Mouse IGFBP-2 cDNA was kindly provided by prof.dr. S.L.S Drop and dr. 
J.W. van Neck (Department of Paediatrics, Subdivision of Paediatrics Endocrinology, 
Sophia Children’s Hospital, Erasmus University, Rotterdam, The Netherlands) via dr. 
S.C. van Buul-Offers (Department of Metabolic and Endocrine Diseases, University 
Medical Center Utrecht, Utrecht, The Netherlands).  
 
Synthesis of digoxigenin-labeled complementary RNA (cRNA) probes 
 
Standard in vitro transcription reactions were carried out using T7- and SP6-RNA 
polymerase with digoxigenin-UTP as a substrate (Melton et al. 1984). cDNA encoding 
mouse IGFBP-2 cDNA, corresponding to amino acid position (98-258) and showing 
95% homology with the corresponding rat IGFBP-2 cDNA fragment, was used as a 
template for the synthesis of antisense and sense digoxigenin-labeled RNA probe. The 
probes were specific for the mRNAs analyzed. The IGFBP-2 probe did not show 
cross-reactivity with different types of mouse tissues (spleen, thymus and brain) 
(Schuller et al. 1993; Smink et al. 1999; Reijnders et al. 2004). 
 
Non-radioactive in situ hybridization 
 
Serial, longitudinal, tibia sections (5 µm), which were cut in the posterior-anterior 
direction, and cross-sectional control brain sections (5 µm) were mounted onto 
RNase-free silane-coated glass slides and dried at 56°C for at least 3 days. 
Corresponding sections of the right and left tibia of one rat were mounted on the 
same glass slide. In situ hybridization was performed on every 50th section with a total 
of five slides per tibia (i.e., sections I, II, II, IV and V)(Figure 3.1). All sections were 
dewaxed, rehydrated and rinsed in water. The sections were pretreated with 0.2 N 
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HCl for 15 min at room temperature, permeabilized in proteinase K (15 µg/ml) for 
30 min at 37°C and subjected to an acetylation treatment (Wilkinson 1992). Sections 
were rinsed in 2x SSC (0.3 M Sodium Chloride and 0.03 M Sodium Citrate) and kept 
in this solution until the start of the hybridization. 
Hybridization was performed in a solution containing 50% formamide, 
2x SSC, 1x Denhardt’s solution, 250 µg/ml transfer RNA, 480 µg/ml herring sperm 
RNA, 10% dextran-sulphate and the mouse IGFBP-2 digoxigenin-labeled cRNA probe 
at a concentration of 500 pg/µl (brain) or 1000 pg/µl (tibia). Sections were hybridized 
overnight at 53°C. After hybridization, sections were washed with 50% formamide in 
2x SSC at the hybridization temperature for 30 min and treated with RNase A 
(1 unit/ml) for 30 min at 37°C. Subsequently, sections were rinsed in 2x SSC, treated 
with 1% blocking reagent for 30 min and incubated with sheep anti-digoxigenin 
Fab fragments conjugated with alkaline phosphatase (1:1500) overnight at 4ºC. 
Chromogenesis was performed in the dark with 0.38 mg/ml NBT (nitro-blue- 
tetrazolium-chloride) and 0.19 mg/ml BCIP (5-bromo-4-chloro-3-indolyl phosphate) in 
the presence of 6% (w/v) polyvinylalcohol (De Block & Debrouwer 1993) resulting in 
a blue precipitate. Finally, sections were counterstained with nuclear fast red, 
dehydrated through a series of ethanol and mounted with Euparal. Sense probes were 
used to investigate the level of non-specific binding. 
 
Quantification and statistics 
 
First, a semi-quantitative screening of all animals per group was performed on the 
anti-sense and sense slides to collect the in situ hybridization data. Sections I until V of 
all tibiae were scored in a semi-quantitative manner, which was defined as follows: no 
expression (0), low expression (1), average expression (2) and high expression (3) on 
a Nikon Eclipse E800 microscope (Uvikon, Bunnik, The Netherlands). 
Effects of mechanical loading were expected in the shaft of the tibiae. 
Therefore, a second quantitative evaluation of the endocortical osteocytes expressing 
IGFBP-2 mRNA was performed with Lucia G Version 4.82 (Uvikon, Bunnik, The 
Netherlands) using coded slides of sections II and III. The defined area of interest, 
which comprised the loading zone, started below the primary spongiosa at the 
endosteal side of the shaft following the total length of the shaft to the distal side 
(total length maximal 3852 µm). At the endosteal side of the shaft all osteocytes, 
which were positioned within 100 µm of the endosteal surface, were included in the 
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area of interest. Within the area of interest total osteocyte number and total IGFBP-2 
mRNA positive osteocyte number were measured. 
The paired-samples Student’s t-test and independent-samples Student’s t-test 
were used for statistical analysis using SPSS version 9.0 for Windows. A P-value of 
<0.05 was considered to reflect statistical significance. 
 
Photography 
 
Brightfield photographs with different magnifications (objectives 10x, 20x and 40x) 
were made using a Leica microscope (DM4000B) with a digital camera (Leica DC500) 
and the Leica software IM50 (Leica Microsystems, Rijswijk, The Netherlands).  
 
RESULTS 
 
Endogenous IGFBP-2 mRNA expression in tissue 
  
The control brain showed IGFBP-2 mRNA expression in the choroid plexus (Figure 
4.1A) and the neurons of the medulla oblongata (data not shown). In the internal 
control, i.e. the growth plate, IGFBP-2 mRNA was located in chondrocytes of the 
proliferative and hypertrophic zone (Figure 4.1C). In control tibiae, IGFBP-2 mRNA 
was expressed in osteoblasts, which were situated against the surface of trabecular 
bone (Figure 4.1C and 4.1E) and on the endosteal side of the shaft (Figure 4.1G). 
IGFBP-2 mRNA expression was also observed in some trabecular osteocytes and in 
cortical osteocytes, which were situated within the first lamella at the endosteal side 
of the shaft (Figure 4.1G). The endocortical osteocytes, which were located within 
the deeper lamellae (Figure 4.1G), and the periosteal osteocytes (Figure 4.1D) did not 
express IGFBP-2 mRNA. IGFBP-2 mRNA was also expressed in the intracortical 
endothelial cells of blood vessels (Figure 4.1G) and in the periosteum of control tibiae 
(Figure 4.1D). Some cells of the bone marrow, i.e. megakaryocytes, macrophages and 
myeloid cells also expressed IGFBP-2 mRNA (Figure 4.1E). No differences of IGFBP-2 
mRNA expression between the right and left tibia of the control group were 
observed using semi-quantitative analysis. Control hybridizations with the 
corresponding sense RNA probe exhibited no signals in the brain (Figure 4.1B) and in 
the tibia (Figure 4.1F). 
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Effect of mechanical loading on IGFBP-2 mRNA expression in osteocytes of the tibia shaft 
 
Induced IGFBP-2 mRNA expression was observed in osteocytes within the first 
lamella and within multiple layers at the endosteal side of the shaft of loaded tibia 
(1.68-fold increase; n=5)(Figure 4.1J) and sham-loaded tibia (1.35-fold increase; 
n=5)(Figure 4.1H), in contrast to the control tibia (n=10), where IGFBP-2 mRNA 
expression was only seen within the first lamella of the endosteal side of the shaft 
(Figure 4.1G). 
The proportion of IGFBP-2 mRNA positive osteocytes was 25.5 ± 12.6% 
(mean ± SD; n=5) for loaded tibiae and 17.2 ± 10.7% (mean ± SD; n=5) for the 
contra-lateral control tibiae (Figure 4.1G, 4.1J and 4.2A). Sham-loaded tibiae and the 
contra-lateral control tibiae showed a proportion of IGFBP-2 mRNA positive 
osteocytes of 20.5 ± 7.5% (mean ± SD; n=5) and 13.2 ± 4.2% (mean ± SD; n=5), 
respectively (Figure 4.1H and 4.2B). Mechanical loading significantly increased the 
number of IGFBP-2 mRNA synthesizing osteocytes in loaded tibiae (P=0.001) and in 
sham-loaded tibiae (P=0.031)(Figure 4.2A and 4.2B). No statistical differences of 
IGFBP-2 mRNA positive osteocytes were observed between the contra-lateral 
controls of the loaded and sham-loaded tibia (P=0.475) nor between the loaded and 
sham-loaded tibia (P=0.468). 
 
Effects of mechanical loading on IGFBP-2 mRNA expression in osteoblasts, chondrocytes and 
bone marrow cells 
 
No differences in IGFBP-2 mRNA expression between loaded, sham-loaded and 
control tibiae were observed in the osteoblasts, chondrocytes, and bone marrow cells 
by semi-quantitative screening. No differences in morphology of the cells were 
observed between groups. 
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Figure 4.2 Influence of mechanical loading on IGFBP-2 mRNA expression in osteocytes at the 
endosteal side of the shaft within individual rat tibiae. Values are expressed as percentage IGFBP-2 
mRNA positive osteocytes. (A) percentage IGFBP-2 mRNA positive osteocytes in control versus 
contra-lateral loaded tibiae (∗∗P=0.001; n=5); (B) percentage IGFBP-2 mRNA positive osteocytes in 
control versus contra-lateral sham-loaded tibiae (∗P=0.031; n=5); No statistical differences of 
IGFBP-2 mRNA positive osteocytes were observed between the CONTROL LOAD and CONTROL 
SHAM group (P=0.475) nor between the LOAD and SHAM group (P=0.468). The lines connect the 
left and right tibia of the same rat. The mean values of each group are represented by a bar. 
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Figure 4.1 pg 98 Expression of IGFBP-2 mRNA in rat brain sections (A-B) and in longitudinal 
control (C-G), sham-loaded (H) and loaded (J) tibiae sections of 12-week-old female Wistar rats. The 
RNA signal is shown as a blue precipitate. The sections were counterstained with nuclear fast red 
and were visualized under bright field illumination. The scale bars represent 100 µm (A-B), 50 µm 
(D-E, G-J), and 100 µm (C and F), respectively. (A) IGFBP-2 mRNA expression within the choroid 
plexus of a control rat brain; red blood cells are negative and do not express IGFBP-2 mRNA;       
(B) hybridization with representative IGFBP-2 sense probe showed no signal in the choroid plexus; 
(C) IGFBP-2 mRNA expression in the chondrocytes of the growth plate and osteoblasts of the 
trabecular bone; (D) IGFBP-2 mRNA expression in the periosteum of a control tibia; the osteocytes 
in the periosteal side of the shaft do not express IGFBP-2 mRNA; (E) IGFBP-2 mRNA expression in 
osteoblasts situated against the surface of normal trabecular bone and IGFBP-2 positive bone marrow 
cells; (F) hybridization with a corresponding IGFBP-2 sense probe showed no signal in the 
osteoblasts, chondrocytes and bone marrow cells of a control tibia; (G) IGFBP-2 mRNA expression 
within the superficial endocortical osteocytes (indicated by arrow heads), osteoblasts and 
intracortical endothelial cells of a blood vessel of a control tibia; (H) IGFBP-2 mRNA expression in 
the endocortical osteocytes within multiple layers (indicated by arrow heads) and osteoblasts of a 
sham-loaded tibia; (J) IGFBP-2 mRNA expression in the endocortical osteocytes within multiple 
layers (indicated by arrow heads) and osteoblasts of a loaded tibia. 
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DISCUSSION 
 
This in vivo study showed an increase in the number of endocortical osteocytes 
expressing IGFBP-2 mRNA in loaded (1.68-fold) and sham-loaded (1.35-fold) tibiae 
6 hours after a single period of mechanical loading with the four-point bending system. 
The upregulation of IGFBP-2 mRNA expression was restricted to osteocytes at the 
endosteal side of the shaft and multiple inner lamellae. No difference between 
IGFBP-2 mRNA expression in the left and right control tibia was observed. We 
conclude that bending and squeezing of rat tibiae result in an increase of locally 
synthesized IGFBP-2 mRNA by endocortical osteocytes. We suggest that IGFBP-2 
plays an as yet un-identified role in the lamellar bone formation process. 
 
We suggest that the IGFBP-2 producing osteocytes of the loaded tibiae are 
involved in the increased lamellar bone formation after mechanical loading. Forwood 
and colleagues reported that a single short period of loading using the four-point 
bending system resulted in an increased lamellar bone formation rate at the endosteal 
surface of rat tibia (Forwood et al. 1996). This has been confirmed in a validation 
study at our laboratory (Chapter 3). The lamellar bone formation is located at the 
endosteal side of the shaft, which is identical to the location of newly synthesized 
IGFBP-2 mRNA after mechanical loading, as demonstrated in this study. IGFBP-2 
mRNA expression was restricted to this area and was not observed in the osteocytes 
at the periosteal side of the shaft. Mechanical loading with an external bending load of 
60 N in vivo will result in an increased woven bone formation rate at the periosteal 
surface as result of irritation of the periosteum and increased lamellar bone formation 
rate at the endosteal surface (Forwood et al. 1998). We suggest that IGFBP-2 mRNA 
may be less involved in the woven bone formation, because the osteocytes at the 
periosteal side of the shaft did not express IGFBP-2. This suggests that IGFBP-2 
mRNA in the mechanosensitive osteocytes is specifically important for lamellar bone 
formation. 
In addition, this study showed that the sham-loaded tibiae have also an 
increased IGFBP-2 mRNA production in endocortical osteocytes 6 hours after sham-
loading. Apparently, besides bending, squeezing alone is also responsible for the 
upregulation of IGFBP-2 mRNA in the endocortical osteocytes. However, squeezing 
did not induce lamellar bone formation.  
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Remarkably, there is a large range in the data for the percentage of IGFBP-2 
mRNA positive osteocytes in the contra-lateral control tibiae of the LOAD group in 
comparison to the data of the contra-lateral tibiae of the SHAM group. This could be 
caused by the biological variation between the individuals, because the animals have 
been randomly divided between the groups and there is no significant statistical 
difference between those tibiae. 
For this study we used the four-point bending model of Forwood, because 
this four-point bending apparatus produces a controlled mechanical strain in the tibia 
of living rats. An advantage of this approach is that it does not require surgical 
intervention and allows normal physical activity after the loading session (Turner et al. 
1991; Forwood et al. 1998). The osteogenic response will occur at a distinct location 
in bone. Therefore we have used the in situ hybridization technique in order to detect 
the local osteogenic response on cellular level. The non-radioactive in situ 
hybridization is a powerful and sensitive technique to localize gene expression within 
decalcified rat tibiae. It was demonstrated that the IGFBP-2 probe is specific, because 
IGFBP-2 mRNA expression is present in the choroid plexus and the neurons of the 
medulla oblongata as described earlier (Reijnders et al. 2004), and in the chondrocytes 
of the proliferative and hypertrophic zone of the growth plate (Smink et al. 2002). 
Nevertheless, this study has some limitations. The applied load of 60 N is 
supra-physiological and 6 hours after a single loading session is too early to 
demonstrate bone formation. 
In summary, this study shows an increase of the number of osteocytes at the 
endosteal side of the shaft and inner lamellae expressing IGFBP-2 mRNA 6 hours after 
mechanical loading and sham-loading in vivo. We conclude that these IGFBP-2 
producing osteocytes in the endosteal shaft are mechanosensitive. We suggest that 
IGFBP-2 plays a role in the lamellar bone formation process. 
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ABSTRACT 
 
Bone is a living tissue and has the ability to adapt its structure to the demands of 
mechanical loading. Bone remodeling is an ongoing process. The effects of mechanical 
loading and hormones on the bone have been widely studied; however, the basal level 
of gene expression during bone remodeling has not yet been described. In this study 
the endogenous gene expression profile in rat tibia was measured with 
oligonucleotide microarray analysis.  
This study shows that collagen alpha-1 type I, collagen alpha-2 type I, 
osteonectin, osteocalcin, major beta globin, hemoglobin alpha and beta chain and 
ribosomal related genes were highly expressed genes relative to the housekeeping 
gene (GAPDH) in normal rat tibia while osteopontin and osteoregulin (synonym: 
MEPE, matrix extracellular phosphoglycoprotein with ASARM motif) exhibited a 
lower expression. We have shown that the isolated cortical shaft mRNA has a high 
quality and predominantly exhibited expression of specific bone matrix genes. In 
addition genes encoding reticulocytes of the intracortical blood vessels were 
abundant; however, contamination with some bone marrow cells could not be 
excluded. Osteoregulin basal expression is low although it is known to be involved in 
bone formation after mechanical stimulation. We conclude that the functionality of a 
gene is dependent on the ability to induce an increase or decrease in the mRNA 
expression level and is not dependent on the basal amount of endogenous mRNA 
expression level. Overall this descriptive study provides a total overview of 
endogenous gene expression levels in the bone matrix of a normal tibia. 
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INTRODUCTION 
 
Bone is a living tissue which consists of 65% mineral and 35% organic matrix. The 
organic matrix is composed of 90% collagen and 10% non collagenous proteins, like 
osteocalcin, osteonectin, osteopontin and bone sialoprotein. In addition, bone has a 
very well developed vascular system. For bone growth, modeling, remodeling and 
bone formation after mechanical loading, the bone cells require oxygen and nutrients 
which are delivered by the vascular system. In addition, the vascular system is capable 
to store immature bone cells in the bone marrow and to transport bone cells to their 
specific site of action. 
 It is well-known that bone is able to adapt its mass and structure in response 
to the demands of mechanical stimulation according to Wolff’s Law (Wolff 1986). 
Bone remodeling is a continuous process and is influenced by several internal and 
external factors, such as dietary pattern, medicaments, sunlight exposure, hormones 
and mechanical loading. Bone remodeling may be increased by mechanical loading or 
by some hormones or decreased by un-loading or the presence or absence of other 
hormones. The effects of mechanical loading and hormones have been widely studied 
using different methods of mechanical stimulation and molecular biological techniques 
to determine changes in mRNA and/or protein levels. However, the basal level of 
gene expression during bone remodeling has not been studied. Current techniques 
were not suitable to determine the endogenous composition of gene expression in 
bone. In addition, exploring the basal protein level is not feasible since the bone-
matrix serves as storage of many proteins and hence may not reflect gene activity. 
The microarray technology overcomes these problems and allows determining the 
endogenous gene expression of multiple genes simultaneously. In the present study, 
we have analyzed the endogenous gene expression profile of the control tibia shaft 
with oligonucleotide microarray analysis. 
 
MATERIALS AND METHODS 
 
Animals and experimental design 
 
Ten female 12-week-old Wistar rats (Harlan, Zeist, The Netherlands) were randomly 
assigned to two weight-matched groups: LOAD (217 ± 16 g, n=5) and SHAM 
(223 ± 8 g, n=5). The animals were kept under standard laboratory conditions. The 
right tibia underwent “medio-lateral” loading (LOAD) or sham-loading (SHAM) using 
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the four-point bending system as described in Chapter 3. All left tibiae served as 
contra-lateral controls. The loading experiments were performed under general 
anesthesia (2% isoflurane in 1 l/min O2 and 2 l/min N2O). The rats were sacrificed 
exactly 6 hours after loading. For this descriptive study we will focus on the normal 
rat tibia, thus the contra-lateral control tibia. 
The animal experiment was in accordance with the governmental guidelines 
for care and use of laboratory animals and approved by the Institutional Animal Care 
and Use Committee (IACUC) of the VU University Medical Center Amsterdam, The 
Netherlands. 
 
RNA isolation 
 
The tibiae were dissected and immediately frozen in liquid nitrogen after removal of 
the proximal and distal end, periosteum and bone marrow. The diaphysis of the tibiae 
was pulverized in presence of Trizol (Invitrogen) using the Freezer mill 6750 (Spex 
Certiprep, Metuchen, NY, USA) subsequently followed by a Trizol extraction, a 
chloroform/isoamylalcohol extraction, and a second Trizol extraction according to 
the manufacturer’s instructions. The RNA pellet was dissolved in RNase-free water 
and stored at -80ºC prior to use for the microarray. Thus the sample included total 
RNA from the tibia shaft, containing osteocytes, osteoblasts, lining cells and 
intracortical blood vessel cells.  
The quality of the RNA samples was determined with the RNA 6000 Nano 
Assay Kit (Agilent Technologies) on an Agilent 2100 BioAnalyzer and the A260/A280 
ratio was used to check for possible contaminations. The yield of RNA was measured 
with the spectrophotometer (A260)(NanoDrop® ND-1000 Spectrophotometer). The 
mean amount of total RNA used for the microarray analysis was 1604 ± 501 ng/µl 
(mean ± SD) ranging from 18.6 µg to 48.9 µg per tibia with an A260/A280 ratio of 
1.97 ± 0.05 (mean ± SD). 
 
Microarray, probe generation, hybridization and washing 
 
The Compugen Rat OligoLibraryTM was purchased from Sigma-Aldrich. Sixtymer 
oligo’s were resuspended to a concentration of 20 µM in a 150 mM sodium phosphate 
buffer, pH 8.5 and printed on CodeLinkTM activated slides (Amersham) using an 
Amersham Pharmacia Biotech Spotter. Features were spotted as duplicates on the 
microarray with pairs divided over two different regions. The total number of spotted 
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oligonucleotides was 4803 per region (RATLIB384, http://www.labonweb.com), 
including 52 spots of the housekeeping gene, glyceraldehyde-3-phosphate 
dehydrogenase (GAPDH). Furthermore, there were 138 empty spots. The slides 
(Buermans et al. 2005) exhibited a crossreactivity of 10%; every spotted 
oligonucleotide has a change of 10% that a part of the spotted sequence interacts with 
another gene than mentioned in the gene name list. cDNA probes were generated 
from 15 µg total RNA with an oligo-dT ([dT]20-VN) primer (Isogen, Maarsen, The 
Netherlands) and SuperScript™ II Reverse Transcriptase (Invitrogen), with 
incorporation of aminoallyl-dUTP (Ambion). Probes were indirectly labeled with 
Fluorolink Cy3 or Cy5 mono-functional dyes (according to a dye-swap design). The 
dye-swap design was used to avoid a possible bias caused by the molecular structure 
of Cy3 and Cy5. Unique intra-rat hybridization was performed, because the treated 
tibia (LOAD or SHAM) was hybridized together with its own contra-lateral 
CONTROL tibia. 
The hybridization protocol was adapted from Snijders and colleagues 
(Snijders et al. 2001) with minor modifications as described in Chapter 6. 
After drying, the slides were scanned at 10 µm resolution for Cy3 and Cy5 
intensities using the Microarray Scanner (Agilent Technologies). Array images were 
processed with BlueFuse version 3.0 for microarrays (BlueGnome, Cambridge, UK). 
 
Generation of the endogenous gene expression profile 
 
Automatically (spots with a confidence value <0.11) and manually (dirty spots and 
spots with a confidence value between 0.11-0.15 with a low intensity or bad 
morphology) flagged features were excluded from further analysis. After this severe 
selection: 2375 genes, including 51 times the housekeeping gene (NM_017008, 
Glyceraldehyde-3-phosphate dehydrogenase [GAPDH]), were left of the original 4803 
genes. The intensity values of 2324 genes of all CONTROL tibia (n=10) were divided 
by the mean intensity of the housekeeping gene per array. Because the genes were 
spotted in duplicate on the array, this results in 20 ratios per gene. Finally the mean 
ratio ± SEM per gene was calculated.  
Besides a second calculation was performed because the GAPDH values 
could be saturated. The intensity values of 2324 genes of all CONTROL tibia (n=10) 
were divided by the mean intensity value of all genes except GAPDH. No relevant 
differences were observed between the two calculations therefore we report the 
results of the first calculation. 
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RESULTS 
 
Table 5.1 represents the overall division of 
the mean intensity ratios of the genes. The 
mean intensity ratio was based on the 
mean intensity value of a gene of the 
CONTROL tibia (n=10, in duplicate) 
divided by the mean intensity of the 
housekeeping gene (GAPDH) of its array. 
Most genes (86.2%) exhibited a mean 
intensity ratio below 1 and less than 1% of 
the genes showed a mean intensity ratio 
above 10 (Table 5.1). 
 
The 50 genes, which exhibited the 
highest ratios, are depicted in Table 5.2. 
The total list of genes is available in the Supplementary Data file. Hemoglobin alpha 
and beta chain, and major beta globin showed the highest mean intensity ratios, 
29.6 ± 4.3, 28.7 ± 4.7 and 28.9 ± 4.5, respectively (MEAN ± SEM)(Table 5.2). These 
genes were followed by collagen alpha-2 type I (segment 2), collagen alpha-2 type I 
(segment 3) and collagen alpha-1 type I, which exhibited mean intensity ratios of 
24.0 ± 4.3, 13.4 ± 2.2 and 22.7 ± 3.7, respectively (MEAN ± SEM)(Table 5.2). 
Osteonectin and osteocalcin, both non-collagenous genes, showed a mean intensity 
ratio of 8.0 ± 1.0 and 7.0 ± 1.1, respectively (MEAN ± SEM)(Table 5.2). Among this 
list of 50 highest ranked genes 28% represented a ribosomal related gene (Table 5.2). 
The two genes, CDK109 and CDK 110, of which the localization is yet unknown, 
showed relatively high expression ratios in bone (Table 5.2). 
 
Division of the genes of interest in several categories, such as collagen genes 
and non-collagenous genes, bone-related genes, insulin like growth factor system 
genes (IGFs) and bone morphogenetic system genes (BMPs) resulted in Table 5.3. 
Collagen alpha-2 type I (segment 2 and 3) and collagen alpha-1 type I exhibited a high 
mean intensity ratio. The non-collagenous genes, osteoregulin (MEPE, matrix 
extracellular phosphoglycoprotein with ASARM motif), osteopontin, osteocalcin and 
osteonectin showed a mean intensity ratio between 1.5 ± 0.3 and 8 ± 1.0 
(MEAN ± SEM)(Table 5.3). The mean intensity ratios of BMP-2, BMP-3, BMP-4, BMP-6 
Table 5.1 Distribution of mean 
intensity ratio in control tibia 
Mean intensity ratios Proportion (%) 
<1 86.2 
1-2 6.8 
2-3 1.8 
3-4 1.7 
4-5 1.0 
5-10 1.8 
>10 0.7 
Total 100.0 
The mean intensity ratio represents the mean 
intensity values of a gene of the CONTROL 
tibia (n=10) divided by the mean intensity of 
the housekeeping gene of its array. Total 
number of genes is 2324. 
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and BMP-type 1A receptor and IGF-I, IGF-II, IGFBP-2 and IGFBP-6 varied from 
0.07 ± 0.01 – 0.35 ± 0.04 (MEAN ± SEM)(Table 5.3). 
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Localization 
 
reticulocyte 
reticulocyte 
reticulocyte 
fetal calvaria 
tooth/bone 
bone marrow 
bone marrow 
rat calvaria  
macrophage (peritoneal cavity) 
bone marrow 
macrophage (peritoneal cavity) 
fetal calvaria 
hypothalamus 
epithelium (lens) 
thyroid; testis 
brain  
component of the ribosome 
ribosomal subunit 
SEM 
4.26 
4.48 
4.72 
4.25 
3.73 
2.61 
3.42 
1.96 
2.48 
1.86 
2.67 
2.23 
0.88 
1.72 
1.64 
0.75 
1.35 
1.41 
Ratio 
MEAN 
29.6 
28.9 
28.7 
24.0 
22.7 
21.1 
18.1 
14.9 
14.8 
14.6 
13.8 
13.4 
11.4 
11.4 
10.5 
10.5 
9.6 
9.4 
 50 Genes with highest endogenous intensity ratios 
Gene Name 
 
hemoglobin alpha chain (partial cds) 
major beta-globin (complete cds) 
hemoglobin beta-chain mRNA 3' end 
alpha-2 type I collagen (segment 2) 
collagen alpha1 type I 
defensin RatNP-1 precursor (complete cds) 
defensin RatNP-4 precursor (complete cds) 
thymosin beta-4 (complete cds) 
intracellular calcium-binding protein (MRP14)(complete cds) 
defensin RatNP-3 precursor (complete cds) 
intercellular calcium-binding protein (MRP8)(complete cds) 
alpha-2 type I collagen (segment 3) 
C1-13=neuronal specific gene {clone E5130-3 estrogen induced 
gene} [hypothalamus Partial 150 nt] 
lens epithelial protein (complete cds) 
ferritin heavy polypeptide 1 (Fth1) 
elongation factor-1 alpha (ef-1)(complete cds) 
acidic ribosomal phosphoprotein P1 
ribosomal protein S6 (Rps6) 
Table 5.2  
Gene ID 
 
M32510 
M17084 
M32509 
M12201 
Z78279 
U16686 
U16684 
M34043 
L18948 
U16683 
L18891 
M12202 
S74342 
U20525 
NM_012848 
L10339 
X15097 
NM_017160 
 1
1
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References 
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Amri et al. 2004) 
(Chan et al. 1993) 
(Liao et al. 1998) 
(Wool et al. 1991) 
(You et al. 1995) 
- 
(Powis et al. 1991) 
(Duckworth et al. 1986) 
(Chan et al. 1987) 
(Denis et al. 1992) 
(Pan & Price 1985) 
- 
(Ginzburg et al. 1986) 
(Tanaka et al. 1985) 
(Dodds et al. 1997) 
(Suzuki et al. 1990a) 
Localization 
 
colon crypts 
- 
ribosomal subunit 
adrenal; brain; spinal cord; testis 
ribosomal subunit 
bone 
component of the ribosome 
kidney 
- 
- 
placenta 
ribosomal subunit 
epithelial cell (colon tumor) 
osteosarcoma; bone 
oligodendrocyte progenitor 
cerebellum 
ribosomal subunit 
brain 
ribosomal subunit 
SEM 
1.29 
1.04 
1.70 
1.19 
1.59 
0.96 
1.40 
1.45 
0.42 
1.37 
1.21 
1.15 
0.50 
1.07 
1.26 
0.84 
0.95 
1.14 
0.81 
Ratio 
MEAN 
8.9 
8.7 
8.7 
8.6 
8.5 
8.0 
7.9 
7.8 
7.7 
7.6 
7.2 
7.1 
7.0 
7.0 
6.8 
6.7 
6.7 
6.6 
6.5 
Gene Name 
 
mink-related peptide 2 (kcne3 gene) 
CDK109 
ribosomal protein L41 
transferrin (Tf) 
ribosomal protein S29 (Rps29) 
secreted acidic cystein-rich glycoprotein (osteonectin)(Sparc) 
ribosomal phosphoprotein P2 
low affinity Na-dependent glucose transporter 
(SGLT2)(complete cds) 
CDK110 
transporter polypeptide mtp2 
placental lactogen II (rPLII)(partial cds) 
ribosomal protein S8 
(clone J13) ferritin light chain subunit (complete cds) 
BGP mRNA encoding gamma-carboxyglutamic acid (Gla) 
protein (osteocalcin) 
putative myosin IIC (ORF1) 
alpha-tubulin 
ribosomal protein S11 (complete cds) 
neuronal pentraxin receptor (complete cds) 
ribosomal protein L35 
Gene ID 
 
AJ271742 
Y17323 
X82550 
NM_017055 
NM_012876 
NM_012656 
X15098 
U29881 
Y17319 
X63854 
M13749 
X06423 
L01122 
M11777 
AJ301656 
V01226 
K03250 
AF005099 
X51705 
  
1
1
7
 
References 
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(Chan et al. 1995b) 
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(Schwab & Wilson 1991) 
Localization 
 
joint 
ribosomal subunit 
brain 
various tissues 
ribosomal subunit 
parotid gland 
ribosomal subunit 
ribosomal subunit 
brain 
ribosomal subunit 
ribosomal subunit  
lung 
liver 
SEM 
1.08 
1.03 
1.10 
0.84 
0.83 
0.52 
0.77 
0.94 
0.86 
1.21 
0.84 
0.44 
0.41 
Ratio 
MEAN 
6.5 
6.4 
6.3 
6.3 
6.0 
6.0 
6.0 
5.9 
5.9 
5.8 
5.7 
5.7 
5.6 
Gene Name 
 
proteoglycan peptide core protein (Pgsg) 
ribosomal protein L37  
myosin heavy chain Myr 8b mRNA (complete cds) 
beta defensin-2 (complete cds) 
ribosomal protein S3a (Rps3a) 
neonatal submandibular gland protein precursor (psp)(complete 
cds) 
fusion protein of ubiquitin and ribosomal protein L40 
hybrid protein (ubiquitin-like protein/rps30) 
diacylglycerol kinase 90kDa (Dagk)  
ribosomal protein L9 
ribosomal protein S18  
proline-rich protein 15 (Prp15)  
hexokinase type III (complete cds) 
Gene ID 
 
NM_020074 
S79981 
AY004215 
AF068861 
NM_017153 
M83209 
X82636 
X62671 
NM_019304 
X51706 
X57529 
NM_012632 
U73859 
Top 50 list of genes with the highest mean intensity ratio values 
Gene ID: unique gene number; Gene name: gene name of rat specific mRNA; MEAN: mean intensity ratio = [(intensity gene)/(mean intensity housekeeping 
gene)]; housekeeping gene: GAPDH; SEM: standard error of the mean; Localization: known site of expression. 
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SEM 
4.25 
3.73 
2.23 
0.24 
0.27 
0.06 
0.01 
0.01 
0.01 
 
0.96 
1.07 
0.85 
0.32 
0.09 
0.02 
0.04 
0.01 
0.01 
0.01 
0.01 
0.01 
0.01 
0.04 
0.06 
0.01 
0.01 
 
MEAN 
24.04 
22.69 
13.43 
1.64 
1.55 
0.68 
0.14 
0.09 
0.08 
 
8.02 
7.01 
2.90 
1.53 
1.12 
0.39 
0.25 
0.15 
0.12 
0.09 
0.08 
0.08 
0.07 
0.35 
0.29 
0.12 
0.08 
Gene Name 
alpha-2 type I collagen (segment 2) 
collagen alpha1 type I 
alpha-2 type I collagen (segment 3) 
collagen binding protein 1 (Cbp1) 
collagen alpha 2 type V partial CDS 
alpha 1 type V collagen (complete cds) 
procollagen C-proteinase 3 (partial cds) 
alpha 4 type V collagen (complete cds) 
procollagen II alpha 1 (Col2a1)  
 
secreted acidic cystein-rich glycoprotein (osteonectin)(Sparc) 
BGP mRNA encoding gamma-carboxyglutamic acid (Gla) protein (osteocalcin) 
sialoprotein (osteopontin)(Spp1)  
osteoregulin (complete cds) 
integrin-binding sialoprotein (bone sialoprotein II)(Ibsp)  
osteoactivin (complete cds) 
osteoadherin (complete cds) 
small proteoglycan I (biglycan) bone (BSPG1)(bone/cartilage proteoclycan 1 precursor)(Bgn)  
bone morphogenetic protein 4 (Bmp-4) 
bone morphogenetic protein 2 (Bmp-2) 
bone morphogenetic protein 3 (Bmp-3)  
bone morphogenetic protein type IA receptor (complete cds) 
bone morphogenetic protein-6 (Bmp-6)(partial cds) 
insulin-like growth factor binding protein 2 (Igfbp2) 
insulin-like growth factor I (3' end of mRNA) 
insulin-like growth factor II 
insulin-like growth factor binding protein 6 (Igfbp6) 
 Gene ID 
M12201 
Z78279 
M12202 
NM_017173 
AJ224880 
AF272662 
AB012139 
AF272661 
NM_012929 
 
NM_012656 
M11777 
NM_012881 
AF260922 
NM_012587 
AF184983 
AF104362 
NM_017087 
NM_012827 
NM_017178 
NM_017105 
D38082 
U66298 
NM_013122 
M81184 
X14834 
NM_013104 
Gene expression bone genes in control rat tibia 
Ranking
4 
5 
12 
188 
207 
491 
1768 
2141 
2214 
 
24 
32 
125 
211 
289 
834 
1209 
1669 
1906 
2120 
2230 
2238 
2278 
935 
1079 
1905 
2189 
Table 5.3  
Category 
collagens 
 
 
 
 
 
 
 
 
non-collagenous 
osteo 
 
 
 
 
 
 
 
BMP 
 
 
 
 
IGF 
 
 
 
 
The genes of interest are divided in several categories, collagens and non-collagenous genes (bone-related genes, insulin like growth factor system genes 
[IGFs] and bone morphogenetic system genes [BMPs]). Of the non-collagenous genes is known that they are involved in bone remodeling. 
Category: functional relationship; Ranking: place of gene based on mean intensity ratio; ID: unique gene number; name: gene name of rat specific mRNA; 
MEAN: mean intensity ratio = [(intensity gene)/(mean intensity housekeeping gene)]; housekeeping gene: GAPDH; SEM: standard error of the mean. 
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DISCUSSION 
 
This descriptive study shows the endogenous gene profile in normal rat tibia which 
comprises highly expressed genes relative to the housekeeping gene (GAPDH) like 
collagen alpha-1 type I, collagen alpha-2 type I, osteonectin, osteocalcin, hemoglobin 
alpha and beta chain and ribosomal related genes and lower expressed genes like 
osteopontin and osteoregulin. The total overview of endogenous gene expression 
levels in the bone matrix of a normal tibia is presented in the Supplementary Data file. 
 Collagen alpha-1 type I mRNA is known to be expressed in tooth and bone 
and collagen alpha-2 type I (segment 2 and 3) mRNA expression is localized in fetal 
calvaria (Genovese et al. 1984; Brandsten et al. 1999). Osteonectin, osteocalcin, 
osteopontin and osteoregulin are non-collagenous bone matrix proteins. Osteoblasts, 
the bone-forming cells, produce type I collagen and alkaline phophatase in an early 
stage and osteopontin, osteocalcin and osteonectin in a later stage (Rodan & Noda M. 
1991). Osteoregulin (MEPE, matrix extracellular phosphoglycoprotein) is produced by 
osteocytes (Gluhak-Heinrich et al. 2005). Thymosin beta-4 mRNA is localized in fetal 
calvaria and might be involved in osteoblast differentiation (Atkinson et al. 1990). In 
addition, hemoglobin alpha and beta chain are localized in reticulocytes (Crkvenjakov 
et al. 1984; Satoh et al. 1987), which are located in the intracortical blood vessel cells 
and mainly in the bone marrow. The defensin genes (RatNP-1 and RatNP-3 
precursors) are present in the bone marrow (Yount et al. 1995). We conclude that 
the isolated cortical shaft mRNA mainly consists of specific bone matrix genes and 
reticulocyte genes of the intracortical blood vessels, however, contamination with 
some bone marrow cells could not be excluded. Since the cell density of the bone 
marrow is much higher than the cell density of bone itself, a minor contamination of 
bone marrow cells could have a large impact on the composition of the isolated 
cortical tibia shaft. 
Among this list of 50 highest ranked genes, 28% represented a ribosomal 
related gene (Table 5.2). We conclude that the isolated mRNA of the cortical tibia 
shaft has a high quality, which was in accordance with the BioAnalyzer analysis. 
The localization of the CDK109 and CDK110 genes is not published yet, but 
this study shows that they are expressed in the bone matrix. However, the spotted 
oligonucleotide fragment of CDK109 and CDK 110 on the microarray is 100% 
homologue to sequences of other genes, like Gene ID J01438, which is a 
mitochondrial gene and codes for 12S ribosomal RNA and 16S ribosomal RNA and 
tRNAs and Gene ID X14848, which is also a mitochondrial gene. 
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The proportion in expression of the collagens and non-collagenous genes in 
the bone matrix is in agreement with the literature, since 90% of the organic matrix 
consists of collagens, predominantly of collagen type I, but collagen type III and type V 
may also be present, and 10% of non-collagenous proteins. 
 The majority of the genes (86%) showed a mean intensity ratio of <1 (ranging 
from 0.99-0.06; SEMmin-max 0.00-0.21). The intensity of those genes was lower than the 
mean intensity of the housekeeping gene (GAPDH). However, the intensity of a gene 
is not related to the ability of a gene to react on a stimulus as shown in Table 5.3. 
Osteoregulin plays an important role in bone formation (Chapter 6) and exhibits a 
low endogenous intensity ratio. We suggest that the functionality of a gene is 
dependent on the ability of a gene to induce an increase or decrease in the mRNA 
expression level and not the basal endogenous mRNA expression level. 
 The intensity ratio is not directly proportional to the RNA concentration of a 
gene. Quantitative rt-PCR analysis of a gene of interest will be necessary to provide 
the amount of RNA and to determine its specificity, since the crossreactivity of 
microarray is 10%. 
This explorative study has some limitations. The oligonucleotide microarray 
technology we used was based on differential gene expression comparing the treated 
with the control sample. Therefore the expression values are only semi-quantitative 
and data are expressed relative to the housekeeping gene GAPDH. Possible 
differences in intensity of the genes in this study may be caused by differences in 
efficiency of dye-labeling, purification, hybridization and post-hybridization washing 
during the microarray experiment. The intensity ratios as described in this study are 
site-specific for cortical rat tibia and age-dependent. It is not impossible that the 
general anesthesia during the experiment evokes changes in the brain which in turn 
alter some genes in the bone matrix within 6 hours after the experiment. 
In summary, this is the first study in the bone research area which showed a 
total overview of endogenous gene expression levels in the bone matrix of a normal 
rat tibia.  
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ABSTRACT 
 
Mechanical loading maintains bone mass. This study showed an upregulation of MEPE 
and a downregulation of creatine kinase (muscle form) and troponin-C in rat tibia 
6 hours after mechanical loading. These genes were identified with microarray analysis 
and validated with real-time rt-PCR analysis. 
 Introduction: Skeletal integrity in humans and animals is maintained by daily 
mechanical loading. It has been widely accepted that osteocytes function as 
mechanosensors. Many biochemical signaling molecules are involved in the response 
of osteocytes to mechanical stimulation. The aim of this study was to identify genes 
involved in the translation of mechanical stimuli into bone formation. 
 Materials and Methods: Nineteen female Wistar rats were randomly assigned 
to two groups: LOAD (n=9) and SHAM (n=10). The four-point bending model of 
Forwood and Turner was used to induce a single period of mechanical loading on the 
right tibia shaft. The contra-lateral left tibia (n=19) served as CONTROL. The effects 
on gene expression 6 hours after mechanical loading were determined with 
microarray analysis, followed by quantitative rt-PCR validation.  
Results: Of the 2375 genes, nine were found to exhibit a significant differential 
gene expression in the LOAD compared to the CONTROL group (false discovery 
rate <20%). Four genes, MEPE, Garnl1, V2R2B, and QFG-TN1 olfactory receptor 
were upregulated, whereas five genes, creatine kinase (muscle form), fibrinogen B 
beta polypeptide, monoamine oxidase A, troponin-C and kinesin light chain C were 
downregulated. No significant differences were observed between the SHAM and 
CONTROL group or between the LOAD and SHAM group. Validation with real-time 
rt-PCR analysis confirmed the upregulation of MEPE and the downregulation of 
creatine kinase (muscle form) and troponin-C in the loaded tibia.  
 Conclusion: Three genes, which play a key role during translation of 
mechanical stimuli 6 hours after mechanical loading, were identified: matrix 
extracellular phosphoglycoprotein (MEPE), creatine kinase (muscle form) and 
troponin-C. The importance of MEPE during the bone formation after mechanical 
stimulation has been described before. Creatine kinase (muscle form) and troponin-C, 
however, will provide new insight into bone formation after mechanical stimulation. 
Future studies on those genes (e.g. in situ hybridization and silencing RNA) are 
recommended to provide a better understanding of the osteogenic response after 
mechanical loading. 
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INTRODUCTION 
 
The ability of the skeleton to form bone after mechanical stimulation is a very 
complicated process, which consists of mechanosensing, mechanotransduction and 
the bone formation response. It is well-known that osteocytes function as 
mechanosensors via canalicular processes and communicating gap junctions in the 
early stage of bone remodeling (Cowin et al. 1991; Nomura & Takano-Yamamoto 
2000). Many biochemical signal molecules are involved during mechanical 
transduction, finally, resulting in bone formation. 
 Several in vitro studies have shown that glucose-6-phosphate dehydrogenase 
(G6PD)(el Haj et al. 1990), prostaglandin E2 (PGE2) and prostaglandin I2 
(PGI2)(Rawlinson et al. 1991; Klein-Nulend et al. 1995b; Ajubi et al. 1996; Klein-Nulend 
et al. 1997), c-fos (Kawata & Mikuni-Takagaki 1998), cAMP (Mikuni-Takagaki et al. 
1996; Kawata & Mikuni-Takagaki 1998), cyclooxygenase-2 (COX-2)(Kawata & Mikuni-
Takagaki 1998; Ogasawara et al. 2001; Wadhwa et al. 2002; Bakker et al. 2003), nitric 
oxide (NO)(Harell et al. 1977; Rawlinson et al. 1991; Klein-Nulend et al. 1995a; 
Johnson et al. 1996; McAllister & Frangos 1999), endothelial nitric oxide synthase 
(eNOS)(Klein-Nulend et al. 1998; Zaman et al. 1999), and insulin-like growth factor-I 
(IGF-I)(Mikuni-Takagaki et al. 1996; Kawata & Mikuni-Takagaki 1998) are important 
regulators of the osteogenic response when using fluid flow or stretching as a 
mechanical stimulus. 
 In vivo studies in animals report glucose-6-phosphate dehydrogenase 
(G6PD)(Skerry et al. 1989; Lanyon 1992), c-fos (Raab-Cullen et al. 1994; Lean et al. 
1996), cAMP (Davidovitch et al. 1984), COX-2 (Forwood 1996), NO and prostanoid 
(Pitsillides et al. 1995), insulin-like growth factors (IGFs)(Raab-Cullen et al. 1994; Lean 
et al. 1995; Bravenboer et al. 2001), transforming growth factor-β (TGF-β)(Raab-
Cullen et al. 1994; Bravenboer et al. 2001), protein kinase B (PKB or Akt)(Skerry & 
Suva 2003) and glutamate transporter (GLAST)(Mason et al. 1997; Skerry 1999; 
Skerry & Genever 2001; Skerry & Suva 2003) as biochemical signal molecules during 
the translation of mechanical loading into bone formation. The responses to in vivo 
mechanical loading are time-dependent. Early strain related changes within 5 minutes 
after loading are shown in osteocytes in which the glucose-6-phosphate 
dehydrogenase (G6PD) activity is increased (Skerry et al. 1989; Lanyon 1992). The 
cAMP level is also rapidly increased after loading (Davidovitch et al. 1984; Nomura & 
Takano-Yamamoto 2000). COX-2 (Forwood 1996), nitric oxide (NO), and 
prostanoid (Pitsillides et al. 1995) are also important for bone formation elicited by 
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mechanical strain. These early events are followed by changes in mRNA expression 
level. Compression of caudal vertebrae results in enhanced c-fos mRNA expression in 
cortical and trabecular osteocytes 30 minutes after loading (Lean et al. 1996). The 
four-point bending system shows an upregulation of c-fos mRNA expression in the 
periosteum of rat tibiae within 2 hours after loading and an increase of IGF-I and 
TGF-β mRNA in the periosteum of rat tibiae within 4 hours after loading (Raab-
Cullen et al. 1994). Increased IGF-I mRNA expression is observed on trabecular 
surfaces and in osteocytes of the diaphysial cortex (cortical and trabecular osteocytes) 
of rat caudal vertebrae within 6 hours after a single loading session (Lean et al. 1995), 
followed by an increased expression of type I collagen and osteocalcin on the bone 
surface (Lean et al. 1995). In addition, the concentrations of IGF-I protein within the 
humerus increased after 6 weeks of weightbearing exercise (5 days/week) in the rat-
with-backpack model, whereas the concentrations of TGF-β protein decreased 
(Bravenboer et al. 2001). 
 All of the above mentioned studies observed one single or a few 
mediators of the osteogenic reponse, however, the microarray technology, which was 
used in this study, allowed to explore multiple genes at once. The aim of this study 
was to identify candidate genes which were involved in the translation of mechanical 
stimuli into bone formation. We have examined differential gene expression 6 hours 
after a single loading session. To induce a single period of mechanical loading the four-
point bending model of Forwood and Turner was used (Turner et al. 1991; Turner et 
al. 1994; Forwood et al. 1998), which results in bone formation in the rat tibia 5-8 
days after stimulation (Forwood et al. 1996). The differential gene expression was 
determined with microarray analysis using non-pooled and non-amplificated rat tibia 
RNA samples. 
 
MATERIALS AND METHODS 
 
Animals 
 
Nineteen female 12-week-old Wistar rats (Harlan, Zeist, The Netherlands) were 
randomly assigned to two weight-matched groups: LOAD (223 ± 14 g, n=9) and 
SHAM (228 ± 10 g, n=10). The analysis of this experiment consisted of two parts: 
I. microarray, LOAD (217 ± 16 g, n=5) and SHAM (223 ± 8 g, n=5), and, 
II. real-time rt-PCR, LOAD (224 ± 14, n=8) and SHAM (228 ± 10 g, n=10). 
A part of the isolated tibia RNA was sufficient for both analyses. 
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The animal experiment was in accordance with the governmental guidelines 
for care and use of laboratory animals and approved by the Institutional Animal Care 
and Use Committee (IACUC) of the VU University Medical Center Amsterdam, The 
Netherlands. The animals were kept under standard laboratory conditions. 
 
In vivo mechanical loading 
 
The right tibiae underwent “medio-lateral” loading (LOAD)(distance between the 
centers of the loading pads: upper pads: 11 mm and lower pads: 23 mm) or sham-
loading (SHAM)(opposed pads were placed at the inner position: 11 mm) using the 
four-point bending system of Forwood and Turner (Turner et al. 1991; Forwood et al. 
1998). Since loading will result in bending and squeezing of the tibia and sham-loading 
only in squeezing of the tibia; the SHAM group was used as control for the LOAD 
group. All left tibia served as contra-lateral CONTROL. The right tibia of the rats 
were subjected to a single episode of loading comprising 300 cycles (2 Hz) using a 
peak magnitude setting of 60 N as described before (Chapter 3). Measurement with 
an external force reader before and after bending revealed that the actually used 
force was 72 ± 3 N (mean ± SD). The loading experiments were performed under 
general anesthesia (2% isoflurane in 1 l/min O2 and 2 l/min N2O). The rats were 
sacrificed exactly 6 hours after loading. This time-point was based on a previous study 
of Lean and colleagues (Lean et al. 1995). A time-course pilot experiment at our 
laboratory using real-time rt-PCR analysis (H.W. van Essen, personal communication) 
also showed the highest IGF-I mRNA expression 6 hours after loading. The tibiae 
were dissected and immediately frozen in liquid nitrogen after removal of the 
proximal and distal end, periosteum and bone marrow. 
 
RNA isolation 
 
The diaphysis of the tibia was pulverized in presence of Trizol (Invitrogen) using the 
Freezer mill 6750 (Spex Certiprep, Metuchen, NY, USA) subsequently followed by a 
Trizol extraction, a chloroform/isoamylalcohol extraction, and a second Trizol 
extraction according to the manufacturer’s instructions. The RNA pellet was 
dissolved in RNase-free water and stored at -80ºC prior to use for the microarray 
and/or rt-PCR analysis. Thus the sample included total RNA from the tibia shaft, 
containing osteocytes, osteoblasts, lining cells and intracortical blood vessel cells. 
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For the real-time reverse-transcriptase polymerase chain reaction (real-time 
rt-PCR) analysis the samples were additionally treated with RNase-free DNAse to 
eliminate DNA contamination. 
The quality of the RNA samples was determined with the RNA 6000 Nano 
Assay Kit (Agilent Technologies) on an Agilent 2100 BioAnalyzer and the A260/A280 
ratio was used to check for possible contaminations. The yield of RNA was measured 
with the spectrophotometer (A260)(NanoDrop® ND-1000 Spectrophotometer). The 
mean amount of total RNA used for the microarray analysis was 1604 ± 501 ng/µl 
(mean ± SD) ranging from 18.6 µg to 48.9 µg per tibia with an A260/A280 ratio of 
1.97 ± 0.05 (mean ± SD). 
 
Microarray, probe generation, hybridization and washing 
 
The Compugen Rat OligoLibraryTM was purchased from Sigma-Aldrich. Sixtymer 
oligonucleotides were resuspended to a concentration of 20 µM in a 150 mM sodium 
phosphate buffer, pH 8.5 and printed on CodeLinkTM activated slides (Amersham) 
using an Amersham Pharmacia Biotech Spotter. Features were spotted as duplicates 
on the microarray with pairs divided over two different regions. The total number of 
spotted oligonucleotides was 4803 per region, including 52 spots of the housekeeping 
gene glyceraldehyde-3-phosphate dehydrogenase (GAPDH)(Buermans et al. 2005). 
Furthermore, there were 138 empty spots. The slides exhibited a crossreactivity of 
10%; every spotted oligonucleotide has a change of 10% that a part of the spotted 
sequence interacts with another gene than mentioned in the gene name list. 
cDNA probes were generated from 15 µg total RNA with an oligo-dT 
([dT]20-VN) primer (Isogen, Maarsen, The Netherlands) and SuperScript™ II Reverse 
Transcriptase (Invitrogen), with incorporation of aminoallyl-dUTP (Ambion). Probes 
were indirectly labeled with Fluorolink Cy3 or Cy5 mono-functional dyes according to 
a dye-swap design. The dye-swap design was used to avoid a possible bias caused by 
the molecular structure of Cy3 and Cy5. Unique intra-rat hybridization was 
performed, because the treated tibia (LOAD or SHAM) was hybridized together with 
its own contra-lateral CONTROL tibia.  
The hybridization protocol was adapted from Snijders and colleagues 
(Snijders et al. 2001) with minor modifications. Pre-hybridization was performed in a 
hybridization mixture containing 60 µg yeast tRNA (ribonucleic acid transfer, Sigma), 
12 µg polyA (Amersham Biosciences) and 24 µg human Cot-1 DNA (Invitrogen) and 
30 µg salmon sperm DNA (Invitrogen) in a total volume of 29.2 µl per array. After 
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precipitation the pellet was dissolved in mastermix (50% formamide, 2x SSC, 
9.4% dextran sulphate) and 0.2% SDS in a total volume of 130.2 µl per array. Pre-
hybridization was maintained for 45 min at 37°C in the Hybridization Station 
(GenetacTM hybridization station or HybArray12 [Perkin Elmer]). The pre-
hybridization mix was gently removed and slides were dried by centrifugation at 200 g 
for 3 min. The probe-hybridization mixture contained 16.0 µl Cy3 and 16.0 µl Cy5 
labeled samples and 26.2 µl hybridization mixture (60 µg yeast tRNA, 12 µg polyA and 
24 µg human Cot-1 DNA). After precipitation the pellet was dissolved in mastermix 
and 0.2% SDS in a total volume of 130.2 µl per array. Probe mix was denaturated at 
70ºC for 15 min and incubated at 37ºC for 60 min. Hybridization was initiated and 
maintained for 16 h at 30ºC in the hybridization station, while the hybridization 
mixture was agitating. After hybridization, excess hybridization mixture was 
automatically rinsed off with 50% formamide, 2xSSC, pH 7.0 at 35ºC and followed by 
a wash step with PN buffer (0.1 M sodium phosphate, 0.1% Igepal CA630, pH 8) at 
25ºC. Excess salt was removed by subsequently rinsing in 0.2x SSC, 0.1x SSC and 
0.01x SSC at 25ºC. Slides were dried by centrifugation at 200 g for 3 min.  
After drying, the slides were scanned at 10 µm resolution for Cy3 and Cy5 
intensities using the microarray scanner (Agilent Technologies) operated by Agilent 
Scan Control software and Feature Extraction software. Array images were 
processed with BlueFuse version 3.0 for microarrays (BlueGnome, Cambridge, UK). 
 
Microarray statistics differential gene expression 
 
Automatically flagged genes (spots with a confidence value <0.11) and manually flagged 
genes (dirty spots and spots with a confidence value between 0.11-0.15 with a low 
intensity or bad morphology) were excluded from further analysis. The duplicates of 
the Cy3 and Cy5 intensities were not averaged, but were treated as separate spots in 
the analysis. The log2 values of the Cy5 to Cy3 ratios were normalized in an intensity 
dependent fashion (lowess). Genes with more than one missing value across arrays 
were excluded from the statistical analysis. 
Differentially expressed genes were identified by fitting a separate linear 
model to the expression data for each gene using the language R 
(http://www.r-project.org). Duplicate spots for each gene, printed on each array, were 
taken into account (Smyth et al. 2005). Differential expression was analyzed using 
moderated t-statistics based on empirical Bayes estimation (Smyth et al. 2005) and P-
values were adjusted according to the linear step-up method of Benjamini and 
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Hochberg to reflect the false discovery rate (Benjamini & Hochberg 1995; Reiner et al. 
2003). Genes with a false discovery rate <20% were considered to reflect statistical 
significance. 
Estimated relative differential expression for LOAD (i.e. relative to its contra-
lateral CONTROL) was compared to the estimated relative differential expression for 
SHAM (i.e. relative to its contra-lateral CONTROL). Thus, aspects of the 
experimental intervention bending and squeezing were compared with squeezing 
resulting in the net effect of bending. 
 
Microarray statistics single channel analysis 
 
Possible differences between the contra-lateral CONTROL of the LOAD group and 
the contra-lateral CONTROL of the SHAM group were investigated. Analyzing the 
differences between both CONTROL groups necessitated single channel analysis to 
compare the intensities of the CONTROL samples between arrays rather than the 
ratios between the two channels. This analysis was performed on 1944 spots, because 
missing values could not be handled by the single analysis (Smyth 2005). 
 
Real-Time rt-PCR 
 
Quantitative real-time rt-PCR analysis was performed on the nine differentially 
expressed genes to validate the microarray results. One hundred ng of total RNA was 
reverse-transcribed using 25 ng/µl random primers (Roche, Basel, Switzerland) and 
5 U/µl M-MLV Reverse Transcriptase (Promega) in a mixture containing 5 mM MgCl, 
1x RT-buffer, 1 mM dNTPs each, 1 M betaine and 0.40 U/µl RNAsin for 10 min at 
25°C, 1 h at 37°C and 5 min at 95°C in a total volume of 20 µl. All RNA samples 
were assayed in triplicate. Three µl of cDNA was amplified by PCR using the primers 
as described in Table 6.1. For every gene two primer sets were developed. The first 
primer set amplified a fragment of the mRNA which overlaps with the oligonucleotide 
that was spotted on the microarray and the second primer set amplified a fragment of 
the mRNA that was not present on the array. Both primer sets were used, because 
the microarray had a crossreactivity of 10%. 
In each case, the PCR consisted of an initial denaturation step for 3 min at 
95°C, followed by 40-50 cycles (15 sec at 95°C, 1 min at 60°C) in a total volume of 
25 µl containing 300 nM primers and SYBR Green Supermix (BioRad, Hercules, CA, 
USA). After the PCR, a melting curve was run from 50°C to 95°C to check the 
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specificity of the reactions. For fibrinogen the Taqman gene expression assay was also 
performed (Assay ID: Rn00709459_m1, Applied Biosystems).  
 
Real-Time rt-PCR statistics 
 
All mean Ct (threshold cycle) values were normalized for the housekeeping gene 
PBGD (porphobilinogen deaminase)(δCt=Ct GENE OF INTEREST – Ct PGBD), followed by a 
natural log-transformation to obtain a normal distribution, which was shown with a 
Kolmogorov-Smirnov test (SPSS, version 9.0). The paired-samples Student’s t-test 
(SPSS, version 9.0) was used to examine differences between the treated right and 
control left tibia in the same rat. The independent-samples Student’s t-test (SPSS, 
version 9.0) was used to compare indirect differences between the LOAD and SHAM 
group (2-δδCt value; δδCt=δCt TREATED – δCtCONTROL). A P-value of <0.05 was 
considered to reflect statistical significance. 
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Product 
(bp) 
100 
107 
106 
90 
116 
106 
122 
102 
90 
100 
135 
Nucleotide 
Position 
(nt) 
165 
3290 
823 
753 
439 
226 
979 
234 
162 
2003 
135 
Reverse 
(5’ - 3’) 
aagtggatgttgccttggtt 
agtcaatggaatccccatca 
ggcggaaaacttccttcata 
acctcccttccgaatgatct 
aggtgaccgaagaggtctca 
tccttggaggcttcaacatc 
tcatgcagccacaatagtcc 
ttcctctttggtgggtgtct 
catgctcaggagcacacact 
tggcaaagctacatgtatccag 
caaggttttcagcatcgctacca 
Nucleotide 
Position 
(nt) 
66 
3184 
718 
664 
324 
121 
858 
133 
73 
1904 
1 
Primer set II 
Forward 
(5’ - 3’) 
aggctgtgtctgttggactg 
tgccttctgaatctgatgactc 
atctggcacaacgacaacaa 
acggaatactgccacactcc 
tgctacagggtgtgagttgc 
cggcttatatccatgcatcc 
accagagcttccacctgaga 
gctgcctttgacatgtttga 
cccaggaagaccatctcctt 
cagccctaggagcttgtcag 
atgtccggtaacggcggc 
 
 
 
 
 
 
 
 
 
 
Product 
(bp) 
129 
95 
115 
115 
115 
105 
100 
111 
99 
96 
- 
Nucleotide 
Position 
(nt) 
1342 
3698 
1214 
1207 
1146 
712 
1540 
461 
378 
2184 
- 
Reverse 
(5’ - 3’) 
cccactggatgatgactcact 
tggtagggagctggagagaa 
tacttctgcgcagggatcat 
tgtggatggtcatggttctg 
gccagcagtccctttgtact 
tcacttggagctcacagttct 
ccacagaagtggaaacacca 
tcctcgtctgtcacatgctc 
acaggccagtttcaggacag 
cagcacatgcctcactccta 
- 
Nucleotide 
Position 
(nt) 
1214 
3504 
1100 
1093 
1032 
608 
1441 
351 
280 
2089 
- 
Primer set I 
Forward 
(5’ - 3’) 
agaacaagccaccctacacg 
agagcacggtacctgcagac 
cttccgaggtcgaacaggt 
accgaggccaacaagtacc 
cgaaatggaggactggaaag 
ccactgttgacaggagcatc 
aaggatgttccagccattga 
ggaactggctgagtgtttcc 
ctggttcaaacatcccttgc 
catcttgaggacaggcgtta 
- 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Target 
Array 
(nt) 
1311-1375 
3625-3689 
1102-1166 
1097-1161 
1097-1161 
655-719 
1460-1524 
347-411 
278-342 
2123-2187 
- 
Table 6.1 Primers for real-time rt-PCR 
 
Gene ID 
AF260922 
NM_020083 
NM_012530 
U05675 
U05675 
AF053990 
D00688 
J00793 
AF091565 
M75148 
PBGD 
Primer set I contained the sequence of the oligonucleotide as spotted on the microarray; 
Primer set II contained a fragment of the gene which was not present on the array; 
target array, position oligonucleotide fragment as spotted on the microarray;  
PBGD, housekeeping gene porphobilinogen deaminase. 
 
  
RESULTS 
 
Identification of differentially expressed mechanosensitive genes with microarray analysis 
 
After severe filtering of spot quality, 2375 spotted genes of the 4803 genes, including 
51 housekeeping genes, were present in the analysis. Of those 2375 genes, 82% had 
no missing values, whereas 18% had only one missing value.  
Comparison of the LOAD tibia and the contra-lateral CONTROL tibia 
resulted in nine significant differentially expressed genes with a false discovery rate 
<20% (Table 6.2). Four genes showed an upregulation ranging from 1.4-fold to 
1.8-fold and five genes were downregulated (Table 6.2).  
Comparison of the SHAM tibia and the contra-lateral CONTROL tibia did not 
result in significant differentially expressed genes (data not shown). Furthermore, the 
nine genes that were differentially expressed between the LOAD and CONTROL 
comparison were not present in the 189 highest ranked genes of the SHAM versus 
CONTROL comparison. This ranking was based on the posterior odds.  
Comparison of the LOAD tibia and the SHAM tibia did not result in significant 
differentially expressed genes (data not shown). However, the nine genes, which were 
significantly different expressed between the LOAD and the CONTROL comparison 
(Table 6.2), also ranked very high (e.g. place 1-5, 7, 10, 16 and 40) between the LOAD 
and the SHAM comparison. These nine genes exhibited an up- and downregulation 
pattern which was similar to the LOAD versus CONTROL comparison. 
 
Single channel analysis 
 
When comparing the contra-lateral CONTROL tibia of the LOAD group with the 
contra-lateral CONTROL tibia of the SHAM group a false discovery rate <20% 
yielded 3 significant downregulated genes: p21 (c-Ki-ras), phosphate regulating neutral 
endopeptidase on the X chromosome (X-linked hypophosphatemia XLH)(PHEX) and 
amino acid transporter system A (ATA2). 
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Biological connection 
skeletal development; regulation of bone 
remodeling; negative regulation of bone 
mineralization 
regulation of transcription 
phosphocreatine biosynthesis and 
metabolism 
blood coagulation; wound healing; 
regulation of blood pressure; positive 
regulation of cell proliferation 
related to Ca2+-sensing receptor and 
metabotropic glutamate receptors 
behavior; catecholamine catabolism and 
metabolism; dopamine catabolism; electron 
transport; neurotransmitter catabolism 
Ca2+-binding-subunit of the troponin 
complex 
G-protein coupled receptor protein 
signaling pathway; perception of smell, 
sensory transduction of chemical stimulus 
- 
B 
2.35 
1.92 
1.44 
1.08 
0.56 
0.50 
0.42 
-0.06 
-0.25 
FDR (%) 
5.4 
5.4 
6.5 
7.4 
9.4 
9.4 
9.4 
14.5 
16.0 
A 
11.60 
11.61 
9.24 
10.18 
7.84 
8.75 
7.64 
7.64 
7.88 
M 
0.87 
0.51 
-1.39 
-1.18 
0.68 
-2.00 
-1.96 
0.55 
-1.06 
Gene Name 
matrix extracellular phosphoglycoprotein (MEPE) 
osteoregulin; osteoblast/osteocyte factor 45 (OF45) 
GTPase activating RANGAP domain-like 1 (garnl1); 
tuberin-like protein 1 (tulip 1); GAP-related interacting 
protein to E12 (GRIPE)(Heng & Tan 2002) 
creatine kinase (muscle form)(CKM) 
fibrinogen B beta chain 
tissue-type vomeronasal neurons putative pheromone 
receptor V2R2B 
monoamine oxidase A 
troponin-C 
QFG-TN1 olfactory receptor 
kinesin light chain C 
Table 6.2 Differentially expressed genes 6 hours after mechanical loading 
Gene ID 
AF260922 
NM_020083 
NM_012530 
U05675 
AF053990 
D00688 
J00793 
AF091565 
M75148 
Nine genes were found to exhibit a significant differential gene expression (FDR <20%) in loaded tibia compared to contra-lateral control tibia measured 
with microarray analysis. This table shows their gene IDs, gene names and their biological connection (PubMed nucleotide; Rat Genome Database). 
M: 2log (LOAD/CONTROL), a positive value of M represents an upregulation and a negative value of M represents a down-regulation in the loaded tibia 
compared to the non-loaded control tibia; A: average log intensity (2log {[LOAD]*[CONTROL]}1/2); FDR: false discovery rate; B: posterior odds,  
natural log (chance that a gene is differentially expressed)/(chance that a gene is not differentially expressed). 
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Validation of mechanosensitive genes with real-time rt-PCR 
 
Real-time rt-PCR analysis showed a significant upregulation of MEPE (P<0.05) and a 
tended downregulation of creatine kinase (muscle form) and troponin-C 
(0.05<P<0.10) in the LOAD tibia compared to its contra-lateral CONTROL tibia 
(n=8) using two different primer sets per gene (Figure 6.1; Table 6.3). No significant 
differences of MEPE, creatine-kinase (muscle form) and troponin-C were found in the 
SHAM tibia compared to its contra-lateral CONTROL tibia (n=10)(Table 6.3). The 
other genes did not show significant differences in gene expression between the 
LOAD tibia and its contra-lateral CONTROL tibia (n=8) or SHAM tibia and its 
contra-lateral CONTROL tibia (n=10)(Table 6.3). Fibrinogen B beta chain was 
undetectable in the tibia irrespective their treatment (LOAD, SHAM, CONTROL) as 
measured with several primer sets and a commercial Taqman assay specific for 
fibrinogen B beta chain. 
  Comparison between the LOAD (n=8) and the SHAM group (n=10) showed a 
significant upregulation of MEPE with the specific primer set of the 2-δδCt value in the 
LOAD group (independent-samples Student’s t-test: P<0.05)(Table 6.3). No 
differences in expression between the LOAD (n=8) and the SHAM (n=10) group 
were shown in the other genes (Table 6.3). 
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P-value 
0.054b 
0.031a 
0.862 
0.814 
0.289 
0.319 
0.474 
0.592 
0.449 
0.867 
0.398 
0.481 
0.828 
0.759 
0.753 
0.963 
LOAD 
(n=8) 
2.36 ± 1.71 
2.03 ± 0.98 
1.09 ± 0.53 
0.91 ± 0.31 
2.00 ± 4.84 
1.65 ± 3.92 
1.11 ± 0.77 
0.96 ± 0.36 
1.20 ± 0.57 
1.03 ± 0.33 
1.89 ± 4.30 
2.31 ± 5.42 
1.12 ± 0.48 
1.02 ± 0.55 
1.23 ± 0.62 
1.10 ± 0.49 
2-δδCt (MEAN ± SD) 
SHAM 
 (n=10) 
1.15 ± 0.64 
1.20 ± 0.53 
1.14 ± 0.45 
0.97 ± 0.40 
10.95 ± 21.38 
15.36 ± 34.94 
1.24 ± 0.58 
1.03 ± 0.28 
1.04 ± 0.55 
1.03 ± 0.33 
6.07 ± 12.14 
9.56 ± 22.36 
1.15 ± 0.72 
1.16 ± 0.82 
1.11 ± 0.45 
1.06 ± 0.24 
P-value 
0.909 
0.455 
0.836 
0.431 
0.522 
0.452 
0.783 
0.892 
0.638 
0.778 
0.376 
0.387 
0.871 
0.905 
0.838 
0.732 
SHAM 
(n=10) 
17.09 ± 8.27 
12.13 ± 4.02 
0.787 ± 0.314 
0.062 ± 0.033 
1.490 ± 2.154 
0.698 ± 1.361 
0.010 ± 0.004 
0.021 ± 0.006 
0.127 ± 0.050 
0.184 ± 0.076 
0.660 ± 1.091 
0.518 ± 0.823 
0.012 ± 0.005 
0.041 ± 0.036 
0.563 ± 0.121 
0.648 ± 0.155 
2-δCt (MEAN ± SD) 
CONTROL 
SHAM 
(n=10) 
16.71 ± 7.87 
11.39 ± 5.90 
0.738 ± 0.259 
0.071 ± 0.031 
2.519 ± 4.069 
0.947 ± 1.516 
0.010  ± 0.004 
0.021 ± 0.006 
0.132 ± 0.040 
0.181 ± 0.053 
1.105 ± 1.516 
1.353 ± 2.260 
0.013 ± 0.007 
0.043 ± 0.035 
0.554 ± 0.147 
0.628 ± 0.134 
P-value 
0.041a 
0.009a 
0.971 
0.346 
0.067b 
0.062b 
0.717 
0.941 
0.538 
0.934 
0.074b 
0.080b 
0.882 
0.586 
0.608 
0.895 
LOAD 
(n=8) 
20.02 ± 5.67 
14.33 ± 4.59 
0.630 ± 0.124 
0.050 ± 0.016 
0.566 ± 1.355 
0.190 ± 0.446 
0.008 ± 0.002 
0.017 ± 0.005 
0.101 ± 0.034 
0.139 ± 0.024 
0.241 ± 0.532 
0.163 ± 0.369 
0.005 ± 0.002 
0.012 ± 0.006 
0.543 ± 0.169 
0.603 ± 0.173 
2-δCt (MEAN ± SD) 
CONTROL 
LOAD 
(n=8) 
12.77 ± 9.65 
8.43 ± 5.24 
0.659 ± 0.239 
0.060 ± 0.024 
2.488 ± 3.569 
1.213 ± 1.922 
0.010 ± 0.005 
0.019 ± 0.009 
0.093 ± 0.034 
0.144 ± 0.046 
1.182 ± 1.700 
0.640 ± 0.827 
0.005 ± 0.003 
0.014 ± 0.010 
0.506 ± 0.213 
0.595 ± 0.196 
 
 
I 
II 
I 
II 
I 
II 
I 
II 
I 
II 
I 
II 
I 
II 
I 
II 
Table 6.3 Validation of differentially expressed genes with real-time rt-PCR 
 
Gene Name 
MEPE 
Garnl1/Tulip 1 
Creatine kinase 
(muscle form) 
V2R2B 
Monoamine 
oxidase A 
Troponin-c 
QFG olfactory 
receptor 
Kinesin light chain 
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I, primer set I: contained the sequence of the oligonucleotide as spotted on the microarray; 
II, primer set II: contained a fragment of the gene which was not present on the array;  
δCt = Ct GENE OF INTEREST – Ct HOUSEKEEPING GENE (PGBD); δδCt = δCt TREATED – δCt CONTROL; 
a P<0.05; b 0.05<P<0.1. 
Figure 6.1 Real-time RT-PCR results of MEPE (A-B), creatinine kinase (muscle form) (C-D) and 
troponin-C (E-F) mRNA expression in the loaded tibiae and their contra-lateral controls represented 
per rat. Different markers represent different rats. Lines connect the right and left tibia of the same 
rat. For each gene, two primers were used, primer set I, which contained the sequence of the 
oligonucleotide as spotted on the microarray (A, C, E) and primer set II, which contained a fragment 
of the gene that was not present on the microarray (B, D, F). * P<0.05; ** 0.05<P<0.10. 
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DISCUSSION 
 
This is the first mechanical loading study which examined the effect on the expression 
of multiple genes in vivo in rats using microarray technology. This in vivo study showed 
differential gene expression in non-pooled and non-amplificated samples of rat tibia 
RNA 6 hours after a single mechanical loading session using the four-point bending 
system of Forwood and Turner (Turner et al. 1991; Turner et al. 1994; Forwood et al. 
1998). Hybridization of loaded or sham-loaded tibia versus the contra-lateral control 
tibia of the same rat was performed. Compared to the CONTROL group, the LOAD 
group showed a significant upregulation of the following genes: MEPE, Garnl1, putative 
pheromone receptor V2R2B and isolate QFG-TN1 olfactory receptor. Furthermore, 
five genes were significantly downregulated i.e., creatine kinase (muscle form), 
fibrinogen B beta polypeptide, monoamine oxidase A, troponin-C and kinesin light 
chain C. A similar trend was shown in the indirect LOAD versus SHAM comparison; 
however, these effects were not statistically significant due to the substantially 
reduced power of this comparison and the limited number of samples. 
 Validation with real-time rt-PCR analysis confirmed the upregulation of MEPE 
and the downregulation of creatine kinase (muscle form) and troponin-C in the 
LOAD tibia compared to the contra-lateral CONTROL tibia 6 hours after a single 
mechanical stimulation. Because the microarrays exhibited a crossreactivity of 10% 
two pairs of primers for the validation analysis were used. The first primer set 
amplified a fragment of the mRNA which overlapped with the oligonucleotide that 
was spotted on the microarray and the second primer set amplified a fragment of the 
mRNA that was not present on the array. Both primer sets showed a similar pattern. 
We therefore conclude that at least three of the differentially expressed genes, MEPE, 
creatine kinase (muscle form) and troponin-C of the microarray analysis were specific. 
Fibrinogen B beta chain was downregulated in the LOAD tibia compared to the 
CONTROL tibia in the microarray analysis, however, fibrinogen B beta chain was 
undetectable in all tibia, despite their treatment, in the real-time rt-PCR analysis using 
four different primersets and a commercial Taqman assay specific for fibrinogen B 
beta chain. In conclusion, the spotted oligonucleotide on the array was not specific for 
fibrinogen B beta chain. 
 
The up- and downregulated genes might play an important role in bone 
formation after mechanical loading. According to Forwood and Turner, a single 
loading session resulted in bone formation in the rat tibia 5-8 days after stimulation 
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(Forwood et al. 1996). Validation of the four-point bending system at our laboratory 
also showed bone formation at the endosteal surface of the rat tibia 15 days after 
loading (Chapter 3). Under normal conditions the upregulated genes might directly or 
indirectly stimulate bone formation, whereas the downregulated genes might directly 
or indirectly inhibit bone formation. 
Since the loading consisted of bending and squeezing and the sham-loading 
consisted of squeezing comparing the results of loaded tibia with the sham-loaded 
tibia will reveal the pure effect of bending. The real-time rt-PCR analysis showed a 
significant upregulation of MEPE and downregulation of creatine kinase (muscle form) 
and troponin-C in the LOAD tibia compared to the contra-lateral CONTROL tibia 
and did not show a significant change of expression between the SHAM tibia and the 
contra-lateral CONTROL tibia. Thus, the increase of MEPE expression and decrease 
of creatine kinase (muscle) and troponin-C expression appears to be due to bending. 
 
The importance of MEPE during the bone formation after mechanical 
stimulation has been described earlier (Gluhak-Heinrich et al. 2005), while the other 
eight differentially expressed genes were never reported to be involved in the 
osteogenic response. This opens new insight into the process of bone formation after 
mechanical stimulation, especially for creatine kinase (muscle form) and troponin-C. 
In rodents, MEPE mRNA and protein are expressed by osteoblasts and 
osteocytes (Petersen et al. 2000), and in human bone by osteocytes within mineralized 
bone (Nampei et al. 2004) and by bone marrow cells (Rowe et al. 2000). Mechanical 
loading induces MEPE mRNA expression in the osteocytes in a unique time-course 
and spatial pattern in mice as shown by in situ hybridization and Northern blotting 
(Gluhak-Heinrich et al. 2005). Throughout ossification, MEPE is transiently expressed 
by mature osteoblasts and subsequently expressed by osteocytes in the skeleton of 
rats (Igarashi et al. 2002). MEPE might play a role during long bone regeneration, 
skeletogenesis (Lu et al. 2004) and odontogenesis (Macdougall et al. 2002). In addition, 
a synthetic fragment of human MEPE (AC-100) stimulates new bone formation in vivo 
(Hayashibara et al. 2004). Our study supports the hypothesis that MEPE plays an 
important role during bone formation after mechanical stimulation. 
MEPE is a member of the Small Integrin Binding Ligand N-linked Glycoprotein 
(SIBLING) family of proteins (i.e. bone sialoprotein, osteopontin, dentin 
sialophosphoprotein, and dentin matrix protein)(Fisher et al. 2001; Qin et al. 2003). 
MEPE plays a role in the regulation of bone mineralization, dentin mineralization, 
skeletal development, regulation of bone remodeling, renal phosphate handling and 
 Mechanical loading and gene expression – microarray study 
 143 
vitamin D metabolism (Petersen et al. 2000; Rowe et al. 2000; Fisher et al. 2001). 
Members of the SIBLING family share features like the RGD motif (arginine-glycine-
asparagine) and the ASARM motif (Acidic-Serine-Aspartate-Rich-MEPE)(Rowe et al. 
2000; Rowe 2004). It was hypothesized by Rowe and colleagues that the ASARM-
peptide of MEPE is responsible for the inhibition of bone mineralization after cleavage 
(Rowe 2004). Our results showed that un-cleaved MEPE is increased 6 hours after 
mechanical loading, which will finally result in bone formation. 
Nagel and colleagues reported that MEPE requires inducible COX-2 to exert 
potent anabolic effects on normal human bone marrow osteoblast precursors (Nagel 
et al. 2004). It is conceivable that upregulation of COX-2, which is an early response 
to mechanical loading (Forwood 1996; Kawata & Mikuni-Takagaki 1998; Ogasawara et 
al. 2001; Wadhwa et al. 2002; Bakker et al. 2003), is followed by an increased MEPE 
mRNA expression 6 hours after loading in vivo. 
 
Both, the microarray study and the validation with real-time rt-PCR showed 
that creatine kinase (muscle form) and troponin-C were negatively regulated by 
mechanical stimulation. Creatine kinase (muscle form) is expressed in adult skeletal 
and cardiac muscle of mice (Zhao et al. 1994). It is involved in phosphocreatine 
biosynthesis and metabolism (Rat Genome Database). Calbindins or vitamin D 
dependent calcium binding proteins are members of the troponin-C (the calcium-
binding subunit of the troponin complex) superfamily (Gross & Kumar 1990). Vitamin 
D deficiency will result in a decreased troponin-C concentration in rabbits (Pointon et 
al. 1979). Our study showed that creatine kinase (muscle form) and troponin-C are 
associated with the regulation of bone formation 6 hours after mechanical stimulation. 
 
The single channel analysis, in which differences between the contra-lateral 
CONTROL tibia of the LOAD group and the SHAM group were investigated, showed 
3 significantly downregulated genes between the CONTROL tibia of the LOAD group 
and the CONTROL tibia of the SHAM group, i.e. p21 (c-Ki-ras), phosphate regulating 
neutral endopeptidase on the X chromosome (X-linked hypophosphatemia XLH) 
(PHEX) and amino acid transporter system A (ATA2). This suggests the possibility 
that loading leads to simultaneous changes in the loaded tibia and the contra-lateral 
tibia. 
Interestingly, PHEX and MEPE are members of the same pathway. Rowe and 
colleagues described a possible role for PHEX, MEPE and the ASARM motif in 
mineralization (Rowe 2004). The MEPE-ASARM complex is an enhancer of 
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mineralization. However, the ASARM-peptide in free form inhibits mineralization. 
PHEX prevents cleavage of the ASARM motif of MEPE by inhibiting cathepsin B and 
proteases (Guo et al. 2002), thereby preventing inhibition of mineralization by the 
ASARM-peptide (Rowe 2004). In our study, bending results in a significant increase of 
MEPE in the right LOAD tibia compared to its left CONTROL tibia and 
simultaneously a decrease of PHEX in its left CONTROL tibia. We suggest that MEPE 
might require PHEX for bone formation after mechanical stimulation. 
 
Recently, Xing and colleagues (Xing et al. 2005) also described the effects of 
four-point bending using the microarray technique. They used the mouse as animal 
model, which has the advantage of exploring 20,280 transcripts at once; however, a 
disadvantage of their model system is the low amount of RNA per tibia: pooling of the 
tibiae was therefore necessary. They reported a list of 346 differentially expressed 
genes 24 hours after 4 days of multiple loading sessions (Xing et al. 2005), whereas we 
studied the osteogenic response 6 hours after a single loading session. So, the genes in 
their study may include genes up- or downregulated between 24 hours and 5 days 
after loading, i.e. a complex cascade of genes, whereas our study is restricted to the 
effects of a single mechanical loading session at 6 hours. Only one gene, (mono)amine 
oxidase A, was differentially expressed in both studies. However, in our study it was 
significantly downregulated, whereas in the study of Xing it was significantly 
upregulated. 
 
This study has some limitations. The number of significant differentially 
expressed genes is low. A possible explanation could be the low number of 
microarrays per condition, which limits the power of the statistical analysis, or the 
severe filtering of the spots before the statistical analysis, in which also some 
mechanosensitive candidate genes, as mentioned in the introduction, were lost. 
 
In conclusion, the present study shows that MEPE, creatine kinase (muscle 
form) and troponin-C play a key role during translation of mechanical stimuli 6 hours 
after mechanical loading. The importance of MEPE during the bone formation after 
mechanical stimulation has already been described (Gluhak-Heinrich et al. 2005). 
Creatine kinase (muscle form) and troponin-C, however, will provide new insights in 
bone formation after mechanical stimulation. Future studies on these genes (e.g. in situ 
hybridization and silencing RNA) are therefore recommended to provide a better 
understanding of the osteogenic response after mechanical loading. 
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Chapter 7 
General Discussion 
 General discussion 
 
GENERAL DISCUSSION 
 
This thesis focuses on the effects of a single mechanical loading session on gene 
expression levels in rat bone. It is desirable to elucidate the role of known 
mechanosensitive genes and to identify novel candidate genes, which are involved in 
the process of bone formation after mechanical stimulation, because identification of 
those genes will provide new tools for the treatment of osteoporosis and other bone 
diseases. In addition, the effect of IGF-II overexpression on the IGF components in the 
brain was investigated in this thesis.  
 
The following questions were addressed in this thesis and will be discussed: 
 
1) What is the endogenous localization of IGF-I and IGFBP-2 mRNA expression 
in the rat tibia? 
2) Does a single mechanical loading session affect the IGF-I and IGFBP-2 mRNA 
expression locally in the rat tibia 6 hours after stimulation? 
3) What is the endogenous gene expression profile in the rat tibia? 
4) Which genes are differentially expressed 6 hours after mechanical 
stimulation? 
5) What is the effect of IGF-II overexpression on the components of the 
IGF-system in brain? 
 
The known mechanosensitive mediators of bone formation after mechanical 
stimulation are summarized in Table 7.1 and Table 7.2. Since the action of the 
mechanosensitive genes is time-dependent, the mediators are depicted on a time-
schedule from 0 minutes until 24 hours post-loading (Table 7.1) and 0 minutes – 12 
hours during loading (Table 7.2). Based on this scheme, it was shown that most 
studies were performed within the 0-1 hour time-frame. To address the underlying 
mechanism of the osteogenic response the present study was focused on changes on 
mRNA level 6 hours after mechanical stimulation. The genes, which were identified in 
our study, i.e. insulin-like growth factor-I (IGF-I), insulin-like growth factor binding 
protein-2 (IGFBP-2), matrix extracellular phosphoglycoprotein (MEPE), creatine 
kinase (muscle) and troponin-C, have been included in Table 7.1. 
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Table 7.1 Mechanosensitive mediators 0 – 24 h post-loading 
Mediator   
Reference 
 
3H-uridine            
el Haj 1990  
3H-uridine       
Dallas 1993 
3H-uridine        
Lanyon 1992 
G6PD                   
el Haj 1990 
G6PD              
Dallas 1993 
G6PD              
Zaman 1997 
G6PD              
Skerry 1989 
G6PD             
Lanyon 1992 
cAMP              
Harell 1977 
cAMP             
Mikuni-Takagaki 1996/99 
cAMP          
Davidovitch 1984 
cGMP         
Davidovitch 1984 
PGE2                
Harell 1977 
PGE2                
Klein-Nulend 1995b 
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Mediator  
Reference 
 
PGE2                      
Klein-Nulend 1995b 
PGE2             
Davidovitch 1984 
PGI2                 
Zaman 1997 
PGI2                 
Klein-Nulend 1995b 
NO               
Pitsillides 1995 
NO               
Pitsillides 1995 
NO               
Pitsillides 1995 
NO                
Zaman 1999 
eNOS              
Klein-Nulend 1998 
COX-2           
Kawata 1998 
COX-2           
Bakker 2003 
c-fos                      
Raab-Cullen 1994 
IGF-I                  
Lean  1995/96 
 1
5
8
 
 
  
  
  
 
 
 
 
 
 
  
24 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
  
 
 
 
 
 
 
 
 
  
 
 
 
 
 
 
 
 
  
12 
 
 
 
 
 
 
 
 
  
 
 
 
 
 
 
 
 
  
11 
 
 
 
 
 
 
 
 
  
 
 
 
 
 
 
 
 
  
10 
 
 
 
 
 
 
 
 
  
  
 
 
 
 
 
 
 
 
  
9 
 
 
 
 
 
 
 
 
  
  
 
 
 
 
 
 
 
 
  
8 
 
 
 
 
 
 
 
 
  
  
 
 
 
 
 
 
 
 
  
7 
 
 
 
 
 
 
 
 
  
  
 
 
  
6 
 
 
6 
6 
6 
6 
6 
6 
  
  
 
 
 
 
 
 
 
 
  
5 
 
 
 
 
 
 
 
 
  
  
 
 
 
 
 
 
  
4 
4 
4  
 
 
 
 
 
 
  
  
 
 
 
 
 
 
 
 
  
3 
 
 
 
 
 
 
 
 
  
  
 
 
 
 
 
 
 
 
  
2 
 
 
 
 
 
 
 
 
  
 
 
 
 
 
 
 
 
(h)
1 
 
 
 
 
 
 
 
 
  
  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
30 
 
 
 
 
 
 
 
 
 
  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
  
15 
 
 
 
 
 
 
 
 
  
 
 
 
 
 
 
 
 
 
  
 
 
 
 
 
 
 
 
 
  
 
 
 
 
 
 
 
 
 
  
 
 
 
 
 
 
 
 
 
  
10 
 
 
 
 
 
 
 
 
  
 
 
 
 
 
 
 
 
 
  
 
 
 
 
 
 
 
 
 
  
 
 
 
 
 
 
 
 
 
  
 
 
 
 
 
 
 
 
 
  
5 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Time 
(min) 
0 
 
 
 
 
 
 
 
 
Mediator   
Reference 
 
IGF-I                
Raab-Cullen 1994 
TGF-β               
Raab-Cullen 1994 
GLAST             
Mason 1997 
IGF-I              
Chapter 3 
IGFBP-2           
Chapter 4 
MEPE             
Chapter 6 
Creatine kinase 
Chapter 6 
Troponin-C        
Chapter 6 
Table 7.1 pg. 155-157 Schematic representation of mechanosensitive mediators post-loading 
t=0, end of loading period; min: minutes; h: hour 
The grey boxes represent the time-point at which that mediator is known to be involved in the process of bone formation after mechanical loading. 
3H-uridine incorporation: an indicator of proliferation; G6PD: glucose 6-phosphate dehydrogenase; cAMP-cGMP: cyclic nucleotides; PGE2: prostaglandin E2; 
PGI2: prostacyclin; NO: nitric oxide; ecNOS; endothelial nitric oxide synthase; COX-2: cyclooxygenase-2, an inducible isoform of prostaglandin G/H synthase; 
GLAST: glutamate/aspartate transporter; Bone Gla protein: osteocalcin; IGF-I: insulin-like growth factor-I; IGFBP-2: insulin-like growth factor-binding protein-2; 
TGF-β: transforming growth factor-β; MEPE: matrix extracellular phosphoglycoprotein. 
Ocyt: osteocyte; Ob: osteoblast; PF: periosteal fibroblast. 
  
Table 7.2  pg 158 Changes in mechanosensitive mediators during the loading period 
t=0, beginning of loading period; bar represents end of loading period; min: minutes; h: hour 
The grey boxes represent the time-point at which that mediator is known to be involved in the process of bone formation during mechanical loading. 
PGE2: prostaglandin E2; PGI2: prostacyclin; PGF2α: prostaglandin-F2α; NO: nitric oxide; COX-2: cyclooxygenase-2, an inducible isoform of prostaglandin G/H 
synthase; 
Ocyt: osteocyte; Ob: osteoblast; PF: periosteal fibroblast. 
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Table 7.2 Mechanosensitive mediators during loading 
Mediator  
Reference  
 
PGE2                
Rawlinson 1991 
PGE2                  
Ajubi 1996 
PGE2                         
Klein-Nulend 1997 
PGI2                            
Ajubi 1996 
PGI2                          
Klein-Nulend 1997 
PGF2α                
Klein-Nulend 1997 
NO                 
Klein-Nulend 1995a 
NO                  
Klein-Nulend 1995a 
NO                  
Pitsillides 1995 
NO                
Pitsillides 1995 
NO                
Johnson 1996 
NO                
McAllister 1999 
COX-2            
Kawata 1998 
COX-2          
Ogasawara 2001 
COX-2          
Wadhwa 2002 
c-fos               
Kawata 1998 
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To test the hypothesis that mechanical loading affects the local gene expression 
of the IGF-system, in situ hybridization studies were performed. These in situ 
hybridization studies were focused on insulin-like growth factor-I (IGF-I) and insulin-
like growth factor binding protein-2 (IGFBP-2), because IGF-I is predominantly 
expressed in rat bone, whereas IGF-II is predominantly expressed in human bone 
(Shinar et al. 1993; Wang et al. 1995; Middleton et al. 1995) and the bioavailability of 
IGFs is influenced by the IGFBPs. IGFBP-2 is most abundantly expressed in rat bone; 
however, the function of IGFBP-2 is poorly understood. Our studies showed that 
endogenous IGF-I mRNA and IGFBP-2 mRNA were mainly expressed in osteoblasts, 
which were located against the surface of trabecular bone and at the endosteal side of 
the shaft, and in some trabecular osteocytes and in cortical osteocytes, which were 
situated within the first lamella at the endosteal side of the shaft. The endocortical 
osteocytes, which were located within the deeper lamellae, and the periosteal 
osteocytes did neither express IGF-I mRNA nor IGFBP-2 mRNA. 
The four-point bending model of Forwoord and Turner was used to induce a 
single session of mechanical stimulation in vivo, which results in an increased bone 
formation rate with a maximal increase during day 5-8 (Forwood et al. 1996; Forwood 
et al. 1998). The validation study in our laboratory confirmed the lamellar bone 
formation at the endosteal side of the shaft (Figure 3.3). An upregulation of both IGF-I 
and IGFBP-2 mRNA expression 6 hours after a single loading session was observed in 
the endocortical osteocytes of the loaded tibia. So, bending and squeezing upregulated 
IGF-I mRNA expression and IGFBP-2 mRNA expression in osteocytes (Table 7.1; 
Table 7.3). In addition, squeezing alone also increased the IGFBP-2 mRNA expression 
in endocortical osteocytes, but did not alter the IGF-I mRNA expression locally in 
endocortical osteocytes (Table 7.3). For lamellar bone formation at the endosteal side 
of the shaft, bending of the tibia is necessary, because squeezing alone is not enough 
to stimulate new bone formation. In osteoblasts, the bone-forming cells, the IGF-I 
mRNA expression and the IGFBP-2 mRNA expression was neither changed after 
bending nor after squeezing the tibiae, which might be due to the high level of 
endogenous mRNA expression of IGF-I and IGFBP-2 in those cells. In conclusion, the 
presence of IGF-I and IGFBP-2 simultaneously in the endocortical osteocytes was 
essential for the bone formation after mechanical loading at the endosteal side of the 
tibia. Thus, we suggest that the osteocytes translate mechanical stimuli into bone 
formation through IGF-I in the presence of IGFBP-2. 
This is supported by a similar finding of Conover and colleagues, who showed 
that the hIGF-II/IGFBP 2 complex is able to stimulate human osteoblast proliferation 
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(Conover & Khosla 2003) and to prevent bone loss in a sciatic neurectomy rat model 
(Conover et al. 2002). 
 
Table 7.3 Effect of a single mechanical loading session on the mRNA 
expression in the endocortical osteocytes and bone formation 
Endosteal side of shaft Load 
(bending and squeezing) 
Sham-load 
(squeezing) 
Chapter 
IGF-I mRNA expression 2-fold increase No difference 3 
IGFBP-2 mRNA expression 1.68-fold increase 1.35-fold increase 4 
Lamellar bone formation Yes No 3 
Fold increase represents the increase of the number positive endosteal osteocytes in loaded tibia 
(n=5) or sham-loaded tibia (n=5) compared to the contra-lateral control tibia (n=10).  
 
Immunohistochemistry (IHC), a method to detect protein expression locally, 
was not used in this study. The aim of our study was to detect changes in the bone 
matrix caused by mechanical loading. Studies on mRNA level represent “direct” 
changes in the synthesis of a gene, whereas studies on protein level represent 
“indirect” changes in the production of the protein. The bone matrix serves as 
storage for growth factors, such as IGF-I protein, thus the endogenous IGF-I protein 
level is high, which makes it difficult to distinguish changes on protein level. 
In situ hybridization on tibia sections with the ribosomal 28S RNA probe 
showed 28S RNA expression in the cytoplasm of all bone cells, including the 
trabecular osteocytes and cortical osteocytes across the tibia shaft (Chapter 3). In 
conclusion, the RNA integrity was maintained during the preparation procedure and 
the in situ hybridization. 
The cDNA probes, which were used in these non-radioactive in situ 
hybridization studies, encode for human IGF-I (258bp, containing exon 2 and 3)(Jansen 
et al. 1983) and mouse IGFBP-2 (amino acid position 98-258)(Schuller et al. 1993). Rat 
IGF-I cDNA shows 93% (exon 2) and 86% (exon 3) homology with human IGF-I 
cDNA and rat IGFBP-2 cDNA corresponding to the mouse fragment shows 95% 
homology. In the brain, which was used as positive control, IGF-I mRNA was 
expressed in neuronal structures such as the nuclei of the medulla oblongata and 
Purkinje cells and IGFBP-2 mRNA was expressed in the non-neuronal structures, i.e. 
the choroid plexus and meninges (Reijnders et al. 2004). In conclusion, the probes 
were specific for IGF-I and IGFBP-2 mRNA expression in mouse and rat tissues. 
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This thesis showed a 10-fold increase the IGFBP-2 mRNA expression in the 
trigeminal nucleus of the medulla oblongata of hIGF-II transgenic mice brain (Reijnders 
et al. 2004). Although the hIGF-II gene is expressed in considerable amounts in 
neuronal cells of the cortex and the piriform cortex, this did not affect the 
endogenous IGF-I and/or IGF-II expression levels in these brain areas. Nor did IGF-II 
overexpression in the brain affect the growth of the brain during postnatal growth 
(van Buul-Offers et al. 1995). This contrasts with the increased growth of the brain in 
IGF-I transgenic mice (Ye et al. 1996), suggesting that IGF-II is much less important for 
brain growth than IGF-I (Carson et al. 1993; Ye et al. 1995). 
The hIGF-II transgenic mice also showed an increased IGF-I mRNA 
expression locally in the growth plate as reported by Smink and colleagues (Smink et 
al. 2002). However, IGF-II overexpression did not affect longitudinal growth (van 
Buul-Offers et al. 1995) nor did it change the length of the tibia and humerus (Rooman 
et al. 1999). The biological activity of IGFs is largely dependent on the presence of IGF 
binding proteins (Firth & Baxter 2002). It has been suggested by Smink and co-authors 
that the absence of increased growth induced by IGF-II overexpression in the spleen 
of our transgenic mice was caused by an increase in IGFBP-2, -3 and -5 expression. 
The thymus of hIGF-II transgenic mice showed overgrowth, but no upregulation of 
these IGF binding proteins (Smink et al. 1999). 
In summary, the 10-fold IGFBP-2 upregulation in the medulla oblongata in 
hIGF-trangenic mice, without any consequences for brain growth, shows again the 
tissue dependency of the actions of the IGFs and their binding proteins. 
 
Since bone formation after mechanical loading is a multi-factorial process, i.e. 
several cascades of mediators are involved during the osteogenic response, we 
hypothesized that exploring a set of genes will provide a new meaningful insight into 
bone formation after mechanical stimulation. Differential display is a method, which 
was used in the past to identify genes that were regulated differently between two 
samples; recently the microarray technology is used for differential studies. Our 
microarray study showed that nine genes were differentially expressed 6 hours after a 
single mechanical loading session, i.e. matrix extracellular phosphoglycoprotein 
(MEPE), Garnl1, putative pheromone receptor V2R2B, isolate QFG-TN1 olfactory 
receptor, creatine kinase (muscle form), fibrinogen B beta polypeptide, monoamine 
oxidase A, troponin-C and kinesin light chain C. Three genes were confirmed with 
real-time rt-PCR analysis, i.e. MEPE, creatine kinase (muscle) and troponin-C 
(Table 7.1). MEPE was upregulated, whereas creatine kinase (muscle) and troponin-C 
were downregulated (Figure 7.1)(Chapter 6). These new mechanosensitive genes 
 General discussion 
 163 
provide new tools for future studies. It would be very interesting to perform time-
course studies, localization studies (in situ hybridization/immunohistochemistry) and 
silencing RNA studies on those genes to elucidate their role during the osteogenic 
response in more detail. 
 
In addition, the single channel analysis, in which the contra-lateral control 
tibiae of the load group were compared with the contra-lateral control tibiae of the 
sham group, showed a downregulation of phosphate regulating neutral endopeptidase 
on the X chromosome (X-linked hypophosphatemia XLH)(PHEX) in the contra-
lateral control tibia of the loaded group compared to the contra-lateral control tibia 
of the sham group. Interestingly, PHEX and MEPE are members of the same pathway 
involved in mineralization (Rowe 2004). The MEPE-ASARM complex is an enhancer of 
mineralization. However, the ASARM-peptide in free form inhibits mineralization. 
PHEX prevents cleavage of the ASARM motif of MEPE by inhibiting cathepsin B and 
proteases (Guo et al. 2002), thereby preventing inhibition of mineralization by the 
ASARM-peptide (Rowe 2004). In our study, bending results in a significant increase of 
MEPE in the loaded tibia compared to its left control tibia and simultaneously a 
decrease of PHEX in this left control tibia (Chapter 6), suggesting that MEPE might 
require PHEX for bone formation after mechanical stimulation. 
 
The development of the microarray analysis provides a possibility to observe 
hundreds of genes at once also in normal cortical rat bone. Thus, the composition of 
the endogenous gene profile of cortical bone could be studied. Most genes (93%) had 
an intensity ratio <2 in normal rat tibia. However, the functionality of a gene is 
dependent on the ability to induce an increase or decrease the basal mRNA 
expression level and is not dependent on the basal amount of endogenous mRNA. In 
this respect, endogenous MEPE expression had a ratio of 1.53 and appeared to be 
involved during bone formation after mechanical loading as shown in the differential 
microarray study (Chapter 5 and 6). Among the genes with a ratio >7 (1.4%) were 
osteonectin and osteocalcin, collagen and hemoglobin-related genes, suggesting that 
the isolated cortical bone of the rat tibia consisted of bone matrix, but also intra-
cortical blood vessel cells and bone marrow cells (Chapter 5). Since the cell density of 
the bone marrow is much higher than the cell density of bone itself, a minor 
contamination of bone marrow cells could have impact on the composition of the 
isolated cortical tibia shaft. 
 
Chapter 7  
164 
The effects observed in the in situ hybridization studies of the tibia, a local 
increase of IGF-I and IGFBP-2 mRNA in the loaded tibia, were not reflected in the 
differential microarray study. The known mechanosensitive genes, such as 
cyclooxygenase-2 (COX-2) and glucose-6-phosphate dehydrogenase (G6PD) were 
also not upregulated in the microarray study. Although those four mechanosensitive 
genes were present on the microarray, no difference in expression between loaded 
tibia and non-loaded control tibia was observed with the microarray technology. 
Apparently the microarray study was not sensitive enough to detect relative small 
local differences in a tissue sample. In conclusion, the microarray technique is an 
excellent method to screen relative large differences in a tissue sample; however, 
real-time rt-PCR analysis is necessary to confirm the specificity of the difference and 
in situ hybridization studies are still preferable to refine the working mechanism of the 
osteogenic response locally in bone cells. On the other hand, MEPE is differentially 
upregulated as shown with the microarray analysis, promising a large effect on local 
tissue level. 
 
The osteogenic response is a complex process, which is not only time-
dependent, but also site-dependent. The results of this study were site-specific. The 
mechanical loading in our studies was applied to the cortical tibia shaft and changes in 
gene expression were determined within the cortical bone of the tibia shaft. 
However, it might be possible that other bones and bone-types, i.e. trabecular bone, 
respond differently than the cortical shaft of the tibia. 
 
In our microarray study we also examined the role of pathways in bone 
formation after mechanical stimulation. The global test of Goeman and colleagues 
(Goeman et al. 2004) was designed to determine differences in pathways between the 
loaded tibia and sham-loaded tibia. However, no significant differences were observed. 
Maybe we might observe differences if we compared the pathways of the loaded tibia 
with its contra-lateral control tibia and the sham-loaded tibia with its contra-lateral 
control tibia. 
 
All data are summarized in Figure 7.1, in which a proposed mechanism of 
bone formation after mechanical stimulation is presented. Mechanical loading is sensed 
by osteocytes, which is followed by changes in the levels of the immediate response 
genes (<1 h) for example: G6PD, cAMP and cGMP, nitric oxide (NO) and 
prostaglandin E2 (PGE2) in osteocytes and osteoblasts, followed by activation of the 
early response genes (1-6 h), for example: COX-2, endothelial nitric oxide synthase 
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(ecNOS), c-fos, IGF-I and transforming-growth factor-β (TGF-β) and the late response 
genes (>6 h) of our study: IGF-I, IGFBP-2, MEPE, creatine-kinase (muscle) and 
troponin-C. In addition, our study showed that the endocortical osteocyte is very 
mechanosensitive. The modulation of the gene activity could be affected directly by 
mechanical loading or indirectly as member of an induced cascade of genes. The most 
components, which are mentioned in this scheme, are members of different pathways; 
however, IGF-I will need the presence of IGFBP-2 to form bone after mechanical 
stimulation. Finally, the activation of several cascades of genes will result in bone 
formation. 
 
Figure 7.1 Proposed mechanism of bone formation after mechanical stimulation. This is a schematic 
representation of the data of this thesis. Bone formation after mechanical stimulation comprises of several steps: 
- the applied mechanical load induces fluid flow in the canaliculi and is sensed by osteocytes; 
- conversion into biochemical signal by activation of immediate response genes (<1h) for example: G6PD, 
cAMP and cGMP, nitric oxide (NO) and prostaglandin E2 (PGE2) in osteocytes and osteoblasts; 
- activation of the early response genes (1-6 h), for example: endothelial nitric oxide synthase (ecNOS), 
cyclooxygenase-2 (COX-2), c-fos, IGF-I and transforming-growth factor-β (TGF-β); 
- activation of the late response genes of our study (>6 h), which probably act downstream: IGF-I, 
IGFBP-2, MEPE, creatine-kinase (muscle) and troponin-C; 
- finally, this will result in bone formation by the osteoblasts 
In our study, especially the endocortical osteocyte is very mechanosensitive. Mechanical loading could directly and 
indirectly modulate the gene activity finally resulting in bone formation. The most components, which are 
mentioned in this scheme, are members of different pathways; however, IGF-I will need the presence of IGFBP-2 
to form bone after mechanical stimulation. 
BONE 
FORMATION 
MECHANICAL 
LOADING 
Osteoblast 
Late response genes > 6h 
IGF-I ↑ 
IGFBP-2 ↑ 
MEPE ↑ 
Creatine-kinase ↓ 
Troponin-C ↓ 
Early response genes 1h-6h 
ecNOS ↑ 
COX-2 ↑ 
c-fos ↑ 
IGF-I ↑ 
TGF-β ↑ 
Immediate response genes <1h 
G6PD ↑ 
cAMP ↑; cGMP ↑ 
NO ↑ 
PGE2 ↑ 
Osteocyte 
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LIMITATIONS OF THIS STUDY  
 
Animal model: Rat or Mouse? 
 
In our study design the Wistar rat was used as animal model despite the fact that the 
microarray slides for rats consist of 5000 genes, whereas the mouse microarray slides 
allow exploring 22000 genes at once. The minimal amount of total RNA, which was 
necessary for the microarray analysis, was fifteen microgram. This implies that pooling 
or amplification of the RNA of the mouse tibia is inevitable, in contrast to the rat 
tibia, which provides the minimal necessary amount RNA per tibia. For both species, 
different mechanical loading models have been developed, for example the four-point 
bending system and the ulna model. In conclusion, the rat was chosen as model, 
because the use of non-pooled and non-amplificated tibia RNA. 
 
Mechanical loading model: four-point bending or ulna model? 
 
An advantage of the four-point bending model is the non-invasive application of a 
mechanical load to the tibia resulting in bone formation 5-8 days after loading 
(Forwood et al. 1996; Forwood et al. 1998). Besides the magnitude of the force, 
frequency, duration and total cycles of the loading can be adjusted. The bone 
formation consists of lamellar and woven bone formation. Lamellar bone formation at 
the endosteal side of the shaft is characteristic for normal bone formation. 
Unfortunately, woven bone is formed at the periosteal side of the shaft and consists 
of non-lamellar bone with a random arrangement of collagen fibers.  
An alternative for the four-point bending model is the non-invasive rat ulna 
model, an axial-compression model, in which no woven bone formation at the 
periosteal side of the ulna is observed. Like the four-point bending model the ulna 
model provides a high degree control over the magnitude of the force, frequency, 
duration and total cycles of loading. However, a main limitation of this model is the 
lack of a sham-loaded control. 
The four-point bending model was used in this study, because several 
characteristics of this model are well described in the literature such as the 
adjustments of different forces, frequency and cycle numbers and their effects on 
bone formation, strain distribution, bone histomorphometry data and effects on 
cellular level and the possibility to use a sham-loading as control. 
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Mechanical loading: supra-physiological or physiological? 
 
During the experiment the force applied to the tibia during a single loading session 
was higher than the usual daily loading. The forces, which were applied to the tibia, 
were comparable to 29 times bodyweight (72 N ~ 7.2 kg; BWrat=250 g;), thus supra-
physiological loading or extreme impact loading. This is comparable to triple jumpers’, 
who experience a maximum resultant force at the knee joint of 24 times bodyweight 
(Heinonen et al. 2001). According to Frost’s mechanical usage windows, the applied 
load was between a mild overload window and the pathologic overload window 
(Frost 1992). The study was aimed to be supra-physiological, because we 
hypothesized that in gene expression is more sensitive to overloading conditions than 
normal mechanical usage. Supra-physiological loading will provide anchors for follow-
up studies with physiological loading, such as the rat-with-backpack in combination 
with in situ hybridization. 
 
Time-point: single time point 6 hours? 
 
The design was focused on a single time-point of 6 hours after loading. Before the 
start of this study a pilot experiment across a series of time-points with genes of the 
IGF-system as outcome was performed. This resulted in a peak mRNA expression of 
IGF-I mRNA expression in the tibia shaft 6 hours after loading (H.W. van Essen; 
personal communication) similar to the results of Lean and colleagues who also 
reported an upregulation of IGF-I mRNA expression in osteocytes within 6 hours 
after invasive loading (Lean et al. 1995; Lean et al. 1996)(Table 7.1; Table 7.2). As 
shown in Table 7.1 and Table 7.2, most studies were performed within the 0-1 hour 
time frame. To address the underlying mechanism of the osteogenic response the 
present study was focused on changes on mRNA level 6 hours after mechanical 
stimulation. In addition, in a practical perspective this in vivo four-point bending model 
was not developed to study early responses (<5 min). A single period of stimulation 
was preferred above repetitive loading sessions due to the accumulation of 
mechanosensitive responses during repetitive loading. 
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CONCLUDING REMARKS 
 
In conclusion, this non-invasive mechanical loading study showed that the 
simultaneous presence of IGF-I and IGFBP-2 in the endocortical osteocytes is 
necessary for the bone formation after mechanical loading at the endosteal side of the 
tibia. Thus, the endocortical osteocytes translate mechanical stimuli into bone 
formation through IGF-I in presence of IGFBP-2. In addition, this study presented 
newly identified mechanosensitive genes, i.e. matrix extracellular phosphoglycoprotein 
(MEPE), which was upregulated after bending, and creatine kinase (muscle) and 
troponin-C, which were downregulated after bending, in a microarray study with non-
pooled and non-amplificated tibia RNA samples. 
A part of the underlying mechanism of the osteogenic response has been 
elucidated in this study. The osteocytes at the endosteal side of the shaft have shown 
to be mechanosensitive 6 hours after loading, which is shown by transduction of the 
signal via IGF-I, IGFBP-2, MEPE, creatine kinase (muscle) and troponin-C, and will 
finally result in bone formation. Those mechanosensitive genes provide new insight 
into the osteogenic response and could be potential candidates for the development 
of new tools for the treatment of osteoporosis and other bone diseases. 
In addition, IGF-II overexpression modulates spatially IGFBP-2 mRNA 
expression in hIGF-II Tg mouse brain, but did not alter the growth of the brain. 
 
SUGGESTIONS FOR FUTURE RESEARCH  
 
A follow-up study based on the results of the experiments described in this thesis 
might be focused on MEPE, creatine kinase (muscle) and troponin-C. At first it is 
interesting to determine the local effects on cellular level with in situ hybridization and 
immunohistochemistry after a single mechanical loading session. This could be 
followed by studies in which the mechanosensitive gene is labeled with a radio-active 
label and followed in time and/or silencing RNA studies. 
 
Since the four-point bending model is a supra-physiological model application 
of the mechanosensitive genes in a more physiological model such as the rat-with 
backpack would be a step forward. However, in the rat-with-backpack model early 
and late responses occur sidewise and the response has to be investigated in all long 
bones since it is unknown in which the strain is the largest. 
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Idealistically to unravel the mechanosensitive mechanism it would be advisable 
to study the effect of a single period of mechanical loading at multiple time-points 
after stimulation in the following time frame: t=0 (onset of loading) until bone 
formation (5-8 days after loading). The sampling will take place in a continuous way 
for example at 30 min, 1 h, 2 h, 4 h, 6 h, 12 h, 24 h, 48 h, 72 h (3 days), 96 h (4 days), 
120 h (5 days), 144 h (6 days), 168 h (7 days) and 192 h (8 days) after loading with the 
four-point bending system. The microarray technique could be used at first as a 
screening method at these time-points. It will give insight into the cascade of 
mechanosensitive mediators (pathways). In addition, real-time rt-PCR analysis and in 
situ hybridization studies could be used to study the mechanosensitive mediators in 
more detail. Parallel to these molecular biologic techniques bone histomorphometry 
measurements has to be done to investigate the bone formation after mechanical 
loading. Finally, the ultimate goal will be to develop a treatment in which bone 
formation is stimulated locally in the bone cells at the place of bone loss. 
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GENERAL SUMMARY 
 
The ability of the skeleton to form bone after mechanical stimulation is a multi-
factorial process, which consists of mechanosensing (i.e. the detection of a mechanical 
stimulus), mechanotransduction (i.e. the translation of a mechanical stimulus into a 
biochemical process) and the bone formation response. It is well-known that 
osteocytes function as mechanosensors via canalicular processes and communicating 
gap junctions in the early stage of bone remodeling. Many biochemical signal 
molecules are involved in mechanical transduction, finally resulting in bone formation. 
 The aim of this study was to determine the cellular localization of 
mechanosensitive genes and to identify new genes which are involved in bone 
formation 6 hours after a single mechanical loading session. Localization and 
identification of those mechanosensitive genes may provide new tools for the 
treatment of osteoporosis and other bone diseases. 
 The non-invasive four-point bending model of Forwood and Turner induces 
bone formation 5-8 days after a single loading session. Loading induces compression at 
the lateral side of the tibia shaft and tension at the medial side of the tibia shaft. 
Lamellar bone is formed by the osteoblasts at the endosteal side of the loaded tibia 
shaft, while woven bone is formed at the periosteal surface. Loading of the tibia will 
result in bending and squeezing of the tibia shaft and sham-loading of the tibia will lead 
only to squeezing of the tibia.  
In Chapter 3 an increase of IGF-I mRNA synthesis is shown in the 
endocortical osteocytes of loaded tibia 6 hours after a single period of mechanical 
loading. The 2-fold increase of IGF-I mRNA expression was restricted to osteocytes 
at the endosteal side of the shaft and inner lamellae. Loaded tibiae exhibited a higher 
number of IGF-I mRNA positive osteocytes within multiple endosteal lamellae than 
the non-loaded contra-lateral control tibiae, whereas sham-loaded tibiae showed a 
similar pattern of IGF-I mRNA expression in sub-endocortical osteocytes as the non-
loaded contra-lateral control tibia. We concluded that the increase of IGF-I mRNA 
expression in the osteocytes is a consequence of bending, because squeezing of the 
tibia during sham-loading did not influence the IGF-I mRNA expression pattern. 
Endogenous IGF-I mRNA was expressed in trabecular and cortical 
osteoblasts, some trabecular and sub-endocortical osteocytes, intracortical 
endothelial cells of blood vessels and periosteum. Megakaryocytes, macrophages and 
myeloid cells also expressed IGF-I mRNA. In the growth plate, IGF-I mRNA was 
located in proliferative and hypertrophic chondrocytes. Mechanical loading did not 
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affect the IGF-I mRNA expression in osteoblasts, bone marrow cells and 
chondrocytes.  
In Chapter 4 a single loading session was shown to increase the number of 
IGFBP-2 mRNA expressing osteocytes at the endosteal side of the shaft and inner 
lamellae after loading (bending)(1.68-fold) and sham-loading (squeezing)(1.35-fold) of 
the tibiae 6 hours after loading in vivo.  
Endogenous IGFBP-2 mRNA was expressed in trabecular and cortical 
osteoblasts, some trabecular and subendocortical osteocytes, intracortical endothelial 
cells of blood vessels and periosteum. Megakaryocytes, macrophages and myeloid cells 
of the bone marrow and the proliferative and hypertrophic chondrocytes of the 
growth plate also expressed IGFBP-2 mRNA. Loading and sham-loading of the tibiae 
did not affect the IGFBP-2 mRNA expression in osteoblasts, bone marrow cells and 
chondrocytes. 
In combination, Chapter 3 and Chapter 4 show that the presence of IGF-I 
and IGFBP-2 within the endosteal osteocytes is required for lamellar bone formation 
at the endosteal side of the tibia shaft after mechanical stimulation. 
Chapter 2 shows the effect of IGF-II overexpression on the components of 
the IGF-system in mouse brain tissue. IGFBP-2 mRNA expression is 10-fold 
upregulated by the hIGF-II transgene in the medulla oblongata. The brain was also 
used as positive control tissue in the tibia studies of Chapter 3 and Chapter 4 for 
the IGF-system components. 
The descriptive study of Chapter 5 presents the endogenous gene 
expression profile in rat tibia measured with oligonucleotide microarray analysis. 
Collagen alpha-1 type I, collagen alpha-2 type I, osteonectin, osteocalcin, major beta 
globin, hemoglobin alpha and beta chain and ribosomal related genes were highly 
expressed genes relative to the housekeeping gene (GAPDH) in normal rat tibia. 
Osteopontin and MEPE (matrix extracellular phosphoglycoprotein; synonym of 
osteoregulin) exhibited a moderately increased endogenous expression in rat bone. 
The bone matrix consists of collagen and non-collagenous proteins. Reticulocytes, 
which are present in blood vessels and the bone marrow, do have mRNA, in contrast 
to the mature erythrocytes and hemoglobin. In conclusion, we suggest that the 
isolated cortical shaft mRNA has a high quality and consists mainly of specific bone 
matrix genes and reticulocyte genes of the intracortical blood vessels; however, 
contamination with some bone marrow cells can not be excluded. 
In Chapter 6 the effect of a single mechanical loading session on the 
expression of multiple genes at once was examined in vivo in rats using microarray 
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technology. This in vivo study showed differential gene expression in non-pooled and 
non-amplificated samples of rat tibia RNA 6 hours after mechanical stimulation. 
Hybridization of cDNA of loaded or sham-loaded tibia versus cDNA of contra-lateral 
control tibia of the same rat was performed. Compared to the contra-lateral control 
tibia, the loaded tibia exhibited a significant upregulation of the following genes: MEPE, 
Garnl1, putative pheromone receptor V2R2B and isolate QFG-TN1 olfactory 
receptor. Furthermore, five genes were significantly downregulated i.e. creatine kinase 
(muscle form), fibrinogen B beta polypeptide, monoamine oxidase A, troponin-C and 
kinesin light chain C. A similar trend was shown in the indirect comparison of the 
loaded tibia with the sham-loaded tibia; however, these effects were not statistically 
significant due to the substantially reduced power of this comparison and the limited 
number of samples. The validation study with real-time rt-PCR analysis confirmed the 
upregulation of MEPE and the downregulation of creatine kinase (muscle form) and 
troponin-C in the loaded tibia compared to the contra-lateral control tibia 6 hours 
after a single mechanical stimulation. In addition, a downregulation of phosphate 
regulating neutral endopeptidase on the X chromosome (X-linked hypophosphatemia 
XLH)(PHEX) was shown in the contra-lateral control tibia of the loaded group. 
Chapter 6 shows that MEPE is enhanced in loaded tibia 6 hours after a single 
mechanical loading session and Chapter 5 describes that the ratio of endogenous 
MEPE expression relative to the housekeeping gene, glyceraldehyde-3-phosphate 
dehydrogenase (GAPDH), is 1.53. Therefore, we conclude that the functionality of a 
gene is dependent on the ability to induce an increase or decrease of the basal mRNA 
expression level and is not dependent on the basal amount of endogenous mRNA. 
Taken together, a single mechanical stimulation leads to an upregulation of 
IGF-I, IGFBP-2 and MEPE and a downregulation of creatine kinase (muscle) and 
troponin-c in the osteocytes of the tibia shaft 6 hours after loading, which finally 
results in bone formation. These mechanosensitive genes provide new insight into the 
mechanism of the osteogenic response and the treatment of osteoporosis and other 
bone diseases. 
 Algemene samenvatting 
 179 
ALGEMENE SAMENVATTING 
 
Het skelet heeft de mogelijkheid om zich aan te passen aan de mechanische krachten 
die erop uitgeoefend worden. Wanneer bot mechanisch gestimuleerd wordt, zal dat 
leiden tot botvorming. Dit is een proces dat bestaat uit meerdere stappen, te weten: 
mechanosensitiviteit (het waarnemen van de mechanische belasting), 
mechanotransductie (het omzetten van het mechanische signaal in een biochemisch 
proces) en ten slotte de botaanmaak. De osteocyten (de botcellen die gelegen zijn in 
de botmatrix) hebben als belangrijkste eigenschap dat ze in staat zijn de mechanische 
belasting waar te kunnen nemen, daarom worden zij ook wel mechanosensoren 
genoemd. Bij de mechanotransductie zijn vele biochemische stoffen betrokken, die 
uiteindelijk ervoor zorgen dat het mechanische signaal wordt vertaald in botvorming. 
 
De doelstelling van dit promotie-onderzoek was om enerzijds de locatie van 
mechanosensitieve genen in bot vast te stellen en anderzijds om nieuwe genen te 
identificeren welke betrokken zijn bij de botvorming 6 uur na een kortdurende 
mechanische belasting. Wanneer men het proces van botvorming na mechanische 
belasting beter begrijpt, dan kan dat uiteindelijk leiden tot nieuwe inzichten voor de 
huidige behandeling van osteoporose (botontkalking) en andere botziekten. 
 
Het niet-invasieve 4-puntsbuigmodel, welke is ontworpen door Forwood en Turner, 
induceert botvorming 5 tot 8 dagen na een eenmalige mechanische belasting van de 
tibia (scheenbeen) van een rat. Bij het buigen wordt de laterale zijde van de tibia 
samengedrukt en de mediale zijde opgerekt. Het samendrukken leidt tot botvorming. 
De osteoblasten (de botvormende cellen) aan de endostale zijde (binnenkant) van de 
mechanisch gestimuleerde schacht vormen lamellair bot, terwijl aan de periostale zijde 
(buitenkant) van de schacht onregelmatiger bot (vezelbeen) gevormd wordt. Wanneer 
de tibia belast wordt met het 4-punts-buigapparaat, zal dat leiden tot buiging van de 
tibia met als bijeffect knijpen. Daarom wordt bij de controle rat de tibia alleen 
geknepen. 
 
In hoofdstuk 3 wordt een verhoging van de productie van insuline-achtige 
groeifactor-I (IGF-I mRNA) aangetoond in de belaste tibiae 6 uur na een eenmalige 
mechanische belasting. Deze 2-voudige toename is gelokaliseerd in de osteocyten, die 
verspreid liggen in meerdere lagen lamellen aan de endostale zijde van de schacht. De 
controle-belaste (geknepen) tibiae en de contralaterale controle tibiae (die helemaal 
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niet zijn belast) hebben enkel IGF-I positieve osteocyten die gelegen zijn in de eerste 
lamellaire laag van de endostale zijde van de schacht. Concluderend, de IGF-I mRNA 
toename in de osteocyten is een gevolg van buigen van de tibia, aangezien knijpen van 
de tibia door middel van sham-belasting geen veranderingen in de IGF-I mRNA 
productie laat zien. 
Endogeen IGF-I mRNA komt tot expressie in trabeculaire en corticale osteoblasten, 
enkele trabeculaire en sub-corticale osteocyten, intra-corticale endotheelcellen van 
bloedvaten en het periosteum. Beenmergcellen zoals megakaryocyten, macrofagen en 
myeloide cellen laten ook expressie van IGF-I mRNA zien. In de groeischijf komt IGF-I 
mRNA endogeen tot expressie in de proliferatieve en hypertrofe chondrocyten. 
Mechanische belasting heeft geen effect op de endogene IGF-I mRNA expressie in de 
osteoblasten, noch in de beenmergcellen en chondrocyten. 
Hoofdstuk 4 toont een verhoging van het aantal osteocyten die positief zijn voor het 
IGF-bindingseiwit-2 (IGFBP-2) in de osteocyten in meerdere lamellen aan de endostale 
zijde van de schacht na zowel buigen als knijpen. 
Endogene IGFBP-2 mRNA expressie is aangetoond in trabeculaire en corticale 
osteoblasten, sommige trabeculaire en subendocorticale osteocyten, intracorticale 
endotheelcellen van bloedvaten en in het periosteum. Bovendien komt IGFBP-2 
mRNA tot expressie in beenmergcellen en in de proliferative en hypertrofe 
chondrocyten van de interne groeischijf. Belasting leidt niet tot verandering van de 
IGFBP-2 mRNA expressie in osteoblasten, beenmergcellen en chondrocyten. 
Samen laten hoofdstuk 3 en hoofdstuk 4 zien dat de aanwezigheid van zowel IGF-I 
mRNA als IGFBP-2 mRNA in de subcorticale osteocyten aan de endostale zijde van 
de schacht nodig is voor lamellaire botvorming aan de endostale zijde van de tibia 
schacht na mechanische belasting.  
In hoofdstuk 2 wordt het effect van IGF-II overexpressie op de componenten van 
het IGF-systeem beschreven in de hersenen van IGF-II transgene muizen. Het IGF-II 
transgen is instaat om de IGFBP-2 mRNA expressie in de medulla oblongata 10-maal 
te verhogen. In hoofdstuk 3 en hoofdstuk 4 zijn de hersenen als positief 
controleweefsel gebruikt voor de componenten van het IGF-systeem. 
 
De beschrijvende studie van hoofdstuk 5 laat het endogene genexpressie profiel van 
de ratten tibiae zien. In normale, niet-belaste tibiae komen collageen alpha-1 type I, 
collageen alpha-2 type I, osteonectine, osteocalcine, major beta-globine, hemoglobine 
(alpha en beta keten) en ribosomaal gerelateerde genen hoog tot expressie ten 
opzichte van het huishoudgen (GAPDH). De botmatrix toont een middelmatige 
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expressie van osteopontine en MEPE (matrix extracellulaire phosphoglycoproteine; 
synoniem voor osteoreguline). We kunnen concluderen dat het geïsoleerde RNA uit 
de corticale schacht van hoge kwaliteit is en hoofdzakelijk bestaat uit genen, die 
specifiek in de botmatrix voorkomen en daarnaast uit genen, die voorkomen in 
reticulocyten van de intracorticale bloedvaten. Echter contaminatie met enkele 
beenmergcellen kan niet worden uitgesloten. 
Met behulp van de microarray techniek kunnen veranderingen in duizenden genen 
tegelijkertijd geanalyseerd worden. In hoofdstuk 6 is er gebruik gemaakt van deze 
techniek om antwoord te kunnen geven op de vraag welke genen betrokken zijn bij 
botvorming 6 uur na een kortdurende belasting in de ratten tibiae. Deze in vivo studie 
toont aan dat er verschillende genen verhoogd of verlaagd tot expressie komen in de 
tibiae 6 uur na mechanische belasting. Tibia monsters van de belaste ofwel controle-
belaste tibia werden gehybridiseerd met de eigen contralaterale controle tibia op een 
microarray, waarop duizenden stukjes genen zijn aangebracht. Deze studie laat zien 
dat er een significante toename is in de belaste tibiae ten opzichte van de 
contralaterale controle tibiae van MEPE (osteoreguline), Garnl1, pheromone receptor 
V2R2B en QFG-TN1 olfactory receptor en een significante afname van creatine kinase 
(spiervorm), fibrinogeen B beta polypeptide, monoamine oxidase A, troponine C en 
kinesine light chain C. Een soortgelijke trend is zichtbaar wanneer de belaste tibiae 
worden vergeleken met de controle-belaste tibiae, echter deze trend is niet 
significant. Dit wordt onder andere veroorzaakt door een gering aantal monsters en 
doordat het een indirecte vergelijking is. De verhoging van MEPE en de verlaging van 
creatine kinase (spiervorm) en troponine C in de belaste tibiae ten opzichte van de 
onbelaste tibiae 6 uur na mechanische belasting zijn in deze studie bevestigd met de 
real-time rt-PCR analyse.  
Hoofdstuk 6 laat zien dat MEPE verhoogd is in belaste tibiae 6 uur na een eenmalige 
mechanische belasting en hoofdstuk 5 geeft aan dat de endogene MEPE expressie ten 
opzichte van het huishoudgen, 1.53 is. Hieruit kunnen we concluderen dat de 
functionaliteit van een gen afhankelijk is van de capaciteit om de basale mRNA 
expressie te verhogen dan wel te verlagen. 
 
Samenvattend, de experimenten, die in dit proefschrift zijn beschreven, tonen aan dat 
IGF-I, IGFBP-2 en MEPE betrokken zijn bij de botvorming na mechanische belasting, 
terwijl remming van creatine kinase (spiervorm) en troponine C eveneens een rol 
speelt bij de osteogene respons. Deze mechanosensitieve genen verschaffen een 
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nieuw inzicht in het mechanisme van de botvorming na mechanische belasting en in de 
huidige behandeling van osteoporose en andere botziekten. 
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bedanken. 
 
Het team met vaste expeditieleden bestond uit prof.dr. Paul Lips, prof.dr. Rien 
Blankenstein en dr. Nathalie Bravenboer. Beste Paul, je hebt me te allen tijde weten te 
stimuleren en inspiratie gegeven. Ook heb je me in de gelegenheid gesteld tot het 
bezoeken van diverse congressen en cursussen in het buitenland. Beste Rien, jij was 
ook al aanwezig bij mijn afstuderen en hebt me nu begeleid tijdens mijn promotie met 
je altijd gezonde kritische blik. Beste Nathalie, jij zorgde voor een goede persoonlijke 
ondersteuning en was goed bereikbaar, wat ik zeer waardeerde. 
 
Bij de geslaagde toppoging ben ik ondersteund door de leden van de leescommissie 
bestaande uit: dr. Sylvia van Buul-Offers, prof.dr. Jaap van Dieën, prof.dr. Jenneke 
Klein-Nulend, dr. Hans van Leeuwen, prof.dr. Coen Netelenbos en prof.dr. Tim 
Skerry. Ik wil u allen hartelijk bedanken voor het kritisch lezen van mijn proefschrift. 
 
Andere vaste deelnemers tijdens de expeditie waren Annechien Tromp, Angela 
Oostlander, Huib van Essen, Paulien Holzmann en Birgitte van Rens. Beste Annechien, 
jarenlang zaten we in dezelfde tent en als foeragering hadden we de befaamde 
“aio-koekjes”. Beste Angela, je kwam als studente binnen en bent nu een zeer goede 
promovendus. Zet hem op! Beste Huib, je hebt veel “polymerase chain reactions” 
uitgevoerd ofwel je hebt meerdere kettingen verankerd na de microarray passage. 
Beste Paulien, jij deed het verfijnde werk en hebt samen met mij vele coupes 
gesneden. Beste Birgitte, jij hebt mede geholpen met het navigeren tijdens de analyse 
van microarray studie. Halverwege de expeditie kwam Farien Bhoelan die me, tijdens 
haar stage, een tijdje geholpen heeft met een aantal in situ hybridisaties. 
 
Aan het begin van de expeditie ben ik in de gelegenheid geweest om de fijne kneepjes 
van het in situ werk (in situ PCR) te leren bij de Manchester Musculoskeletal Research 
Group van Judith Hoyland met praktische begeleiding van Pauline Baird in Manchester 
te Groot-Brittannië. 
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Een vast baken tijdens de tocht waren de leden van het “Endo-lab team”, die ook zeer 
vele andere expedities ondersteunen. Een aantal van hen wil ik bij name noemen: 
Marie Lomecky, voor alle bestellingen tijdens de reis, Jeany Huijser, voor de mentale 
interesse en steun, Frans Martens, voor de digitale ondersteuning, Glenn van Heck 
voor de IGF-I serum bepaling en hun aanvoerders Corrie Popp en Hilde Dijstelbloem. 
Bij het “Endo-lab team” kon je bijtanken tijdens de koffiepauze.  
 
Op het basiskamp bij de buigexperimenten heb ik hulp gekregen van de leden van het 
KDL (klinisch dierenlaboratorium): Ger Vink, Esther Lok, Suzanne Bonne en Paula 
Mul. Om de kracht te kunnen meten tijdens het buigexperiment op het basiskamp zijn 
Theo Smit, Albert van der Veen en Micha Paalman ingeschakeld en zij hebben het 
krachtmeter apparaat ontwikkeld. 
 
Gedurende de expeditie moesten er beenmergcellen worden gekarakteriseerd en 
hierbij heb ik uitstekende hulp ontvangen van patholoog prof.dr. Paul van der Valk. 
 
Later in de expeditie zijn er microarray experimenten door mij uitgevoerd op de 
microarray faciliteit. Leden van het “microarray-team” waren Bauke Ylstra, Mark van 
de Wiel, Paul van den IJssel, Paul Eijk, Marianne Tijssen en Erik Hopmans. 
 
Daarna heeft Hans van Beek het kompas in handen genomen en geweldig de 
statistische analyse van de microarray uitgevoerd. 
 
Tijdens dat deel van de expeditie kwam ik mede-microarrayers tegen van wie ik ook 
ondersteuning gekregen heb: Jacqueline Cloos, Renske Steenbergen, Saskia Wilting, 
Jilian de Wilde en Henk Buermans. 
 
Daarnaast waren er tijdens de expedities een aantal vaste kampen: het lab op 4D met 
de diverse afdelingsgroepen en de gang in de Meander. Natuurlijk waren de mensen 
daar ook een ondersteuning, waaronder leden van o.a. het “kinder-endo team” met 
Tamara Prins, Floor Remmers en wijlen Mariann Fodor, het “derma team” met Sander 
Spiekstra, Melanie Breetveldt, Heleen Moed en Mascha Toebak, het “HOI team” met 
Josefien Vink en Richard Broekhuijzen, het “KNO team” met Serge Smeets en Janny 
Dijkstra en van het “ELFO team” Simone Span. 
 
Dankwoord  
186 
Ontspanning tijdens inspanning is ook belangrijk. Daarom wil ik alle expeditieleden en 
vrienden van VAMOS, FLENS (dwarsfluitensemble) en het NJK (Nationaal 
Jongerenkoor) inclusief hulptroepen danken voor de vele uren muziek maken tijdens 
deze tocht. Ook Maaike de Jong en David Eijlander wil ik hierbij noemen. 
 
Tijdens het allerlaatste deel van deze expeditie zal ik steun krijgen van mijn paranimfen 
Angela Oostlander en Hilde Stolker. 
 
Tot slot word ik op al mijn expedities geweldig ondersteund door mijn lieve ouders 
en lieve zus. Erg fijn om deel uit te maken van zo’n hecht team. Een unicum: een vader 
die ter ontspanning met je gaat langlaufen op de “Hoher Knochen” (hoe toepasselijk!) 
en gaat skaten in Barcelona, een moeder die je helpt met doorzetten en alle kracht 
geeft welke je nodig hebt voor onderweg en een zus die het volste vertrouwen in je 
heeft dat je de top gaat halen. Ik heb bewondering voor jouw doorzettingsvermogen! 
 
Uiteindelijk is deze toppoging geslaagd! Met hulp van de ervaring die iedereen in zijn 
rugzak als bagage meedroeg op deze expeditie, is dit proefschrift tot stand gekomen. 
Ik wil mijn waardering uitspreken voor de inzet van een ieder en iedereen heel 
hartelijk danken voor de ondersteuning tijdens deze expeditie. Gelukkig waren er 
onderweg geen gebroken botten en hebben we voldoende lichaamsbeweging gehad! 
Op naar de volgende top! 
 
 
 
 
 Dankwoord 
 187 
 
